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ABSTRACT
GENOME INTEGRITY AND CELL DIVISION:
NEXT-GENERATION ANSWERS TO ENDURING QUESTIONS
Jacob Joseph Paiano
André Nussenzweig

Studies of genome integrity have been historically limited to low-resolution tools that afford littleto-no information on precise genomic locations of DNA damage. Because many sources of
genomic instability begin with endogenous DNA breaks at specific genetic sequences, it is
possible to develop new, next-generation sequencing approaches to understand classic
cytological observations in the field of DNA repair. I have employed here protocols to map DNA
breaks (END-seq) and nascent DNA synthesis (EdU-seq) to address mechanisms of genomic
instability during both meiosis and mitosis. Cell division presents unique challenges to genome
integrity. During meiosis, the enzyme SPO11 generates intentional, requisite DNA breaks to
initiate meiotic recombination and homologous chromosome synapsis. In contrast, DNA damage
during mitosis is primarily used to prevent deleterious outcomes that have been implicated in
cancer and age-related pathologies. I have utilized and modified next-gen technologies to
address numerous unanswered mechanisms of fragility and repair during both meiosis and
mitosis. While it is common to think of DNA repair as evolved processes that combat
environment-derived damage, these studies in cell division, a process that relies on inducing and
repairing damage, illustrate a different evolutionary perspective in which damage and repair are
also controlled pathways to maintain and adapt genomes across the tree of life.
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PREFACE

I approached my graduate training with a definitive interest in immunology; however, my
primary goal as a graduate student was to explore who I was, and who I could become, as a
scientist beyond just subject matter. I was initially drawn to the immune system as a series of
effectual communications between cells that maintain tissue integrity and host identity. I had
spent three years prior as a research assistant studying complement protein signaling in B cells
during class switch recombination and systemic lupus erythematosus. Admittedly, this was an
esoteric, if not slightly bizarre, research question, as complement proteins are rarely considered
in adaptive immune responses. Despite this, I was fascinated by the evolutionary cooperation of
innate immune signaling components and lymphocyte viability and activation. My experiments
pushed me to think beyond the biology as defined by textbooks and fostered a strong scientific
curiosity as I entered graduate school.
Wishing to continue my studies of B cell class switch recombination, I rotated in the
laboratory of Dr. André Nussenzweig at The National Institutes of Health in Bethesda, MD. My
rotation project focused on the interplay of nonhomologous end-joining factors that were recruited
to sites of DNA damage during class switch recombination. The localization of these proteins, and
all DNA repair proteins, is highly contextualized based on the type of damage and recognition by
the cell. Signaling cascades result in chromatin and protein modifications that ultimately
determine the fate of DNA lesions. Returning to my immunology laboratory rotations and
coursework at The University of Pennsylvania, I was constantly reminded of what I studied at
NIH. The contextual recruitment of immune cells to tissue damage appeared thematically similar
to protein repair of DNA damage. The activities of DNA repair complexes and immune cells
seemed to follow analogous trajectories: damage-specific recognition, computation of contextual
information, directed repair pathway choices, further intentional damage and processing
surrounding the insult in a controlled manner, and eventual repair of the injury—for better or for
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worse. I realized that these parallels exist as means to establish, maintain, and modify biological
identity (or as an immunologist may refer to it, self) from genome to organism.
In Chapter 5, I attempt to address these ideas and discuss how biological identity might
be viewed, through both DNA repair and immunity, in the context of evolution and multifaceted
disease phenotypes. I also argue that this is more significant than a mere philosophical exercise.
New perspectives can influence our approaches to many active research areas. Consider cancer
and aging: both are driven largely by the dramatic loss of genomic and tissue identity. To better
understand these complex diseases that develop over time, we can start by asking what are the
inherent flexibilities in modulating biological identity and at what point does it become “disease”? I
believe these are important questions to ask ourselves as we rapidly advance into a new era of
medicine that will include genetic engineering and integration of inorganic materials. The best
advancements will consider the fundamentals of the systems to be modulated, once those
fundamentals are well established.
In Chapters 1 through 4, I more specifically discuss my graduate research on genome
integrity and cell division. I was drawn to cell division because of its complexity and importance.
DNA damage during division can be both beneficial (sometimes requisite) and deleterious. This
duality captured well what I wanted to learn from genome integrity maintenance: the good, the
bad, and the ugly, so to speak. Moreover, when I joined, the Nussenzweig Lab had recently
developed powerful next-generation sequencing methods that allowed us to address various
enduring questions that had been waiting for higher resolution techniques to answer. Cell
division, both meiosis and mitosis, have many of these enduring questions, including
mechanisms of meiotic recombination and site-specific mitotic fragility. Focusing my studies on
these questions and learning innovative technologies have given me a unique training that I will
use to continue asking important questions, from genome to organism.
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CHAPTER 1: Next-Generation Sequencing and the Need for Greater Resolution in
Studies of DNA Damage

The study of double-strand DNA breaks
DNA can be damaged in numerous fashions. Double-strand breaks (DSBs), in which the
backbone of both strands of DNA are cleaved at one site, are the most dangerous lesions for the
integrity of the genome (Ciccia and Elledge, 2010). Moreover, repair can be aberrant, and while
the DNA lesion no longer exists, the end product of repair can be deleterious for the health of the
cell. This is especially evident in cancers. For example, improper repair of multiple, simultaneous
DSBs could result in potentially oncogenic chromosomal translocations by inaccurately joining
breaks on different chromosomes (Ferguson and Alt, 2001). Once cancerous, cells experience
frequent genomic stresses that can overwhelm repair systems and result in continuous
generation of mutations that drive tumor heterogeneity, aggression, and chemotherapy resistance
(Gaillard et al., 2015; Macheret and Halazonetis, 2015; Foo and Michor, 2014). On the other
hand, these mutations may generate novel amino acid sequences that can be recognized by
immune cells as “neoantigens” to trigger antitumor responses (Schumacher et al., 2019). For
these reasons, understanding the multitudinous functions of DNA repair can provide new
therapeutic targets and research avenues for cancer treatments.
DNA damage has a plethora of roles outside of cancer in many disease contexts in which
genomic instability contributes to deleterious phenotypes, such as aging, degeneration, and
genetic disorders. While it is tempting to vilify DNA damage because of these associations, we
must also address the advantages of breaking DNA that cells routinely employ. Most famously,
the mechanism of natural selection relies on mutations in pre-existing allele sequences to confer
diversity in offspring and environmental fitness (Basener and Sanford, 2018; Hershberg 2015).
Most famously to immunologists, B and T lymphocytes rearrange their receptors via RAG-
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mediated DSBs to generate massive diversity in their ability to recognize pathogens (Jung and
Alt, 2004). Mature B lymphocytes continue to diversify their receptors in germinal centers of
lymphoid organs through AID-mediated DNA damage and mutations (Maul and Gearhart, 2010).
In fact, DNA damage is so physiologically prevalent that it can be studied in almost any topic of
cell research, such as chromatin organization, metabolism, and cell division (Canela et al., 2017;
Turgeon et al., 2018; Hustedt and Durocher, 2017).
Cell division presents several genomic challenges to cells as they must fully and faithfully
duplicate every chromosome, package them tightly, align them properly, segregate them fully,
and finally unpackage them into the same configuration as before division began (Sullivan and
Morgan, 2007; Batty and Gerlich, 2019). There are many enduring questions to these processes
to ultimately understand how genome integrity is maintained throughout the entirety of division. In
several ways, division utilizes DNA damage to efficiently package and segregate chromosomes,
as discussed throughout Chapters 2, 3, and 4. Most DSBs are purposefully induced, and repair is
tightly regulated to prevent gross chromosomal aberrations from forming during division. The
inherent risks to intentionally breaking DNA during division have resulted in many evolved
pathways to ensure genomic stability. While chromosomal activity during division has been
studied for over a century, there remain outstanding questions regarding the initiation,
processing, and resolution of these nuclear events, including the requisite roles for DNA damage
(Batty and Gerlich, 2019). Advances of the last few decades in microscopy methods have
identified many of the pathways and proteins critical to mediating damage and repair during
division. However, just as microscopy enhanced our resolution of molecular events on
chromosomes, further resolution at the level of nucleotide sequence is possible through nextgeneration sequencing (NGS) approaches. These emerging techniques have and will continue to
provide unprecedented detail of how cells maintain genome integrity in various contexts, including
division.
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Common methods and their limitations
Studies of DNA repair heavily rely on microscopy methods to visualize damage and
repair events in the nucleus. Immunofluorescence (IF), fluorescence in situ hybridization (FISH),
and other cytological approaches, such as metaphase spreads, are commonly used. IF and FISH
offer effective means to assess localization of repair proteins at sites of damage. Common protein
markers of DSBs are phosphorylated histone variant H2AX (γH2AX) and 53BP1 (Bonner et al.,
2008; Schultz et al., 2000). These proteins can be visualized as discrete foci of IF following DNA
damage. The numbers of foci and overall fluorescence intensity per nucleus are helpful
quantifications that reflect the extent of damage and repair in a given setting. Advances in superresolution microscopy continue to make IF studies attractive, even potentially probing at singlemolecule resolution (Sydor et al., 2015). Moreover, IF is quantified at a single-cell level, allowing
for observation of any biological heterogeneity that exists within the cell population. To increase
statistical robustness of these methods, several advances in high-throughput IF analysis can be
utilized, such as flow cytometry-based protocols or quantitative image-based cytometry (QIBC)
(Forment and Jackson, 2015).
While there are many advantages and appropriate uses for microscopy-based
techniques, the inherent lack of high resolution at the DNA level handicaps these methods for use
in genomic studies of DNA repair. IF cannot resolve precisely where in the genome damage
occurs. Other techniques, such as metaphase spreads, allow for visualization of aberrant
structures (fragmentations and translocations) or IF/FISH events on individual chromosomes
(Deng et al., 2003; Misenko and Bunting, 2014). This can be combined with chromosome
banding or chromosome painting techniques to enhance gross chromosomal resolution, but
information on which DNA sequences are broken is unavailable (Huang and Chen, 2017; Hua
and Mikawa, 2018). Nucleotide resolution (i.e. knowing exactly which nucleotides in the genome
are broken) grants critical insight into how DNA sequence, chromatin, nuclear architecture, and
processes such as replication and transcription influence damage and repair. Additionally, it can
be compared to mutational signatures in patients to better understand disease etiology and how
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DNA repair could be targeted for more efficacious treatments. With the advent of CRISPR-Cas9
genome engineering, it is of highest priority to thoroughly investigate precisely where damage is
induced, including potential off-targets throughout the genome (Adli, 2018; Pickar-Oliver and
Gersbach, 2019). Failure to do so may result in unwanted, deleterious consequences for
research models and, ultimately, patients (Zhang et al., 2015; Han et al., 2020). For these
reasons, and many more, the amount of information and detail obtained through NGS methods
provide exciting new research avenues to probe in vivo molecular events that maintain genome
integrity.

Next-generation mapping methods
NGS technology has illuminated chromosome biology for researchers to precisely map
many genomic features. Most commonly utilized is chromatin immunoprecipitation sequencing
(ChIP-seq) that can map histones and their modifications, transcription factors, and any other
protein that binds DNA, including DNA repair factors (Furey, 2012). Several studies have made
advantageous use of ChIP-seq to map DNA repair proteins at sites of damage, such as γH2AX,
53BP1, RPA, and MRE11 (Wienert et al., 2019; Purman, et al., 2019; Harrigan et al., 2011;
Clouaire et al., 2018; Shastri et al., 2018). While these data are very informative about general
features of DSBs, ChIP-seq methods are unable to map the precise nucleotide sequence where a
DSB occurs or the physical structure of the DSB. ChIP-seq applications are also limited in nonmodel organisms or for certain proteins in which high-quality antibodies are unavailable.
Over the years, several sequencing methods have been developed to directly or
indirectly detect DSBs in the genome without reliance on antibody detection. High-throughput,
genome-wide translocation sequencing (HTGTS) maps translocations occurring after DSB
induction at a specific site (Frock et al., 2015). While a powerful technique to map certain repair
events following damage, there are several limitations to using HTGTS as a means to study
DSBs. HTGTS detects mutagenic repair rather than the DSB itself, ultimately resulting in
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underestimation of DSB prevalence. A more direct approach is BLESS, and its newly modified
protocol BLISS, that detects unrepaired DSB ends (Crosetto et al., 2013; Yan et al., 2017).
BLESS/BLISS can be used with high degree of success to detects DSBs and their locations in an
unbiased manner; however, the data contain high background likely due to the fixation of cells,
making it difficult to detect rarer or less localized DSBs. Additionally, BLESS/BLISS do not give
insight into the end structures of DSBs and therefore cannot elucidate early processing events
during repair. Another method, S1-seq, bypasses the need for cell fixation, but relies on the
promiscuous enzymatic activity of the S1 nuclease to blunt DSB ends for detection (Mimitou and
Keeney, 2018). This may generate substantial noise in the sample preparation, but S1-seq has
been demonstrated to accurately map DSB locations, secondary DNA structures, and DSB end
structures associated with repair (Mimitou et al., 2017). Because S1 can act wherever ssDNA
exists, it may not be suitable for all experimental applications, such as studies of DNA damage
and replication stress in actively dividing cells.
Our lab has recently developed a technique, END-seq, to directly map DSBs and early
processing events of repair (Canela et al., 2016). END-seq is a highly sensitive method that can
map DSBs with nucleotide precision in the genome. Compared to coexisting techniques, ENDseq avoids cell fixation, protects DNA from artificial damage by preventing excessive handling
and pipetting, and utilizes a careful combination of exonucleases to specifically probe for DSB
end structures (see below). Thus, END-seq does not share many of the limitations of
contemporary methods (Wong et al., 2021). Since its inception in 2016, our lab has published
several major advances using END-seq in fields of chromatin organization, DNA replication, VDJ
rearrangement, and meiotic recombination (see Chapters 3 and 4) (Canela et al., 2016; Canela et
al., 2017; Tubbs et al., 2018; Shinoda et al., 2019; Paiano et al., 2020; Mahgoub and Paiano et
al., 2020). The applicability of END-seq is still being explored in many other areas of research
and will continue to elucidate critical aspects of both DNA repair biology and disease phenotypes
in diverse contexts.
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While any individual sequencing method can alone provide extraordinary detail to
genomic events, the true power of these data is most apparent when combining methodologies.
Consider the cellular processing of a simple DSB in a cell, such as a restriction enzyme break.
Multiple techniques can be applied in parallel to probe various aspects of processing and repair
simultaneously, broadening the scope of experimental inquiry. Figure 1 demonstrates three
distinct sequencing methods, END-seq, EdU-seq, and RPA ChIP-seq, to understand the role of
DNA synthesis in countering and balancing the nuclease processing of a restriction enzymeinduced DSB in a cell. The genetic background of this cell is deficient for the protein LIG4 and
thus cannot repair the DSB. Over the course of 18 hr, the cell will begin to digest the free ends of
the DSB, creating large 3’ overhangs that are coated by the RPA protein.
To balance this digestion, localized DNA synthesis occurs on the overhang to limit the
amount of ssDNA generated. EdU, an exogenously added thymidine analog, is incorporated by
polymerases in the cell at sites of synthesis, allowing for detection and sequencing after capturing
EdU-containing DNA (see below). This complex understanding of how synthesis acts locally at
unrepaired DSBs is possible through the lens of the combined techniques. Treating cells with the
ribonucleotide reductase inhibitor, hydroxyurea (HU), inhibits DNA synthesis by preventing the
production of deoxyribonucleotides (Chapman and Kinsella, 2012). In turn, this increases the
fraction of processed DSBs and ssDNA bound by RPA (Figure 1). This level of detail at the
nucleotide level, combined with the ability to aggregate signal genome wide for robust statistical
significance, is impossible to achieve by microscopy methods alone and demonstrates how nextgeneration sequencing methods are filling the need for greater resolution in DNA damage
studies. However, these technologies are not without their limitations, as discussed in detail
below.
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Figure 1. Employment of multiple sequencing methods to understand DNA synthesis at double-strand breaks (DSBs) in
G1 phase. Lig4–/– Abelson-transformed murine pre-B cells were G1-arrested and induced to express nuclear-localized
AsiSI restriction enzyme cutting for 18 hours in culture. Cells were concurrently given 20 uM EdU with or without 10 mM
hydroxyurea (HU) during AsiSI cutting to address the interplay of localized DNA synthesis and resection at DSBs. ENDseq, EdU-seq, and RPA ChIP-seq were simultaneously performed to measure DSB resection, nascent DNA synthesis,
and RPA-bound ssDNA overhangs, respectively. HU treatment decreased synthesis (EdU-seq), resulting in increased
resection (END-seq) and increased ssDNA (RPA ChIP-seq), suggesting that DNA polymerases can counteract resection
proteins at DSBs in G1.

END-seq method
END-seq is performed on unfixed cells, precluding artificial DNA breakage from the
fixation process. Moreover, to protect from mechanical damage, live cells are embedded in
agarose to limit direct DNA handling. After digesting all protein and RNA, the initial series of steps
labels all existing DNA ends (i.e. DSBs) with a custom biotinylated sequencing adapter.
Afterwards, the agarose is melted, and the DNA is sonicated into 200-400 nucleotide fragments.
Fragments previously labeled with the adapter are enriched through streptavidin capture, and a
library is prepared for single-read Illumina sequencing. Details of all steps are outlined in Figure 2
and Chapter 3.
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Figure 2. END-seq workflow. Figure borrowed from Wong et al., 2021. Briefly, live cells harboring DSBs are embedded
into agarose plugs, followed by protein and RNA degradation. Exonucleases blunt DSB ends, and biotinylated sequencing
adapters are ligated. After shearing, adapter-ligated fragments are enriched by streptavidin pulldown, and libraries are
prepped for Illumina sequencing. See Chapter 3 for more information.

The most critical step in END-seq is the blunting of DSB ends with exonucleases (Figure
2). To ligate an adapter, the DSB end must be fully blunted (i.e. no ssDNA overhangs). However,
virtually all DSBs arising in a cell will have some degree of ssDNA overhang due to either the
nature of the breakage itself or additional processing of the ends by cellular nucleases (Raynard
et al., 2008). This additional processing, referred to as end resection, is a purposeful mechanism
to degrade DNA and produce 3’ ssDNA overhangs for proper repair of DSBs, such as homology
directed repair pathways (Huertas, 2010; Katsuki et al., 2020). Because END-seq involves
blunting all DSBs and removing any overhangs, END-seq not only maps locations of DSBs but
also the extent to which DSBs are physiologically resected in the cell. Therefore, END-seq is a
powerful method to study the initial processing events of a DSB that govern which repair pathway
will ultimately be used.
END-seq typically employs consecutive reactions of two exonucleases, ExoVII and ExoT,
to blunt DSB ends. This is nontrivial, as ExoVII and ExoT act on similar but distinct DNA
substrates. We have recently exploited these substrate differences to detect specific DSB
structures, namely a DSB end covalently bound to a protein adduct such as topoisomerase II or
SPO11 (Canela et al., 2019). Because ExoVII can remove amino acids bound to DSB ends and
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ExoT cannot, comparing ExoVII+ExoT digests to ExoT alone grants valuable insight into the
prevalence of this class of DSB structure. This also permits a biochemical flexibility to tailor ENDseq to specifically probe for certain DSB structures over others. For example, DSBs harboring
covalently bound SPO11 protein in meiotic cells are more readily detectable using a combination
of purified TDP2 protein and ExoT digestion over ExoVII+ExoT (see Chapter 3). The in vitro
blunting of END-seq is therefore the most critical and customizable step for DSB detection.

END-seq limitations
While END-seq is a powerful technique that allows for unprecedented resolution of DSBs
in many biological contexts, there are several important limitations to consider when planning
experiments and interpreting results. The foremost concern is signal-to-noise in the sequencing
data, i.e. the number of reads mapping to DSBs of interest (signal) versus the number of reads
mapping to background DSBs (noise) contaminating the dataset. A great advantage of END-seq
over other DSB sequencing methods is the agarose embedding that precludes the need for
fixation and direct DNA handling, limiting background DSB generation. Because of this, we
estimate that a DSB occurring as infrequently as 1 in 10,000 cells in a population will be amplified
and sequenced by END-seq at a usable resolution (Canela et al., 2016). This is calculated based
on a spike-in DSB that can be added at a desired percentage to cells prior to agarose embedding
that allows for the quantification of a DSB within the population (see Chapter 3). However, this
also assumes that other conditions that could generate noise in the data are minimized, such as
apoptotic cells, DNA replication, and non-localized DSBs.
Fragmented DNA from dead cells could be recognized as DSBs by END-seq and
contribute substantially to background. This can impose limits on experimental design, as certain
treatments to induce DSBs may cause apoptosis. Additionally, this could hinder the ability of
END-seq to detect DSBs in tissue samples, as there may be significant cell death inherent to
some tissue preparation protocols. Ways to eliminate dead cells, such as Percoll or Ficoll
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centrifugations, can help prevent to apoptotic noise in data. More important than dead cell
contamination is how recurrent the DSB is at a unique DNA sequence within the population. For
example, if END-seq is performed on gamma irradiated cells, in which many DSBs will be
generated at random throughout chromosomes, the resulting sequencing data will only be
background noise. Even though DSBs are physically present and amplified by END-seq, to
generate signal over noise, at least 1 in 10,000 (perhaps more depending on other experimental
conditions) cells must have a DSB at the same location to amplify reads that will accumulate at
that genomic position. This can confound negative END-seq results when studying a new system
of DSB induction: either there are no/too few DSBs generated or they are not localized enough to
a specific location to amplify over noise. Because of these limitations, experiments should be
troubleshooted for the appropriate amount of starting material. More cells used to generate a
library will typically result in more signal; however, if significant background exists, simply more
input may not be enough and other changes to experimental design need to be considered, as
discussed above.
A very important limitation to consider is the actual DNA sequence of the DSB itself.
Many cases of DNA damage are associated with repetitive sequences of DNA that are difficult to
replicate through or may take secondary structures that are susceptible to nuclease breakage in
the cell (Madireddy and Gerhardt, 2017; van Wietmarschen et al., 2020). While DSBs at repetitive
sequences, such as LINE and SINE elements, telomeres, centromeres, and ribosomal DNA units,
are of high interest to the field of genome integrity, the nature of these sequences make it too
difficult to properly align data, as repetitive sequences can map to many places at once and are
discarded from computational analyses (Treangen and Salzberg, 2012; De Bustos et al., 2016).
Moreover, there are still many sequences in the genome that are unmappable simply because
there is no consensus sequence in the genome assembly yet, such as many parts of sex
chromosomes (Ross et al., 2020). Additionally, as END-seq relies on PCR amplification during
library preparation, sequence bias and polymerase errors during amplification can ultimately
affect the number of reads mapping to certain locations (Kebschull and Zador, 2015). As a
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control, an input library should always be generated to determine false positives and artifacts
created during PCR and sequencing amplification. Therefore, END-seq, like other methods, is
bound by the current limitations of NGS technologies that have the potential to influence data
interpretation, especially in new and unknown treatment conditions.

Potential future of END-seq
Although END-seq is a highly sensitive technique, at the moment it requires millions of
cells to generate one library. Thus, all data are representative of the location and processing
DSBs within a population. In most physiological contexts, this can result in vast heterogeneity in
DSB detection even at a single genomic site (see Chapter 3). A powerful move forward for ENDseq would be DSB detection at the single-cell level. This could theoretically be achieved by
combining END-seq with other single-cell sequencing protocols, such as single-cell whole
genome sequencing that employs linear amplification via transposon insertion (LIANTI) that
avoids PCR amplification (Chen et al., 2017). Another approach could be single-cell CUT&RUN
sequencing using protein fragments either known or engineered to bind free DNA ends of DSBs
(Skene and Henikoff, 2017; Kaya-Okur et al., 2019; Shee et al., 2013).
As discussed above, the initial end processing steps of END-seq permit adaptations to
probe for specific DSB species (e.g. DSBs with free ends versus DSBs with protein-bound ends).
This flexibility can theoretically be exploited to map non-DSB DNA structures as well, such as
aberrant replication fork structures and secondary non-B DNA structures that have important
implications for genome integrity. While there are several alternative approaches to detect DSBs,
there is a dearth of approaches to map these sorts of secondary structures at the nucleotide
level. A likely future for the END-seq method will involve combinatorial methodologies for
detecting specific DSB species and secondary structures.
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EdU-seq method
DNA replication in S phase cells presents unique challenges to genome integrity, as
replication stress can cause chromosomal breakage and mutations (Gaillard et al., 2015). It is
becoming increasingly popular to study DNA damage in the context of replication, as replication
stress in cancer cells has been shown to contribute to much of their characteristic genomic
alterations (Macheret and Halazonetis, 2015). While techniques such as END-seq can map
where and how DSBs are formed, it can also be highly relevant to map where replication is
occurring, especially as it may relate to the generation of DNA damage. A common method to do
so is EdU sequencing (EdU-seq) that involves in vivo labeling of nascent DNA synthesis using
exogenously added thymidine analog 5-ethynyl-2’-deoxyuridine (EdU) (Macheret and
Halazonetis, 2018; Tubbs et al., 2018). After cells are fixed, EdU incorporated sequences are
biotinylated through copper click chemistry. After sonicating the DNA, fragments containing
biotinylated EdU are enriched with streptavidin capture, and a library is prepped for Illumina
sequencing (see Chapter 2). Additionally, it is possible to denature DNA with sodium hydroxide
prior to PCR amplification to determine on which DNA strand synthesis occurred, further
enhancing resolution of physiological events.
Aside from studying replication activity in S phase cells, EdU-seq can interrogate any
situation in which DNA polymerases synthesize nascent nucleotide sequences. As shown in
Figure 1, this can be observed in non-replicative, G1-arrested cells at sites of DSBs. Localized
DNA synthesis by specific polymerases occurs at DSBs to facilitate proper repair, filling in any
remaining ssDNA gaps. In the case of Figure 1, EdU-seq can be used to ask how resection and
synthesis counteract each other distally from the DSB. As demonstrated in Chapter 2 and
described further below, EdU-seq can measure discrete regions of mitotic DNA synthesis
(MiDAS) associated with replication stress in cancer cells (Minocherhomji et al., 2015).
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Applicability of END-seq and EdU-seq to answer enduring questions in cell division
The two main forms of eukaryotic cell division, mitosis and meiosis, have been studied for
almost a century and a half. Despite this, substantial mystery persists regarding the complex,
orchestrated nuclear activities of division. Moreover, diseases such as inherited genetic disorders
and infertility or cancer and aging are associated with chromosomal defects during meiosis or
mitosis, respectively. Further characterizing the mechanisms driving these defects would shape
our understanding of how these diseases originate and advance. Beyond medicine, studies of
mitosis and meiosis have granted invaluable insight into many areas of biology, including
homologous recombination, evolution, chromatin architecture, and DNA repair more generally.

Meiosis begins similarly to mitosis, in which DNA is replicated and condensed into sister
chromatids. However, one goal of meiosis is to produce gametes with new allele frequencies to
stimulate genetic diversity and evolutionary advantages in offspring (Hunter, 2015). This is
achieved by the pairing and recombination of homologous chromosomes and exchange of
genetic information (i.e. crossovers) between maternal and paternal chromosomes. Additionally,
proper recombination repair is vital for fertility and preventing aneuploidy or other genetic
disorders in offspring. Interestingly, the inability to properly repair meiotic DSBs is a known
genetic basis for speciation in animals and may be under evolutionarily pressure to both maintain
existing and produce new species (Paigen and Petkov, 2018; Mukaj et al., 2020). Meiotic
recombination is initiated by intentional and localized DSBs at distinct “hotspots”. Much work has
been done to locate these hotspots in mammalian genomes with a high degree of success;
however, previous studies have been limited to indirect methods of DSB detection that do not
fully characterize their processing or repair (Lange et al., 2016; Brick et al., 2012; Smagulova et
al., 2016).
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Because sexual reproduction depends so critically on the proper fate of meiotic DSBs, it
is imperative to understand how repair is regulated and how it can go awry. The most informative
method would be to directly assess breakage itself, which END-seq permits. Using this technique
in Chapters 3 and 4, all meiotic hotspots were mapped in primary mouse spermatocytes,
confirming and extending previous studies of indirect DSB mapping (Paiano et al., 2020).
Because END-seq detects not only break sites but also the extent to which DSBs are processed
for recombination, these results have clarified how meiotic DSBs are initially handled for repair
and homolog pairing. New roles for ATM, a key regulator of DNA repair, and PRDM9, a
methyltransferase that guides meiotic DSB location, were elucidated in governing meiotic
recombination in mammals (Paiano et al., 2020). Additionally, these data have clarified the roles
of other important DNA repair and chromatin factors that had previously remained elusive in
mammalian meiosis.

Unlike meiosis, in which genetic diversity must be produced, mitosis is the assurance that
a dividing cell will produce two genetically identical daughter cells. This is key to the maintenance
of proper cellular function within a tissue. DNA lesions during mitosis threaten this assurance and
can yield daughter cells with unstable genomes (Bakhoum et al., 2017). Mitotic defects arising
from under-replication and/or faulty chromosome segregation can lead to gene nondisjunction,
micronuclei formation, and extensive mutational events (Mankouri et al., 2013; Zhang et al., 2015;
Harding et al., 2017). There is a growing body of literature linking these mitotic defects to tumor
progression, cellular senescence, and aging (Dou et al., 2017; Andriani et al., 2016; Ly et al.,
2000). Any difficult-to-replicate loci, including human common fragile sites (CFSs), that remain
under-replicated after S phase will undergo a burst of replication in mitosis (i.e. MiDAS) to avoid
such chromosomal defects (Minocherhomji et al., 2015).

MiDAS has gained much research interest lately as a pathway to prevent massive errors
in mitosis at CFSs while perhaps at the expense of small mutations (Minocherhomji et al., 2015;
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Sakofsky et al., 2014; Hastings et al., 2009). These mutations, such as copy number variations,
may contribute to tumor heterogeneity and progression (Shlien and Malkin, 2009). Thus,
continued studies on MiDAS are necessary to determine if this is a targetable pathway in
cancers. These pathways more generally represent the mechanisms employed by the cell to
maintain genome integrity during replication stress while simultaneously packaging chromosomes
for separation. In Chapter 2, EdU-seq is utilized to sequence all sites of MiDAS specifically in
mitotic cells. Using human cancer cell lines and mild replication stress, hundreds of difficult-toreplicate sequences were identified and characterized that utilize MiDAS upon mitotic entry.
These data, including studies that interrogate MiDAS activation, clarify cell cycle-regulated
pathways of DNA repair and illuminate how cell cycle checkpoints are utilized to maintain genome
integrity during division.

Overall, the studies presented in the subsequent chapters not only elucidate new aspects
of biology critical to the health of cells and integrity of the genome but demonstrate well how
emerging NGS techniques are shaping the future of experimental questions in historic fields of
study. This thesis not only explores how life both tolerates and takes advantage of harm to
produce benefit but is also an accomplishment of technological progress that is helping to shape
a new frontier of research avenues in studies of DNA repair.
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CHAPTER 2: Mapping Difficult-to-Replicate Loci in the Human Genome Through
Nascent DNA Capture in Mitosis

Summary
Cancer cells often experience replication stress that can prevent full genome duplication during
division. These under-replicated sites must rapidly finish synthesis in early mitosis to avoid
deleterious chromosome mis-segregations and bridges. Mitotic DNA synthesis (MiDAS) was
recently reported as a pathway to resolve under-replication and prevent genomic instability at
common fragile sites (CFSs); however, these studies have been limited to low-resolution
microscopy methods. We report here a high-throughput assay to detect precise MiDAS locations
genome-wide by sequencing mitotic incorporation of EdU (mitotic EdU-seq). While many MiDAS
sites overlap with characterized CFSs, we find that late-replicating, large, actively transcribed
genes are most vulnerable to under-replication and mitotic synthesis. Moreover, we observe that
prolonged G2 arrest allows for repair of most under-replicated sites and developed an alternative
mitotic synchronization method to study MiDAS that avoids CDK1 inhibition. Lastly, we find that
HLTF- and SMARCAL1-mediated fork reversal and fork protection are critical for MiDAS to occur,
perhaps by maintaining forks’ capacity to restart after CDK1 activation. Together, data presented
here argue for a spectrum of replication difficulty across the genome, with many sites relying on
mitotic entry to complete replication, and imply a more complex view of the G2/M checkpoint.

Background
Successful mitotic division necessitates that all chromosomes are faithfully and
completely replicated prior to prophase condensation and anaphase separation. Replication of
the genome is performed by bidirectional, DNA polymerase-driven replication forks (Burgers and
Kunkel, 2017). Complete duplication requires total polymerase coverage at every nucleotide. This
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presents several physical complications, as many roadblocks to replication forks can exist
throughout chromosomes, such as secondary DNA structures, damaged nucleotides, proteinDNA crosslinks, and active transcription (Kohn et al., 2008; Duxin et al., 2014; Garcia-Muse and
Aguilera, 2016). These obstacles can stall the movement of replication forks and potentially
trigger several pathways of DNA repair recognition that ultimately remedy the collision and allow
for replication to complete (Mirkin and Mirkin, 2007; Michel et al., 2004; Yeeles et al., 2013). This
can be achieved either by removing the roadblock ahead of the fork to permit progression or by
forcing a structural reconfiguration of the fork itself, known as fork reversal. Fork reversal is a
“backtracking” (i.e. reversal) of the fork that anneals nascent strands, generating a “chicken foot”
structure that prevents further polymerase activity (Neelsen and Lopes, 2015). Reversal is
thought to protect replication forks by limiting the amount of exposed single-strand DNA (ssDNA)
that could be degraded by cellular nucleases with time (Neelsen and Lopes, 2015; Quinet et al.,
2017). The mechanisms and consequences of fork reversal are still not well understood, and
many of the events following reversal that allow for replication completion remain largely elusive.
Typically, cells can replicate chromosomes well, proficiently dealing with inherent
obstacles before mitosis. However, several scenarios can subject cells to significant replication
stress, a term used to describe a multifaceted phenomenon in which many replication forks
experience stalling, sometimes at genomic locations that otherwise would not present difficulty
(Zeman and Cimprich, 2014). While many situations can result in global replication stress, it is
well established that oncogenesis can be inherently linked to replication stress, likely due to the
loss of cell cycle control and unchecked proliferation (Macheret and Halazonetis, 2015). Targeting
replication stress has become a popular and promising field of study for cancer treatments;
however, a complete understanding of how replication stress influences tumor progression is still
necessary (Kitao et al., 2018; Ubhi and Brown, 2019). Genomic instability (i.e. an increased
proclivity for deleterious mutations) in cancer cells can be driven by defective, reiterative rounds
of replication and mitosis. Numerous chromosomal aberrations in mitosis may result in apoptosis
or senescence in normal conditions. In cancer cells that lack these checkpoints, mitotic defects,
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such as improperly segregated chromosomal bridges and fragmented micronuclei, can lead to
massive mutational events or innate immune signaling that drive tumor heterogeneity and
aggression (Zhang et al., 2015; Harding et al., 2017; Bakhoum et al., 2018). Thus, it is imperative
to elucidate the interplay of replication stress and mitosis to better understand how genomic
instability in cancer cells can intensify with each rapid division.
It was recently reported that mitosis can trigger a burst of replication at the beginning of
chromosome condensation in prophase (Minocherhomji et al., 2015). Immunofluorescence (IF)
was used to detect discrete foci of nascent DNA synthesis in mitotically synchronized cells while
inducing low levels of global replication stress. This method has been historically used to
measure fragility of human chromosomes and resulted in the study of common fragile sites
(CFSs) that appear to be perpetually broken at specific chromosomal locations on metaphase
spreads (Schwartz et al., 2006). Mitotic DNA synthesis (MiDAS) was observed at a few well
known CFSs by combining IF and fluorescence in situ hybridization (FISH) CFS probes
(Minocherhomji et al., 2015). These data strongly suggested that CFSs, at least the few that were
detected, represented regions of the genome that remained under-replicated upon mitotic entry.
To prevent mitotic errors associated with under-replication, such as bridges and gene
nondisjunction events, the MiDAS pathway rapidly completes replication at these loci and
presents a unique pathway in cancers that could be therapeutically targeted.
While these IF studies firmly established the presence of MiDAS and characterized
several key proteins, such as MUS81 and RAD52, microscopy foci alone cannot provide enough
resolution to know exactly which DNA sequences are prone to under-replication and mitotic
synthesis (Bhowmick et al., 2016). This level of resolution would allow for the analysis of
mutational signatures observed in primary tumors to determine how oncogenic mutagenesis
arises and evolves through mitosis-driven genomic instability. For example, regions of the
genome that frequently utilize MiDAS in cancer cells can be compared to tumor mutations, such
as copy number variations (CNVs), translocations, kataegis, and extreme mutational events such
as chromothripsis. Defining these mechanisms could grant important insight into cancer genome
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evolution. To accomplish this, we labeled nascent DNA with the thymidine analog, EdU, in mitotic
cells followed by biotin-streptavidin capture of EdU-incorporated DNA and sequencing (EdU-seq).
Mitotic EdU-seq reveals all genomic coordinates that present difficulty to complete replication
under oncogenic conditions.
MiDAS predominantly occurs at long, active genes within late-replicating genomic
regions, consistent with CFS literature. Importantly, we find that fork reversal and fork protection
are necessary to preserve the capacity to restart replication forks upon CDK1 activation in
mitosis. Additionally, we observe that prolonged G2 arrest allows for the resolution of many
under-replicated sites, perhaps reflecting a spectrum of replication difficulty across the genome,
such that the most difficult to replicate sites require mitotic entry for completion. This implies a
more complex view of the G2/M checkpoint, as significant stretches of under-replicated DNA
would rely on mitosis, perhaps through mitotic nuclease activity or chromosome condensation, to
repair replication stress.

Results
Under-replicated DNA completes replication upon mitosis
To generate a situation of replication stress that would utilize MiDAS, we treated U2OS
osteosarcoma cells with a low dose of the DNA polymerase inhibitor aphidicolin (APH). Low
doses of APH result in slowing, but not stopping, polymerases required for replication and will
allow cells to complete S phase while exacerbating replication stress at preexisting difficult-toreplicate loci. Cells were grown asynchronously with respect to cell cycle and treated with 0.4 μM
APH for 24 hrs. After 16 hr, 10 μM of the CDK1 inhibitor (CDK1i) RO3306 was added for the last
8 hr of APH treatment to increase the fraction of cells in G2 (Figure 3a). These G2-arrested cells
will have largely completed replication genome-wide yet will retain discrete under-replicated
regions at difficult-to-replicate sites in the presence of APH.
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Washing out CDK1i quickly releases cells from G2 and results in a semi-synchronous
wave of mitotic entry in the population. At the time of CDK1i washout, cells were treated with 20
μM of the thymidine analog EdU to detect nascent DNA synthesis upon mitosis. Cells were fixed
after just 30 minutes of CDK1i washout, before mitotic exit, and stained for both EdU
incorporation and mitosis-specific phosphorylation on histone H3 Ser 10 (H3S10p). In accord with
previous studies, a significant fraction of mitotic cells exhibited easily identifiable EdU foci (Figure
3b) (Minocherhomji et al., 2015). While non-treated cells showed low levels of EdU incorporation
at baseline, suggestive of endogenous replication stress already present in the U2OS cell line,
APH treatment greatly increased the number of cells with more than 10 EdU foci (Figure 3c).
Moreover, ~15% of mitotic cells had more than 25 foci per nucleus.

Figure 3. Detection of mitotic DNA synthesis (MiDAS) during low levels of replication stress.
(a) Experimental workflow to induce global replication stress with the DNA polymerase inhibitor aphidicolin (APH). CDK1
inhibitor (CDK1i) was added for the last 8 hrs of APH treatment to arrest cells in G2. Washing out CDK1i and adding EdU
results in semi-synchronous mitotic entry while labeling of nascent DNA synthesis specifically in mitosis.
(b) Immunofluorescence images of APH-pretreated mitotic cells with varying quantities of EdU foci. S10 phosphorylation
on histone H3 (H3S10p) marks mitotic cells. The bottom left image shows the contrast between MiDAS (H3S10p+
nucleus) and S phase (H3S10p– nucleus) EdU incorporation.
(c) Histogram of MiDAS EdU foci per nucleus in non-treated (NT) vs APH-pretreated H3S10p+ cells. 100 nuclei were
counted for each treatment.

Mitotic EdU sequencing reveals exact MiDAS locations genome-wide
Although the number of EdU foci per nucleus varied greatly among mitotic cells,
approximately half of the population had visible foci (Figure 3c). If these sites of synthesis are
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recurrent in the population, then the DNA sequence of MiDAS regions should be detectable by
next-generation sequencing methods. While much can be learned through EdU
immunofluorescence about factors that regulate MiDAS, the exact locations and nature of DNA at
under-replicated sites that utilize MiDAS is widely unexplored. We therefore sought to isolate
mitotic DNA after APH pretreatment and sequenced EdU incorporated regions (EdU-seq). To
enrich for mitotic cells and diminish background detection of S phase cells, we performed a
mitotic shake-off after 30 minutes of CDK1i washout and EdU labeling (Figure 3a). The harvested
mitotic cells were fixed and EdU reacted with biotin azide Click-iT. Proteins were then degraded
with proteinase K followed by genomic DNA isolation. After DNA sonication, EdU fragments were
pulled down with streptavidin-coated beads and PCR amplified for sequencing (Figure 4a).

Figure 4. EdU-seq reveals under-replication and mitotic synthesis within large, late-replicating genes.
(a) EdU-seq workflow. After APH treatment and mitotic release in the presence of EdU, mitotic cells are harvested via
shake-off and fixed and permeabilized for EdU biotin azide reactions. Biotin labeled DNA fragments after sonication are
enriched by streptavidin-coated bead pulldown. Fragmented ends are repaired and ligated to Illumina adapters for PCR
amplification and sequencing.
(b) Genome browser track examples of genes WWOX and CDH13. Top two tracks: 0.4 μM aphidicolin (APH) treated
EdU-seq from cycling or mitotic U2OS cells with equivalent track axes. Middle track: FANCD2 ChIP-seq from 0.4 μM APH
treated cycling U2OS cells. Bottom two tracks: U2OS replication timing as determined by Repli-ChIP and gene locations
as annotated by RefSeq. Positive (orange) Repli-Chip values indicate early replication while negative (grey) values
indicate late replication.
(c) Two examples of common fragile site genes, WWOX and FHIT, with depicted introns below EdU-seq reads. DNA
synthesis coincides with introns that are actively transcribed in late S phase.
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Mitotic EdU-seq revealed 77 distinct genomic sites statistically enriched by the peak
calling software MACS (table reference). Peaks were generally very broad spanning from 0.5-1
Mb with ~90% of peaks occurring within annotated gene bodies. Using available RNA-seq data in
U2OS cells, ~70% of these genes are actively, yet lowly, transcribed. EdU-seq positive genes
were statistically very large and exclusively within late-replicating genomic regions as determined
by U2OS Repli-ChIP (Figure 4b). Together, these are hallmarks of common fragile sites (CFSs)
and is consistent with previous literature that discovered MiDAS at a few known CFSs
(Minocherhomji et al., 2015).
Robust EdU-seq enrichment was observed at the WWOX gene within the CFS FRA16D,
a well-characterized fragile locus in the human genome (Figure 4b) (Fungtammasan et al., 2016).
Importantly, EdU-seq correlated strongly with previously published FANCD2 ChIP-seq in 0.4 μM
APH cycling U2OS cells (Figure 4b) (Okamoto et al., 2018). FANCD2 has been shown to
accumulate at stalled replication forks, perhaps reversed forks as well, to grant stability and
prevent degradation (Kolinjivadi et al., 2020; Schlacher et al., 2012). This suggests that in the
presence of low-dose APH, sites that utilize MiDAS experience significant replication stress, and
potentially fork reversal, during S phase and are likely under-replicated prior to mitotic entry.
To confirm this, we performed EdU-seq on cycling 0.4 μM APH treated cells with no
CDK1i. After APH treatment for 24 hr, cells were pulsed with EdU for 30 minutes and EdU-seq
performed. Genes normally enriched with EdU incorporation in mitotic cells were instead slightly
depleted of EdU signal over background in cycling cells (Figure 4b). This suggested that S phase
cells experienced significant replication stress with low-dose APH at specific sites that
subsequently complete replication in mitosis.
While many large, late-replicating genes were enriched for mitotic EdU, we were unable
to predict if a locus would experience under-replication and MiDAS based solely on gene size,
transcriptional status, or replication timing. Therefore, there must exist additional factors that
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influence replication outcomes that are thus far uncharacterized. Despite this, several known CFS
other than FRA16D were observed to use MiDAS in U2OS cells. Among them is FRA3B
containing the known fragile gene FHIT (Figure 4c). While we were unable to predict MiDAS
using only transcription, it was clear that active transcription within late-replicating, large genes is
a common attribute.
Consistent with this, EdU incorporation within WWOX and FHIT reproducibly
accumulated within intron 8 and introns 4-5, respectively (Figure 4c). Previous work found that
one round of transcription through these large genes extends beyond one round of division, such
that nascent RNA can be detected at specific introns at different cell cycle stages (Helmrich et al.,
2011). Specifically, WWOX intron 8 and FHIT introns 4-5 were reported to be transcribed in late S
phase. These introns are also exclusively positive for mitotic EdU-seq (Figure 4c). Similar results
were also observed for the CFS gene IMMP2L (data not shown). Although the prior study was
performed in human leukemic cells, it is conceivable that the transcription and replication
dynamics are shared with other human cell lines such as U2OS. Because these genes are latereplicating, this suggests that active transcription may result in fork stalling within specific introns,
resulting in under-replication and subsequent MiDAS.

WEE1 inhibition synchronizes mitotic entry with no CDK1 inhibition
Some studies have suggested that prolonged G2 arrest with CDK1i can prevent MiDAS,
ostensibly by allowing for replication to fully complete at difficult-to-replicate locations before
CDK1i washout and mitotic entry (Feng and Jasin, 2017). Given that we initially expected to
detect MiDAS at many more sites throughout the genome, presuming all large, transcribed, latereplicating genes are prone to similar pathways of replication stress, we sought to alter mitotic
EdU-seq to avoid use of CDK1i and G2 arrest. We hypothesized that new sites throughout the
genome would now be forced to utilize MiDAS to complete replication without artificially extending
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S/G2. To do so, we used a short-term WEE1 inhibitor (WEE1i) treatment to activate CDK1 in very
late S/G2 cells to generate a semi-synchronous wave of mitotic entry (Figure 5a).

Figure 5. WEE1 inhibition can be used for mitotic EdU-seq to avoid prolonged G2 arrest.
(a) Experimental diagram of WEE1 inhibitor (WEE1i) mitotic EdU-seq. Cells are treated with or without low-dose
aphidicolin (APH) for 24 hr. To induce a semi-synchronous mitotic entry in the population, WEE1i is given for 60 min. The
last 30 min, after the first mitotic cells appear in the dish, EdU is added to label MiDAS events.
(b) FACS profiles of WEE1i-synchronized U2OS cells treated with (bottom) or without (top) APH. Left panels show the
increased fraction of mitotic cells in the population as determined by H3S10p+ and DAPI 4N staining. Right panels show
cell cycle profiles determined by EdU incorporation and DAPI with fractions of G1, S, and G2/M denoted. Regardless of
APH status, all mitotic (H3S10p+) cells generated by short-term WEE1 inhibition are found in G2/M fraction (blue vs red).
(c) Experimental workflow for combined CDK1 inhibitor (CDK1i) G2-arrest and WEE1i synchronization into mitosis.
(d) Venn-diagram of Class 1 (CDK1i sites) vs Class 2 (WEE1i sites) as determined by mitotic EdU-seq.

Because CDK1 remains inactive in S phase due to WEE1 inhibitory phosphorylation,
WEE1i prematurely triggers CDK1 activity and forces mitotic progression (Duda et al., 2016).
Long exposures of WEE1i will eventually induce mitosis in most S phase cells with ongoing,
genome-wide replication. However, we hypothesized that a very short-term, high-dose WEE1i
treatment would prompt mitotic entry only in cells that are mostly poised for mitosis, i.e. very late
S/G2 phase cells with low levels of CHK1 activity that are conducive to abrupt CDK1 activation.
To achieve this, we treated asynchronously growing U2OS cells with 0.4 μM APH for 24 hr
followed by 3 μM WEE1i for 30 min. After 30 min WEE1i treatment, a small increase in mitotic
cells, visible by a rounded morphology, began to appear (not shown). After 1 hr of WEE1i, a
significant fraction of cells entered mitosis that were easily removed by shake-off. We therefore
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added 20 μΜ EdU to cells during the 30-60 min WEE1i duration in which we observed the
greatest increase in mitotic entry, i.e. semi-synchronous wave of mitosis (Figure 5a).
To confirm that no early-to-mid S phase cells were prematurely entering mitosis, we
performed FACS analysis on all cells after WEE1i. Regardless of APH treatment, WEE1i induced
a significant fraction of mitotic cells after 60 min, as determined by H3S10p staining (~15%
without APH and ~20% with APH) (Figure 5b). We expected more mitotic cells with APH
treatment as very late S/G2 cells accumulate slightly in the presence of replication stress.
Importantly, all mitotic cells were confined to the G2/M population as determined by EdU
incorporation and DNA content (Figure 5b). Therefore, short-term, high-dose WEE1i can be used
to synchronize mitotic entry in the absence of CDK1i, allowing for studies that are not confounded
by prolonged G2 arrest.
We next performed mitotic EdU-seq on WEE1i-induced mitotic cells pre-treated with lowdose APH. Similar to CDK1i synchronization, we observed broad EdU peaks throughout the
genome, confirming the presence of MiDAS in this setting. While most (84%) of CDK1i MiDAS
sites were found in the WEE1i EdU-seq data, hundreds of new loci across the genome were
apparent with WEE1i (CDK1i=77 sites; WEE1i=363 sites) (Figure 5c). To test if this was an effect
specific to either WEE1i or the absence of CDK1i (i.e. G2 arrest), we performed a combination of
CDK1i and WEE1i mitotic EdU-seq by arresting cells in G2 during APH treatment and adding 3
μM WEE1i at the time of CDK1i washout and mitotic entry (Figure 5d). EdU-seq revealed equal
numbers of MiDAS sites between CDK1i and CDK1i+WEE1i treatments with no signs of
synthesis at novel WEE1i sites. We therefore conclude that while CDK1i is an efficient method of
obtaining significant numbers of synchronized mitotic cells, prolonged G2 arrest likely allows for
resolution of many difficult-to-replicate loci before mitosis.

Lack of G2 arrest reveals a second class of MiDAS sites
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We next wanted to understand the nature of the 82% of WEE1i EdU-seq sites that did not
show mitotic synthesis after G2 arrest with CDK1i. From here on, we refer to these sites as Class
2 MiDAS sites and sites common to both CDK1i and WEE1i mitotic synchronization as Class 1.
We argue that this distinction is biologically relevant as outlined further below. Succinctly, Class 1
sites are more difficult to replicate, are more susceptible to poor replication outcomes in S phase,
and subsequently utilize MiDAS more frequently than Class 2 sites. The dichotomous
nomenclature of Class 1 vs Class 2 used here is simply to illustrate gross differences between
two ostensibly unique datasets. Using this distinction, we ultimately propose a more nuanced,
complex spectrum in difficulty to replicate across the genome that likely results in heterogeneous
resolution pathways.
Class 1 sites were present in all datasets analyzed (Figure 6a) and included wellcharacterized human CFS genes such as WWOX (FRA16D), FHIT (FRA3B), IMMP2L (FRA7K),
and LINGO2 (FRA9C). Class 1 sites were also strongly correlated (>60% of sites) with FANCD2
accumulation (Figure 6a), indicating substantial and severe replication stress at these locations
with low-dose APH treatment. While EdU-seq was robust at these sites even after prolonged G2
arrest, the addition of WEE1i after CDK1i washout further increased signal (Figure 6a), perhaps
due to either an increased fraction of mitotic cells with replication stress in the shake-off or
increased MiDAS activity at Class 1 sites with WEE1i. Surprisingly, low yet significant EdU-seq
reads were apparent at Class 1 sites without APH treatment, suggesting that in U2OS cells, and
likely other cancer lines, these sites commonly experience endogenous replication stress that
utilize MiDAS at low levels. This is consistent with IF data showing several mitotic nuclei with EdU
foci in the absence of APH (Figure 3c).
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Figure 6. CDK1i vs WEE1i mitotic EdU-seq reveal distinct classes of MiDAS sites.
(a) Genome browser track examples of U2OS EdU-seq reads surrounding the CFS gene FHIT. Class 1 loci (common
between CDK1i and WEE1i) and Class 2 loci (WEE1i unique) are highlighted. From top to bottom: 1) 0.4 μM aphidicolin
(APH) 24 hr treatment in cycling cells. 2) CDK1i mitotic EdU-seq in APH treated cells. 3) CDK1i mitotic EdU-seq in APH
treated cells with addition of WEE1i after CDK1i washout. 4) WEE1i mitotic EdU-seq without APH treatment. 5) WEE1i
mitotic EdU-seq with APH treatment. 6) FANCD2 ChIP-seq in cycling cells with APH treatment. 7) U2OS replication timing
as determined by Repli-ChIP. Positive (orange) Repli-Chip values indicate early replication while negative (grey) values
indicate late replication. 8) Gene locations as annotated by RefSeq.
(b) Box plots comparing replication timing between Class 1 and Class 2 sites vs randomly positioned sites throughout the
genome. Positive and negative values indicate early and late replication, respectively.
(c) Average gene length of Class 1 vs Class 2 MiDAS sites that intersect with genes, compared to randomized genic
overlap genome-wide.
(d) EdU-seq genome browser example of Class 1 site, NRG3 gene, between WEE1i EdU-seq with (top) or without
(middle) APH vs CDK1i EdU-seq with APH (bottom).

Class 2 sites exhibited some similar characteristics to Class 1: broad EdU-seq peaks with
>90% of sites lying within genes (Figure 6a), ~70% of which are actively transcribed. Class 2
sites depend on APH and do not utilize MiDAS after G2 arrest (Figure 6a). Interestingly, these
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locations, as with Class 1, exhibit slight EdU signal dips in cycling U2OS cells treated with APH
(Figure 6a). Together with transcription association, this implies that Class 2 sites also experience
replication stress that correlates with active transcription. Importantly, while >60% of Class 1 sites
intersected with FANCD2 ChIP-seq peaks, only 5% of Class 2 sites showed overlap with
FANCD2 signal (Figure 6a). This suggests that while Class 2 loci likely experience replication
stress, it is less severe than Class 1 sites such that FANCD2 does not accumulate and underreplication is typically resolved in very late S/G2 before mitosis.
Class 1 and Class 2 peaks are equally late-replicating as determined by U2OS Repli-Seq
data (Figure 6b). However, we observed a significant difference in gene length, such that Class 1
sites on average are contained within larger genes than Class 2 (Figure 6c). Additionally, while
Class 2 sites exhibit unimodal distributions of EdU-seq similar to Class 1, Class 1 sites detected
by WEE1i mitotic EdU-seq show reproducible bimodal distributions that flank that single peak
detected by CDK1i mitotic EdU-seq (Figure 6a, d). However, the bimodal pattern was not
observed in the absence of APH treatment (Figure 6d), demonstrating a WEE1i specific effect on
the location of DNA synthesis surrounding the site of under-replication.

MiDAS correlates with transcriptomes between tissue types
To further confirm a relationship between transcription and MiDAS, we performed WEE1i
mitotic EdU-seq on other human cell lines: colon cancer HCT116 and hTERT-immortalized retinal
pigment epithelial RPE-1. WEE1i synchronization was used instead of CDK1i-induced G2 arrest
in order to observe the maximal number of MiDAS events in each tissue type. Because U2OS
and RPE-1 cells are very adherent to tissue culture plates, shake-off was sufficient to obtain
mitotic cells for analysis. However, HCT116 cells are relatively loosely attached to plates, and
shake-off alone was insufficient to obtain high purities of mitotic cells. We therefore additionally
FACS sorted HCT116 shake-off cells using anti-H3S10p staining post fixation and
permeabilization to limit contaminating S phase cells and increase EdU-seq signal-to-noise.
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MiDAS was prevalent throughout the genome in all cell lines, with U2OS having the most
(363 loci), followed by HCT116 (245 loci) and RPE-1 (196 loci) (Figure 7a). In HCT116 and RPE1 cells, we again found robust enrichment of MiDAS at large, late-replicating genes. Interestingly,
there was limited overlap in MiDAS sites between tissue types, with over half of U2OS loci unique
to U2OS and about a third of HCT116 and RPE-1 sites respectively unique to themselves (Figure
7a-b). This suggested at least two possibilities: Cell types are differentially susceptible to APHinduced replication stress or cell type-specific transcriptomic differences result in tissue-specific
locations of under-replication.
Using HCT116 nascent RNA-seq, RPE-1 mRNA-seq, and U2OS mRNA-seq, we
assessed transcriptional status as a function of MiDAS utilization. Indeed, when genes were
clustered between cell types according to mitotic EdU-seq positivity, we observed similar
clustering of active transcription unique to each cell type (Figure 7c). This further demonstrates
that transcription is an important factor that determines if a region will be unable to complete
synthesis and use MiDAS upon mitosis. Intriguingly, while an obvious pattern exists between
EdU-seq and transcription between cell types, many other genes that show active transcription
did not use MiDAS (Figure 7c). As we noted in U2OS cells, transcription, while a clear factor,
alone is insufficient to fully predict MiDAS.

Figure 7. WEE1i mitotic EdU-seq corresponds to transcriptional status between tissue types.
(a) Venn-diagram depicting extensive division in MiDAS locations between U2OS, HCT116, and RPE-1 human cell lines.
Numbers below cell type denote total MiDAS sites discovered.
(b) Genome browser tracks of three nearby large genes that illustrate differences in MiDAS utilization between tissues.
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(c) Left: Heatmap clustering WEE1i MiDAS peaks between cell types. Right: Heatmap of transcriptional status, clustered
by EdU-seq on left.

Fork reversal is required for MiDAS
When replication forks encounter blocks that hinder polymerase progression, forks can
undergo a structural DNA changed known as fork reversal. To better understand the mechanism
of how transcription results in under-replication, U2OS cells deficient for three genes known to
mediate fork reversal (HLTF, SMARCAL1, and ZRANB3) were tested for mitotic synthesis
(Quinet et al., 2017; Bai et al., 2020). Individual and triple HLTF/SMARCAL1/ZRANB3 (TKO)
knockouts were treated with low dose APH and mitotically synchronized with either CDK1i or
WEE1i. Mitotic synthesis was virtually abolished at all Class 1 and Class 2 sites in HLTF-KO,
SMARCAL1-KO, and TKO cells (Figure 8a-b). Interestingly, synthesis was unaltered in ZRANB3KO cells, suggesting that at least in U2OS cells, HLTF and SMARCAL1 are both required for
MiDAS while ZRANB3 plays a minimal role.
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Figure 8. HLTF and SMARCAL1 mediated fork reversal is required for MiDAS.
(a-b) CDK1i mitotic EdU-seq (a) or WEE1i mitotic EdU-seq (b) after 24 hr 0.4 uM aphidicolin treatment in WT, HLTF-KO,
SMARCAL1-KO, ZRANB3-KO, and triple HLTF/SMARCAL1/ZRANB3-KO (TKO) U2OS cells. All tracks shown at equal
axis heights.
(c) EdU-seq of asynchronously cycling U2OS cells treated 24 hr with 0.4 uM aphidicolin and pulsed for 30 minutes with
EdU. Under-replication at WWOX (left) or aggregated genome-wide at all MiDAS peaks (right) is observed in all mutants.

It has been shown that HLTF-KO cells, in which fork reversal is prevented, exhibit
“unrestrained” fork progression through small replication barriers (Bai et al., 2020). This suggests
two possibilities to explain the dependence of MiDAS on fork reversal: 1) unrestrained fork
progression through long genes mostly completes replication before mitosis, thus eliminating
substantial under-replicated sequences or 2) reversed forks are required substrates for the
initiation of mitotic synthesis. As unrestrained fork progression has only been demonstrated with
small replication blocks, it is unlikely that the same mechanism can occur across large barriers
that transcription may present. Moreover, it is thought that mitotic nucleases, such as MUS81 and
GEN1, may act to initiate MiDAS by first breaking DNA to induce replication, a process similar to
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break-induced replication (BIR) first defined in yeast (Bhowmick et al., 2016; Kramara et al.,
2018). In this context, a reversed fork structure is a suitable substrate for MUS81 or GEN1 and
may be required to initiate synthesis.
To test this, asynchronously growing fork reversal mutant cells were treated for 24 hrs
with low dose APH and EdU-seq was performed on all cells after a 30 min EdU pulse. As shown
in Figure 4, this method can be done to detect regions of the genome that are under-replicated on
average after APH treatment. If unrestrained fork progression occurs in HLTF-KO or SMARCAL1KO cells, then little under-replication would be expected at MiDAS sites in actively cycling cells.
However, equal degrees of under-replication were observed across all cells tested (Figure 8c),
indicating that forks still stall at large genes and replication remains unfinished. Therefore, it is
likely that the initiation of mitotic DNA synthesis requires a reversed fork as a substrate, perhaps
through nuclease breakage.

Fork protection and restart may be required for MiDAS
While a reversed fork may be a required substrate on which mitotic synthesis initiates, it
may also be indicative of a requirement for fork protection as cells enter mitosis to complete
replication. As fork reversal is thought to be a means of protecting ssDNA at stalled forks from
nuclease cleavage (i.e. fork degradation), we tested other pathways that may affect fork
protection. Recently, it has been shown that CDC7, MRE11, and RAD52 may influence
degradation of stalled forks for restart (Rainey et al., 2020; Malacaria et al., 2019; Cheng et al.,
2017). Interestingly, RAD52 is already known to promote MiDAS, although it was suggested to do
so in a BIR-like promoting manner (Bhowmick et al., 2016). First, we tested WEE1i mitotic EdUseq on cells treated with two CDC7 inhibitors, PHA-767491 and XL413, 1 hr prior to WEE1i
mitotic induction. XL413 has recently been reported as a more specific inhibitor of CDC7 (Rainey
et al., 2020). Treatment with either drug totally prevented MiDAS from occurring (
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Figure 9a), indicating a critical role for CDC7 activity at the time of MiDAS initiation. As CDC7 was
reported to act with MRE11 to promote restart of stalled forks, the MRE11 exonuclease inhibitor,
mirin, was also tested prior to WEE1i treatment. Mitotic synthesis was detected at WT levels
across the genome, perhaps reflecting redundant roles of MRE11 and other nucleases to
promote fork restart.

Figure 9. Fork protection and restart may be required for MiDAS.
(a) WEE1i mitotic EdU-seq with 1 hr treatments prior to WEE1i of two CDC7 inhibitors (PHA-767491 and XL413) or
MRE11 exonuclease inhibitor, mirin.
(b) WEE1i mitotic EdU-seq in MCM2-AID tagged HCT116 treated with or without auxin for 1 hr prior to WEE1i. Total
MCM2 protein levels after auxin treatment determined by Western blot (right).
(c) CDK1i mitotic EdU-seq in RAD52-KO U2OS cells.

An alternative explanation for the dependence of CDC7 is that mitotic synthesis is simply
the firing of dormant origins that complete replication (Brambati et al., 2018; Courtot et al., 2018).
CDC7 is well known to promote origin firing, and inhibitors are typically used to prevent dormant
origin activation (Bousset and Diffley, 1998). Counter to this is the prevailing idea that transcribed
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long genes become under-replicated because they lack dormant origins to rescue replication after
fork stalling (Debatisse et al., 2012). This would make it highly unlikely that MiDAS results from
dormant origin rescue, as there are none present within long genes. To test this, we used
HCT116 cells engineered with MCM2-auxin induced degron (MCM2-AID) to allow for the rapid
degradation of MCM2 proteins after treating cells with auxin. The MCM helicase complex is
required for origin firing, and depletion of MCM2 will totally inhibit replication origin activity (Alver
et al., 2014). Before WEE1i mitotic induction, MCM2-AID cells were treated with or without auxin
for 1 hr and EdU-seq performed after H3S10p+ FACS sorting. While total MCM2 levels were
dramatically, yet not completely, reduced, mitotic EdU-seq signal was entirely unaffected (
Figure 9b). Altogether, these data suggest that restart of protected, reversed forks may be
required to initiate mitotic synthesis.
RAD52 has been suggested to have a role in annealing DNA to initiate a BIR-like
synthesis in mitosis. Consistent with previous data, we found that RAD52-KO U2OS cells exhibit
no mitotic synthesis after CDK1i mitotic synchronization (
Figure 9c). In light of data presented here and recent reports of RAD52-mediate fork protection, it
is possible that RAD52 promotes MiDAS by ensuring protection of reversed forks in addition to, or
instead of, its ability to anneal DNA to initiate synthesis. Further work is necessary to determine
which function of RAD52 is more at play.

Discussion
We report here a method to sequence genomic locations that utilize MiDAS following
replication stress by mitotic EdU-seq. Moreover, we show that mitotic EdU-seq positivity can be
used as a proxy for genetic sequences that are most susceptible to replication stress and underreplication (i.e. difficult-to-replicate loci and CFSs). Detecting specific sites of MiDAS by
sequencing, rather than calculating total events by immunofluorescence, permits a highresolution and high-sensitivity method to probe mechanisms that underly both replication stress
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and mitotic repair. While we observed MiDAS at several CFSs as previously reported by
immunofluorescence, we additionally found hundreds of other difficult-to-replicate sites
throughout the genome that have not yet been annotated as such. Knowing specific sites of
MiDAS allows for a more detailed understanding of replication stress susceptibility through
association with DNA sequence and genomic features, such as transcription and replication
timing.
We find that all sites of mitotic synthesis occur at under-replicated, large, lowly
transcribed genes that are late replicating. This is consistent with CFS literature and suggests
that hundreds of regions across the human genome could be considered fragile as well, rather
than the canonical list of CFSs. While the mechanism is still unclear for how transcription
interferes with replication, possibly through R-loop formation or direct collision of transcription and
replication machineries, we find that gene length and transcriptional activity are the most
significant indicators of difficult-to-replicate locations. As such, the transcriptome of a given cell
can determine that extent of potential fragility during mitosis. However, gene length, replication
timing, and transcription alone are insufficient to predict under-replication, as many regions
exhibiting these characteristics do not exhibit mitotic synthesis. Further work is necessary to
continue to elucidate additional factors that influence these outcomes.
Using two methods of mitotic synchronization, either invoking a prolonged G2 arrest
(CDK1i) or not (WEE1i), two distinct classes of difficult-to-replicate loci were observed. Class 1
sites (n=77) represent the largest gene sizes, accumulate FANCD2 at regions of mitotic
synthesis, and remain under-replicated until mitosis regardless of G2 arrest. Class 2 sites
(n=286), while still found within large genes, are significantly shorter than Class 1 genes, do not
exhibit FANCD2 ChIP-seq signal, and do not undergo mitotic synthesis after G2 arrest. While
difference in gene length itself does not provide an underlying mechanism as to why Class 1 and
Class 2 sites exhibit distinct mitotic features, it perhaps gives some insight. Larger introns present
in Class 1 genes may have greater affinity for R-loop formation or other obstructions that could
interfere with replication, such as secondary structures and repetitive sequences (Fungtammasan
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et al., 2012; Debatisse et al., 2012). It is also possible that shorter genes, after prolonged G2
arrest, complete transcription and allow for completion of replication before mitosis. At the largest
genes, even with G2 arrest, transcription continues through mitosis, keeping the gene underreplicated. The role of FANCD2 at these sites, and its potential for promoting MiDAS, is likely
nontrivial and requires further exploration. Ultimately, the ability to categorize difficult-to-replicate
loci into (at least) two classes, suggests a spectrum of difficulty to complete replication under
stressed conditions and a resultant spectrum of potential fragility across the genome that may
explain unique mutational signatures commonly observed in cancers.
At both Class 1 and Class 2 sites, replication fork reversal, mediated by HLTF and
SMARCAL1, are necessary for mitotic synthesis to occur. This is perhaps due to the creation of a
stable fork structure that acts as a substrate for synthesis initiation upon mitotic entry. In the
absence of fork reversal, genes remain under-replicated and do not show synthesis during
mitosis. This likely results in deleterious mitotic structures, such as bridges, that can promote
mutagenesis, gene nondisjunction, and micronuclei in daughter cells. This could have significant
consequences in tumors with decreased expression of fork reversal proteins, such as HLTF.
Moreover, this implicates a mechanism of mitotic synthesis more akin to fork restart rather than
BIR necessarily, as most highlighted by our observed dependence on CDC7 activity. In this way,
fork protection until mitosis is required to maintain the ability to restart synthesis and complete
replication upon mitotic activation, potentially initiated by the mitotic nucleases MUS81 and/or
GEN1. The essential role of RAD52 to promote MiDAS may be in the maintenance of reversed
forks until mitosis rather than annealing activity in a BIR-like mechanism of synthesis.
Figure 10 summarizes these potential pathways following fork reversal at long,
transcribed genes. Most likely is a heterogeneity of mechanisms to ensure complete genome
duplication during replication stress. An inherent spectrum of replication difficulty across
chromosomes combined with several possible mitotic resolution pathways could generate
multitudinous outcomes within a single cell division. While some pathways may operate
predominantly over others in some cell types or settings, these data suggest that MiDAS, as a
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targetable pathway in cancers, may employ several unfavorable pathways that could contribute to
genomic instability within a tumor. Any potential therapeutics should consider this heterogeneity,
as what may kill one cancer cell may cause further tumor variation in others and actually
contribute to tumor aggression.

Figure 10. Proposed model for mitotic resolution of under-replicated genes. HLTF and SMARCAL1 mediate fork reversal
after transcription halts replication in long, late-replicating genes. Reversed forks entering mitosis complete replication in
an MCM2 independent but CDC7 dependent mechanism. However, prolonged G2 arrest permits mitosis-independent
replication completion of many genes, yet under-replication persists at longest genes until mitotic entry and complete in a
RAD52 dependent manner. Alternatively, FANCD2 accumulation at longest genes may protect reversed forks until
mitosis, while at shorter genes, FANCD2 does not protect forks and degradation during G2 arrest eliminated MiDAS
substrates for synthesis.

MiDAS is thought to occur by a BIR-like, RAD52 annealing mechanism to complete
replication. Data presented here offer a second, although not necessarily mutually exclusive,
pathway of fork protection and restart at the boundaries of under-replicated regions. As no
dormant origins exist to complete replication, it is plausible that forks stalling at these sites must
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be preserved to restart synthesis where they were paused. Mitotic activation, perhaps by mitotic
nuclease breakage or CDK1 driven replisome disassembly, restarts forks to complete synthesis.
The role of RAD52 in this case could be to preserve the reversed fork and/or anneal nascent
strands for synthesis. If mitosis triggers fork restart, a mechanism possible in S phase at stalled
forks, then mitosis can in some ways be viewed as an extension of S phase to complete
replication. CDK1 activity may drive a wave of fork restart and resolution of recombination
intermediates, such as reversed forks and Holliday junctions, that would prevent proper
condensation and segregation. This degradation of reversed forks may trigger synthesis
completion.
Therefore, what is typically considered to be the major importance of the G2/M
checkpoint, namely ensuring replication completion before mitotic entry, may rely on M phase
activation in addition to pausing in G2. This is particularly evident in our distinction of Class 1 and
Class 2 sites, as prolonged G2 arrest seems to complete replication at most difficult-to-replicate
loci, while dozens appear to wait until mitotic entry to resolve under-replication. As mitosis is an
all-or-nothing event with minimal negative feedback to correct errors, relying on mitotic pathways
for replication resolution is inherently dangerous for the cell and helps to explain how mitosis can
generate diverse genomic instability in tumors.
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CHAPTER 3: ATM and PRDM9 regulate SPO11-bound recombination intermediates
during meiosis

Summary
Meiotic recombination is initiated by SPO11-induced double-strand breaks (DSBs). In most
mammals, the methyltransferase PRDM9 guides SPO11 targeting, and the ATM kinase controls
meiotic DSB numbers. Following MRE11 nuclease removal of SPO11, the DSB is resected and
loaded with DMC1 filaments for homolog invasion. Here, we demonstrate the direct detection of
meiotic DSBs and resection using END-seq on mouse spermatocytes with low sample input. We
find that DMC1 limits both minimum and maximum resection lengths, whereas 53BP1, BRCA1
and EXO1 play surprisingly minimal roles. Through enzymatic modifications to END-seq, we
identify a SPO11-bound meiotic recombination intermediate (“SPO11-RI”) present at all hotspots.
We propose that SPO11-RI forms because chromatin-bound PRDM9 asymmetrically blocks
MRE11 from releasing SPO11. In Atm–/– spermatocytes, trapped SPO11 cleavage complexes
accumulate due to defective MRE11 initiation of resection. Thus, in addition to governing SPO11
breakage, ATM and PRDM9 are critical local regulators of mammalian SPO11 processing.

Background
Recombination between homologous chromosomes during meiosis requires DNA
double-strand break (DSB) formation by the topoisomerase-like protein SPO11 (Keeney et al.,
1997). After cutting, SPO11 remains covalently bound to a two-nucleotide, 5’ overhang at both
ends of the DNA via phosphotyrosyl linkage. Recombination then begins with the processing of
SPO11-bound DSBs into resected 3’ single-stranded DNA (ssDNA) tails that preferentially invade
the homologous chromosome by the recombinases DMC1 and RAD51. Studies in budding yeast
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Saccharomyces cerevisiae determined that the MRE11/RAD50/NBS1 (MRN) complex detects
SPO11 and cooperates with Sae2 to produce a nick on the SPO11-bound strand via MRE11
endonuclease activity (Garcia et al., 2011). The nick serves as an entry point for both short-range
MRE11 3’-5’ exonuclease activity to degrade back to the DSB, thereby removing covalently
bound SPO11 attached to a ssDNA oligonucleotide, as well as for more extensive long-range
processing of 5’ strands (Figure 11a) (Garcia et al., 2011). In budding yeast, Exo1 nuclease is
uniquely responsible for this long-range 5’-3’ resection (Zakharyevich et al., 2010). Moreover,
short- and long-range resection are tightly coupled in a single processive reaction (Figure 11a).
As a result, meiotic DSBs are maximally resected as soon as they appear and unresected
SPO11-bound DSBs are extremely rare (Bishop et al., 1992; Joshi et al., 2015; Mimitou et al.,
2017). While ATM has been shown to regulate DSB numbers and locations (Lange et al, 2011;
Lange et al., 2016), it remains unclear whether it also functions downstream in regulating SPO11
processing and resection.

Figure 11. SPO11 generates meiotic DSBs that are detectable by END-seq.
(a) Illustration of meiotic break generation and processing. SPO11 induces a double-strand break (DSB) and remains
covalently bound to both DNA ends. MRE11 recognizes the DSB and induces a nick on the SPO11-bound strand. Tightly
coordinated short-range 3’-5’ resection by MRE11 and long range 5’-3’ resection by an unknown nuclease generates 3’
overhangs for homology search. MRE11 activity releases SPO11 bound to short oligonucleotides (SPO11 oligos).
(b) Brief schematic of END-seq detection of SPO11 DSBs (only one side of the DSB is shown for simplicity). In vivo
processing of SPO11 by coordinated bidirectional resection removes covalently bound SPO11 and produces a 3’
overhang present at the time of END-seq preparation and agarose cell embedding. Initial END-seq processing degrades
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all proteins by proteinase K and blunts ssDNA overhangs by in vitro nuclease digestion (dark blue). Once fully blunted and
dA-tailed, the DNA end is ligated to a biotinylated Illumina sequencing adapter (orange), sheared, and streptavidin
captured. A second Illumina adapter is ligated at the other end of the sonicated fragment after end repair and sequenced.

Distinct from yeast, DSB hotspots in mice and humans are determined by the DNA
binding specificity of the PRDM9 methyltransferase (Grey et al., 2018). Besides positioning
DSBs, PRDM9 binding activity also reorganizes nucleosomes in a manner that creates a
nucleosome depleted region (NDR) within which DSBs and PRDM9 itself are centered (Baker et
al., 2014). Moreover, PRDM9 has been suggested to have a role in DSB repair post-cleavage
(Brick et al., 2012; Paigen et al., 2019). Crossover resolution is facilitated by PRDM9 binding
symmetrically to the template (uncut) homolog which generates an NDR within which the DSBinitiating chromosome can stably engage (Davies et al., 2016; Hinch et al., 2019; Li, R. et al.,
2019). If PRDM9 remains bound post-cleavage, it is possible that it could influence downstream
processing events that facilitate synapsis and crossover recombination.
Here we demonstrate that ATM regulates multiple steps of initial SPO11 processing,
including the activation of MRE11, the coordination of short and long-range resection, and the
assurance of minimal SPO11 cutting per hotspot. However, we find that ATM-mediated SPO11
processing can be hindered by the obligate binding of PRDM9 to hotspots post SPO11 cutting.
We suggest that PRDM9 acts as a physical barrier to MRE11 activity, preventing SPO11 release
during the early stages of homolog engagement. This generates a PRDM9-dependent SPO11bound recombination intermediate (SPO11-RI). We propose that SPO11-RI may favor highfidelity homologous recombination by facilitating crossover and noncrossover events.

Results
END-seq Robustly Detects Mouse Meiotic DSB Hotspots
To probe the early steps of mouse meiotic recombination, we utilized END-seq (Canela
et al., 2016; Canela et al., 2017; Canela et al. 2019). In this method, a sequencing adapter is
ligated to each end of a DNA break inside an agarose plug after a combination of nucleases
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ExoVII and ExoT removes ssDNA overhangs. As a result, sequencing reads begin at the terminal
end of physiological resection, resulting in libraries of ssDNA-DSB junctions (Figure 11b). These
exonucleases can be used to detect DSB termini that are either protein-bound or protein-free. For
example, etoposide-induced DSBs, which are covalently attached to topoisomerase 2 (TOP2) via
an active site tyrosine at the 5’-termini, require ExoVII to remove covalently bound TOP2 (Canela
et al., 2019), whereas ExoT can only blunt protein-free overhangs resulting in a ligatable DNA
end (Canela et al., 2016). Like TOP2, the topoisomerase-like protein SPO11 remains attached to
DSB 5’ ends prior to release by MRE11-mediated nicking as short 20-40 bp oligonucleotides
(SPO11 oligos) (Lange et al., 2011; Neale et al., 2005) (Figure 11a).
We assayed spermatocytes from juvenile mouse testes during the first wave of semisynchronous meiosis I. We embedded spermatocytes from 20 pooled, 12-14 dpp C57BL/6J (B6)
mice in agarose plugs and blunted meiotic ssDNA overhangs with ExoVII and ExoT before
ligating sequencing adapters (Figure 1b). Approximately 5000 reproducible broken hotspots were
called with a threshold of at least 2.5-fold enrichment (Figure 12a). We overlapped these ENDseq peaks with previously reported B6 meiotic hotspots determined by SPO11-oligo sequencing
and DMC1 single-strand DNA sequencing (SSDS) (Lange et al., 2016; Brick et al., 2012;
Smagulova et al., 2016). By visual inspection and correlative analysis, both END-seq break
location and peak intensity overlapped with SPO11-oligos and SSDS, which accounted for 97%
and 98% of END-seq peaks respectively (Figure 12b-d). END-seq therefore provides a map of
directly detected meiotic DSB resection in mammals.
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Figure 12. Assessing END-seq accuracy and sensitivity.
(a) Comparison of two WT END-seq biological replicates each made from 20 pooled juvenile mice. Left panel: Correlation
(Pearson’s r) between break intensity of the two replicates in a ±3kb window around SPO11 summits. Right panel: Venn
diagram showing overlap of peak calling from two END-seq replicates. P value <2.2e-16, fisher’s exact test.
(b) Representative genome browser profiles of meiotic hotspots for SPO11-oligo sequencing, DMC1 SSDS, and ENDseq. Browser axis scales are adjusted between techniques to show both hot and cold hotspots simultaneously.
(c) Comparison of END-seq and SPO11-oligo sequencing hotspot mapping. Left panel: Correlation (Spearman’s r) of
END-seq and SPO11-oligo intensity in a ±3kb window around SPO11 summits. Right panel: Venn diagram showing
overlap of END-seq peaks and SPO11-oligo peaks. P value <2.2e-16, fisher’s exact test.
(d) Comparison of END-seq and DMC1 SSDS hotspot mapping. Left panel: Correlation (Spearman’s r) of END-seq and
SSDS intensity in a ±3kb window around SPO11 summits. Right panel: Venn diagram shows overlap of END-seq peaks
and SSDS peaks. P value <2.2e-16, fisher’s exact test.

Using the 2.5-fold enrichment criteria, END-seq peaks called a third of the total hotspots
determined by SPO11-oligo seq or SSDS (Figure 12c-d). However, END-seq peaks that did not
meet this cut-off were nevertheless associated with previously mapped hotspots. For example,
66% of SPO11-oligo loci that were “END-seq negative” showed the same DSB detection pattern
when these END-seq reads were aggregated (Figure 13a-b). Moreover, these END-seq-negative
SPO11-oligo sites show a significant reduction in SPO11-oligo reads (Figure 13c), indicating that
these are the coldest meiotic hotspots. We conclude that END-seq detects breakage at all
~15,000 previously mapped hotspots, yet the more frequently broken top 33% of hotspots yield
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the most robust signal. Therefore, unless otherwise stated, the subsequent analyses were
performed on the 5,000 strongest END-seq breaks.

Figure 13. END-seq detects all broken hotspots in mouse genome as determined by SPO11-oligo.
(a) Aggregated END-seq signal at SPO11-oligo sites for END-seq peak called hotspots (END-seq positive) versus nonpeak called hotspots (END-seq negative) around hotspot centers.
(b) Heatmaps of END-seq signal for END-seq positive or negative hotspots ±2.5kb around SPO11 summits.
(c) Aggregated SPO11-oligo seq signal at END-seq positive versus END-seq negative hotspots around SPO11 summits.

The Landscape of Mouse Meiotic DSB Resection
END-seq captured a strikingly uniform pattern of breakage at all sites that consisted of a
strong central peak directly at the site of SPO11 cutting with an accumulation of reads flanking
the cut site at a defined distance away (Figure 14a-c). We interpret the central peak to be the
direct detection of SPO11 breakage while adjacent, distal reads reflect minimum and maximum
resection endpoints in the population of spermatocytes. Reads comprising the central peak are
entirely coincident with SPO11-oligo mapping and reflect a subset of breaks within the
spermatocyte population that has not yet released covalently bound SPO11 from the DSB (Figure
14d). As discussed later, the central peak in WT cells is dependent on engagement of the cut
chromosome with the uncut homolog, and therefore represents unreleased SPO11 associated
with recombination.
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Figure 14. END-seq uncovers a uniform pattern of SPO11 processing at all hotspots.
(a) Heatmaps of END-seq, SPO11-oligo, and SSDS ±2.5kb around hotspot centers (determined by SPO11-oligo
summits), ordered by total read count of END-seq, for top 5000 END-seq breaks.
(b) END-seq ligates adapters to terminal end of physiological resection in a heterogeneous population of spermatocytes.
(c) Schematic of END-seq break pattern, consisting of 1) a central peak at the SPO11 break site 2) a read-less gap
produced by MRE11-mediated short-range resection and minimum distance of long-range resection and 3) distal reads at
the terminal ends of long-range resection. This pattern is evident at individual hotspots (middle) and when signal from all
hotspots is aggregated (bottom). Minimum resection lengths are calculated by the absence of sequencing reads (blue
highlighted region); mean and maximum long-range resection are calculated by the average and most distal reads from
the DSB, respectively (red highlighted region).
(d) END-seq central peak and SPO11-oligo reads are coincident as evidenced by aggregated signal around SPO11-oligo
summits (normalized to the same height). Both the primary SPO11 peak and adjacent secondary peaks are apparent.
(e) Aggregate signal comparison of murine meiotic END-seq around SPO11-oligo summits and yeast meiotic S1-seq
around yeast hotspot centers.

END-seq detects the terminal end of physiologic resection after in vitro blunting of the 3’
overhang, with the first nucleotide sequenced corresponding to the position of the ssDNA-DSB
junction (Figure 14b) (Canela, et al., 2016). If bidirectional resection of DNA-bound SPO11 by
short- and long-range resection machineries are entirely coordinated as in yeast 4-6, then the
ssDNA-DSB junction will always be beyond the most distal MRE11 nick and correspond to the
terminal end of long-range resection. In this case, the location of short-range 3’-5’ MRE11
exonuclease activity would not yield any sequencing reads since it does not operate
independently of 5’-3’ resection. Indeed, at every hotspot, we observed a readless “gap” in
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resection, consistent with the tight coupling of resection initiation (by MRE11) and 5’-3’ extension
by the long-range resection machinery (Figure 14a,c). The length of this gap reflects the minimum
resection endpoints in the spermatocyte population and corresponds to the maximum distance
from the DSB at which MRE11 nicks the strand plus any constant, minimum distance that 5’-3’
exonucleases traverse. This pattern is reminiscent of S1 nuclease detection of meiotic
recombination in yeast 6 (Figure 14e). Thus, both SPO11 cutting and its initial processing by
coordinated resection mechanisms are highly conserved evolutionary features of meiotic
recombination that span unicellular eukaryotes to mammals.
The gap size was extremely uniform at all hotspots, with mean maximum distance of 647
nts (Figure 15a) and was largely restricted to the two-nucleosome H3K4/K36me3 signal
surrounding SPO11 cut sites as determined by ChIP-seq (Figure 15b-c). Thus, minimum
resection distances correlate well with PRDM9-mediated methylated histone deposition 10.
Interestingly, the majority of crossover and non-crossover boundaries in mice are also restricted
to this region, rarely extending beyond the 650 bp gap (Figure 15d) (Li, R. et al., 2019; Cole et al.,
2014). Because minimum resection correlated well with methylated histones, we asked if longrange resection endpoints were similarly well positioned. Between two replicate END-seq
samples, we found high correlation in the pattern of resection endpoints among the hotter
hotspots detected with recurrent subpeaks apparent at a mean distance of 210 nucleotides
(Figure 15e-f). This suggest that nucleosome occupancy far from the break site may influence
long-range resection endpoints.
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Figure 15. Resection calculations and reproducibility between hotspots.
(a) Histogram distributions of END-seq minimum resection lengths and maximum long-range resection endpoints in WT
spermatocytes. Mean values (bp) are listed.
(b) Aggregated END-seq and H3K4me3 ChIP-seq signal (normalized to the same height).
(c) Aggregate signal of WT END-seq and WT H3K36me3 ChIP-seq around SPO11-oligo summits at top 5000 breaks.
Signals are normalized to the same height.
(d) Distribution of short-range resection endpoints by END-seq (red), crossover breakpoints and noncrossover midpoints
(black), and DMC1 resection endpoints (blue) relative to SPO11-oligo summits.
(e) Between two biological END-seq replicates, hotspot break pattern is highly reproducible. Hotspots were binned into
20nt bins and reads per bin were correlated between replicates (Pearson correlation). Two hotspot examples demonstrate
the reproducibility in resection pattern.
(f) Correlation score (determined in “e”) plotted against END-seq intensity per hotspot. Hotter hotspots produce more
reproducible resection patterns between replicates.

Meiotic DSB Hotspots Are Detectable in a Single Mouse
To determine the sensitivity of the method, we compared 20 pooled juvenile mice to a
library made from a single 12 dpp mouse. Both samples called approximately 5000 peaks, with
77-89% shared breaks with highly correlated (r=0.98) END-seq intensities (Figure 16a).
Importantly, the break pattern at individual hotspots was fully retained in testes from a single
mouse (Figure 16b). To compare signal-to-noise ratio (S/N) in the two libraries, we followed
ENCODE’s assessment of fraction of reads in peaks (FRiP) and cross-correlation profiles (CCPs)
for ChIP-seq datasets (Landt et al., 2012; Nakato et al., 2017). FRiP and CCP values for both
libraries exceeded ENCODE’s criteria for signal to noise ratios (Figure 16c-d). We conclude that
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END-seq can accurately assess individual meiotic DSB locations and processing with remarkably
little biological material. This high sensitivity bypasses the limitations of other hotspot mapping
methods that require either impractical quantities of mice (SPO11-oligo seq) or the availability of
species-specific, high-quality antibodies (DMC1 SSDS).

Figure 16. END-seq detects meiotic DSBs in a single mouse.
(a) Left panel: Correlation (Pearson’s r) between END-seq RPKM from twenty mice versus RPKM from one 12 dpp mouse
±3kb around SPO11 summits. Right panel: Venn diagram overlap of called peaks between twenty mice and one mouse. P
value <2.2e-16, Fisher’s exact test.
(b) Left panel: Full END-seq break pattern in aggregated signal from one mouse, centered around SPO11 oligos. Right
panel: Heatmap of END-seq signal from one mouse in a ±3kb window around SPO11 oligos, ordered by total read count.
(c) FRiP values for twenty mice versus one mouse. Recommended ENCODE value denoted by dotted red line.
(d) Cross-correlation plot profiles for twenty mice and one mouse. The plot shows Pearson cross-correlations (CCs, yaxis) of read intensities between the plus strand and the minus strand, after shifting minus strand (x-axis). One peak
corresponds to read length (CCread, blue dash line) and the other one corresponds to the fragment length (CCfrag,red
dash line). Normalized strand coefficient (NSC) is CCfrag divided by minimal CC value (CCmin) and relative strand
coefficient (RSC) is the ratio of CCfrag-CCmin divided by CCread-CCmin. Higher NSC and RSC values mean more
enrichment. ENCODE’s recommendation for ChIP-seq: NSC ≥1.05 and RSC ≥0.8.

Increased Breakage in Atm–/– Spermatocytes
ATM is thought to negatively regulate SPO11 cutting, and in its absence, hotspot
breakage and SPO11-oligos have been shown to dramatically increase in mice (Lange et al.,
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2011). This ultimately results in early meiotic arrest and apoptosis of Atm–/– spermatocytes that
carry an excess of unrepaired DSBs (Lange et al., 2011). To further validate this model using
direct, genome-wide detection, we performed END-seq on Atm–/– spermatocytes that were
backcrossed eleven times to the B6 background. Indeed, Atm–/– END-seq detected 99% of WT
END-seq breaks while calling ~6.3k more peaks (Figure 17a). These Atm–/– breaks overlapped
even better with SPO11-oligos and SSDS sites and showed amplified signal over WT at weak
SSDS hotspots (Figure 17b-d). These data confirm previous reports that colder hotspots become
preferentially hotter in the absence of ATM due to a loss of negative feedback of SPO11 cutting
(Figure 17e) (Lange et al., 2011; Lange et al., 2016). To quantify this increase, we added a spikein normalization control to END-seq plugs consisting of a G1-arrested Ableson-transformed
murine pre-B cell line (Lig4–/–) carrying a single zinc-finger-induced DSB at the TCRβ enhancer
16, which was mixed in at a 2% frequency with bulk testicular cells. After normalizing END-seq
reads at all ~15,000 SPO11-oligo hotspots using the signal at the TCRβ enhancer, we found that
Atm–/– cells harbor a 4.5-fold increase in total breaks over WT. As discussed later, increased
SPO11 double-cutting within the same hotspot may account for the 10-fold increase in SPO11
oligos released in Atm–/– spermatocytes (Lange et al., 2011); yet END-seq would detect doublecutting as a single event, yielding a 4.5-fold increase in DSBs.
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Figure 17. Comparing ATM-null END-seq to previous hotspot mapping methods.
(a) Comparison of WT and Atm–/– END-seq. Venn diagram shows overlap between WT and Atm–/– END-seq peaks. P
value <2.2e-16, fisher’s exact test. Atm–/– END-seq peaks are provided in Supplementary Table 2.
(b) Venn diagram shows overlap of Atm–/– END-seq peaks and B6 SPO11-oligo sequencing peaks. P value <2.2e-16,
fisher’s exact test. Of the 1,753 hotspots found in ATM-null END-seq and not SPO11-oligo seq, 48% (833 out of 1,753)
overlap with breaks specific to Prdm9–/– SSDS hotspots, of which 48% are at promoters.
(c) Venn diagram shows overlap of Atm–/– END-seq peaks and DMC1 SSDS peaks. P value <2.2e-16, fisher’s exact test.
Of the 726 hotspots found in ATM-null END-seq and not SSDS, 82% (597 out of 726) overlap with breaks specific to
Prdm9–/– SSDS hotspots, of which 59% are at promoters.
(d) Representative genome browser profiles of meiotic hotspots on Chromosome 2 for WT SSDS, Atm–/– END-seq, and
WT END-seq. Browser axis scales are equal for Atm–/– and WT END-seq tracks to highlight the increased signal in the
absence of ATM at typically cold hotspots.
(e) The END-seq intensity of weaker hotspots preferentially increase more than stronger hotspots in Atm–/– mice. WT
RPKM per hotspot plotted against RPKM ratio of Atm–/– to WT (signal normalized to spike-in control).

Unexpectedly we found that 7-16% (700 to 1,800) of break sites were not shared in WT
SSDS or SPO11-oligo maps respectively (Figure 17b-c). Among these were several hundred
promoter breaks, typically associated as “default” hotspots in organisms lacking PRDM9 (Figure
18a). Indeed, these break locations are among the hottest Prdm9–/– sites as determined by SSDS
(Figure 18b) (Brick et al., 2012; Brick et al., 2018). Thus, in the absence of ATM, colder hotspots
and default hotspots become increasingly broken. This is consistent with previous observations
that ATM-null spermatocytes have increased SPO11-oligo mapping at PRDM9-independent
hotspots (Hinch et al., 2019).
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Figure 18. Increased default hotspot breakage at promoters in ATM-null cells.
(a) Genome browser example of an ATM-null END-seq break at a Prdm9–/– SSDS promoter hotspot. Top (+) and bottom
(–) strand-separated Prdm9–/– SSDS and Atm–/– END-seq tracks show significant signal at the promoter of the Srsf7 gene
(bottom). WT END-seq tracks are shown to the same scale as ATM-null, illustrating that these breaks are specific to the
loss of ATM regulation of SPO11.
(b) Boxplot comparison of Prdm9–/– SSDS intensity per hotspot of Atm–/– and Prdm9–/– shared hotspots versus hotspots
found only in Prdm9–/– mice. Hotspots shared between Atm–/– END-seq and Prdm9–/– SSDS are among the hottest
Prdm9–/– hotspots.

Minimal Roles for EXO1, BRCA1, and 53BP1 During Resection
Long-range resection end points showed greater variation (1-3 kb) relative to the
minimum resection gap region (0.4-1kb). Previous studies estimated total mammalian meiotic
resection lengths based on the extent of DMC1 bound to ssDNA overhangs as measured by
DMC1 SSDS (Lange et al., 2016). Strikingly, we found that maximum resection end points
extended significantly farther at all hotspots than DMC1-bound ssDNA (Figure 19a-b). ssDNA
occupied by DMC1 ranged from 800-2700 nts, whereas maximum long-range resection lengths
determined by END-seq were 1.2-1.6 fold greater (Figure 19b-c). These data indicate that DMC1
binds to only a portion of the available ssDNA and underestimates the total extent of meiotic
resection. One potential explanation is that single tracks of ssDNA can be co-occupied by DMC1
and RAD51 filaments with DMC1 loaded more proximally to the break site than RAD51 (Brown et
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al., 2015). While unlikely, this difference may also be due to technical limitations in SSDS library
preparation that relies on microhomology-mediated hairpin formations naturally present in ssDNA
tracks (Khil et al., 2012).

Figure 19. END-seq accurately measures hotspot resection lengths and elucidates resection regulation.
(a)Top (+) and bottom (–) strand distributions of END-seq and SSDS show increased resection detection by END-seq
(left, signal normalized to the same height) that is evident at individual hotspots (right).
(b) Boxplot of END-seq vs SSDS maximum resection per hotspot. ****p < 1e-10; T test.
(c) Correlation (Pearson’s r) of maximum resection endpoints detected by END-seq and SSDS.

Because the resection pattern in mouse mirrored so closely that observed in yeast
(Figure 14e) (Mimitou et al., 2017), we wanted to know whether they utilized the same long-range
end processing machineries. Exo1-deficient yeast exhibit total loss of 5’-3’ long-range resection 3.
In contrast, EXO1 and DNA2 act redundantly in yeast vegetative and mammalian somatic cells to
mediate end resection (Gravel et al., 2008; Mimitou et al., 2008; Zhu et al., 2008). Surprisingly,
END-seq analysis of juvenile Exo1–/– spermatocytes revealed that long-range resection was
largely intact (Figure 20a). When averaged genome-wide, we found a small, though significant,
reduction in long-range resection distance in Exo1–/– cells (median resection tract: WT, 1,129 nts,
vs. Exo1–/–, 996 nts) (Figure 20a). We therefore conclude that compared to yeast, mammalian
meiosis has evolved additional mechanisms to achieve extensive 3’ overhangs, perhaps through
utilization of redundant DNA2 exonuclease activity (Gravel et al., 2008; Mimitou et al., 2008; Zhu
et al., 2008).
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Figure 20. Minimal roles for EXO1, 53BP1, and BRCA1 in regulation mammalian meiotic resection.
(a)Aggregate plot of END-seq signal in WT and Exo1–/– spermatocytes (signal normalized to the same height) around
SPO11 oligos.
(b) Boxplots of mean resection between WT, Exo1–/–, 53bp1–/–, Brca1 1153bp1–/–, Brca1△1153bp1S25A, and Brca1△11p53+/– at
top 250 hotspots. *p < 0.01; ****p < 1e-10; T test with mu=10 (mu is estimated as standard deviation of WT replicates).

In somatic interphase cells, 53BP1 has been shown to inhibit long-range resection of
DSBs (Bunting et al., 2010). One principle role of BRCA1 is to counteract 53BP1’s block to
resection in S phase, possibly by excluding it from chromatin proximal to DNA damage sites
(Chapman et al., 2012). In addition, BRCA1 acts post-resection to load the RAD51 recombinase
onto 3’ ssDNA (Chen et al., 2018). Despite these extensive studies demonstrating their
importance in somatic cells, the roles of 53BP1 and BRCA1 in regulating meiotic resection are
unknown. We therefore performed END-seq on 53bp1–/– and BRCA1-deficient spermatocytes
and measured overall resection lengths. In striking contrast to 53BP1-deficient somatic cells in
which DSB resection is consistently and acutely increased 18,30,33, we found that resection
lengths were comparable at all meiotic hotspots in 53bp1–/– and WT spermatocytes (Figure 20b).
We then assayed Brca1Δ11p53+/– mice, which exhibit known defects in BRCA1 function
yet are alive due to partial p53 apoptotic suppression (Xu et al., 2001). Contrary to our
expectations (Bunting et al., 2010; Callen et al., 2020), Brca1Δ11p53+/– spermatocytes showed a
mild increase in DSB resection relative to WT controls (Figure 20b). Moreover, Brca1Δ1153bp1–/–
and Brca1Δ1153bp1S25A spermatocytes (Callen et al., 2020) exhibited a similar increase in
resection as Brca1Δ11p53+/– spermatocytes (Figure 20b). Based on these findings, we conclude
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that in contrast to their well-defined antagonistic roles in DSB processing in interphase cells,
53BP1 does not inhibit resection while BRCA1 does not promote resection during meiotic
recombination. As discussed below, one reason why end resection increases (rather than
decreases) in BRCA1-deficient cells may be due to inefficient loading of the recombinase.
Consistent with this, Brca1Δ11p53+/– spermatocytes have reduced RAD51 and DMC1 focus counts
(Xu et al., 2003).

RAD51, DMC1, and ATM Negatively Regulate Long-Range Resection
In budding yeast, cells lacking DMC1 show hyper-resection, perhaps due to a negative
feedback on resection mediated by recombinase loading (Bishop et al., 1992; Mimitou et al.,
2017). Given our results that BRCA1-deficient spermatocytes exhibited increased resection
associated with defective RAD51/DMC1 foci (Xu et al., 2003), we hypothesized that RAD51 or
DMC1 loading onto ssDNA might limit long-range resection. Consistent with this, Dmc1–/–
spermatocytes showed substantially increased resection relative to WT at all hotspots (Figure
21a-c). Minimum resection lengths also increased in Dmc1–/– cells by approximately 400 nts
relative to WT (Figure 21b).
HOP2 protein is required for proper homolog pairing after loading of DMC1/RAD51
recombinases (Petukhova et al., 2003). In Hop2–/– spermatocytes, resection lengths were similar
to WT (Figure 21a). Thus, recombinase loading post-resection, independent of strand invasion,
limits both the minimum and maximum length that the long-range resection machinery processes
DSBs. DMC1/RAD51 loading onto ssDNA might limit resection by preventing the re-initiation of
exonucleases on already resected ssDNA.
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Figure 21. DMC1 loading onto resected DSBs limits the length of resected ssDNA.
(a) Boxplots of maximum resection endpoints between WT, Dmc1–/–, and Hop2–/– at top 5000 hotspots. *p < 0.01; ****p <
1e-10; T test with mu=43 (mu is estimated as standard deviation of WT replicates).
(b) Histogram distributions comparing WT and Dmc1–/– END-seq minimum and maximum resection endpoints at top 5000
hotspots. Mean values (bp) are listed.
(c) WT vs Dmc1–/– END-seq heatmap of top 5000 breaks showing lack of central signal and increased short- and longrange resection in DMC1-null background. All hotspots show absence of central signal by heatmap in a ±2kb window
around SPO11 summits, ordered by total read count of WT END-seq.
(d) Histogram distributions comparing WT and Atm–/– END-seq minimum and maximum resection endpoints at top 5000
hotspots. Mean values (bp) are listed.

ATM negatively regulates DSB induction by SPO11 (Lange et al., 2011). Despite the fact
that Atm–/–spermatocytes harbor a 10-fold increase in SPO11 oligos (Lange et al., 2011),
RAD51/DMC1 foci form at similar levels as in WT while RPA foci counts are increased in mutant
cells (Widger et al., 2018). One possible reason why the number of foci does not correlate with
the large increase in DSBs could be that recombinase level or activity is limiting filament
formation. In this scenario, when excess DSBs are generated in an ATM-null background, the
pool of RAD51 and/or DMC1 is insufficient to load onto all ssDNA regions. In accord with this
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hypothesis, the mean maximum resection lengths increased almost 2-fold in Atm–/–
spermatocytes relative to WT (WT: 1,845 nts. vs. ATM: 3,351 nts) (Figure 21d).
Moreover, in ATM knockouts, resection lengths were significantly greater and more
widely distributed than even DMC1 knockouts (Figure 21b,d), perhaps due to combined
deficiency in RAD51 and DMC1 loading onto ssDNA (Widger et al., 2018). In accord with the idea
that increased DSB numbers rather than deficiency in ATM signaling contributes to the hyperresection phenotype in the ATM-null background, S1-seq analysis of Atm–/–Spo11+/–
spermatocytes, in which SPO11 oligo complexes are reduced by half (Lange et al., 2011),
revealed normal resection lengths (Yamada et al., 2020). Together these data support the idea
that the availability of recombinases to form filaments is limiting and insufficient when there is
excessive SPO11 cutting.

ATM Coordinates Short- and Long-Range Resection
In addition to the hyper-resection observed at a subset of breaks, distinct boundaries
between the short- and long-range resection practically disappeared in Atm–/– spermatocytes.
This resulted in reads mapping within the gap region (Figure 22a-b), in contrast to WT which
always generates ssDNA-DSB junctions beyond the most distal MRE11 nick. The decreased
minimum resection could indicate that ATM regulates the tightly coupled activities of short-range
and long-range resection (Figure 22c). This could reflect a role for ATM in promoting normal
MRE11 resection initiation as suggested for Tel1 in yeast (Mimitou et al., 2017).
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Figure 22. ATM coordinates multiple levels of resection machinery.
(a) Aggregate plots of END-seq signal in WT vs Atm–/– at top 5000 WT breaks around SPO11-oligo summits. Signals are
normalized to the same height for DSB pattern clarity.
(b) Heatmaps of WT and Atm–/– END-seq ±5kb around SPO11-oligo summits for top 5000 WT hotspots. Signals are
normalized to spike-in control to show increased Atm–/– break intensity per hotspot.
(c) Illustrations of ATM’s multiple roles in coordinating resection that gives overall heterogeneous END-seq pattern. Left:
MRE11 is recruited yet not activated in a subset of cells, resulting in reads directly at SPO11 DSB within the population.
Middle: MRE11 is activated in another subset of cells, yet long-range resection is not sufficiently initiated, resulting in
reads from only MRE11 nicking, and perhaps 3’-5’ exonuclease activity, flanking the DSB in regions that are read-less in
WT. Right: Resection is properly initiated another subset of cells, yet long-range resection travels significantly farther than
in WT.

If some DSBs remain unresected in ATM-deficient spermatocytes, we would predict that
MRE11 would accumulate at these unprocessed DNA ends. Consistent with this hypothesis,
ChIP-seq for MRE11 revealed significant chromatin binding at all hotspots in Atm–/– cells (Figure
23a-b), which correlated with END-seq intensity (Figure 23c). In contrast, we detected no signal
in similarly broken regions in WT cells (Figure 23a) indicative of completed resection. Strikingly,
the MRE11 signal in ATM-null cells was contained within the WT read-less gap (Figure 23d). This
lends further support to the idea that the gap reflects MRE11-dependent end-processing, which is
defective in the absence of ATM. Interestingly, within this gap region, MRE11 binding greatly
diminished in the small central H3K4me3/K36me3 nucleosome-depleted area (NDR) (Figure 23ab). The NDR in Atm–/– cells may be depleted of DNA due to SPO11 double-cutting.
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Figure 23. MRE11 accumulates at hotspots in the absence of ATM.
(a) Aggregated END-seq signal and MRE11 ChIP-seq RPM in WT (left) and Atm–/– (right). To fairly compare ChIP-seq
signal between WT and Atm–/–, MRE11 scale is proportional to spike-in normalized END-seq RPM for each genotype.
Individual hotspot examples (chr12:34,592,264-34,598,265) are shown below. Note that decreased MRE11 coverage is
observed within NDR of Atm–/–.
(b) Heatmaps of END-seq and MRE11 ChIP-seq in Atm–/– +/-5kb around SPO11 summits. Note that decreased MRE11
coverage is observed within NDR of Atm–/–.
(c) Correlation (Spearman’s r) between END-seq intensity and MRE11 ChIP-seq per hotspot in Atm–/– spermatocytes.
(d) Aggregate plot overlapping WT END- seq and Atm–/– MRE11 ChIP-seq, normalized to the same height. MRE11
shows prominent localization to the WT END-seq read-less gap.

END-seq Central Peak Reflects DNA-Bound SPO11
At all hotspots, END-seq detected a uniform accumulation of reads aligned to the center
of the DSB. This central peak was coincident with mapped SPO11-oligos, having a width (400 bp)
similar to SPO11-oligo seq hotspots (300-400 bp) and was restricted to the NDR of
H3K4/K36me3 (Figure 14d, Figure 15b) (Lange et al., 2016). Moreover, even low-level secondary
oligos that are adjacent to the central SPO11 hotspot peak (Lange et al., 2016) were detectable
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by END-seq (Figure 14d). This suggested that the central peak represented a fraction of the total
DSBs in the spermatocyte population in which SPO11 is not yet released, thereby highlighting the
heterogeneity of DSB processing.
If 5’ covalently-bound SPO11 DSBs existed at the time of END-seq processing, then the
proteinase K digestion would leave behind a two-bp 5’ overhang with a phosphotyrosyl bond that
requires ExoVII digestion to fully blunt the end, analogous to our studies on TOP2 cleavage
complexes (TOP2cc) (Canela et al., 2019). To test this hypothesis, we performed END-seq with
ExoT blunting only, allowing adapter ligation only to protein-free DNA ends while excluding ends
with protein adducts, such as any remaining unresected SPO11 cleavage complexes (SPO11cc).
Strikingly, ExoT detected only fully resected DNA ends with a total absence of central signal at all
hotspots (Figure 24a-b). These data indicate that the central peak, which represents
approximately 11% of the total DSB signal and is present all hotspots, reflects SPO11 covalently
bound to its break site.

Figure 24. END-seq processing with ExoT blunting alone shows total absence of SPO11 central peak.
(a) Heatmap of ExoT only signal ± 3 kb around hotspot centers, ordered by total read count of END-seq (right).
(b) A single hotspot example of END-seq with ExoVII/ExoT versus ExoT alone. SPO11 central peak detection entirely
depends on ExoVII blunting.

To validate that the ExoVII-dependent central peak was due to SPO11 bound to the
break and not some other form of occlusion, we speculated that it might be possible to remove
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SPO11 tyrosyl-linked DNA through incubation with purified human MRE11/RAD50/NBS1 (MRN)
and CtIP prior to blunting with ExoVII+ExoT, mimicking the in vivo processing of meiotic DSBs.
Indeed, we observed a dramatic loss of central signal by preincubation with MRN and CtIP
(Figure 25a) (Myler et al., 2019). Incubation with MRN alone (prior to ExoVII+ExoT) or MRN and
CtIP in the absence of manganese did not efficiently remove the central peak (Figure 25a-b)
consistent with the finding that CtIP and manganese is required for the in vitro MRE11
endonuclease processing of protein-bound DSBs (Anand et al., 2016; Deshpande et al., 2016).
Thus, purified MRN+CtIP recognizes and removes the remaining SPO11 phosphotyrosyl bonds
associated with the central signal. These data therefore support the idea that a fraction of SPO11
remains physiologically bound to a subset of breaks (~11%) at virtually all hotspots after cutting.

Figure 25. In vitro MRN removes bound SPO11 in WT spermatocytes.
(a) Pretreatment with purified human MRN + CtIP reduces ExoVII + ExoT central peak detection (red) over no
pretreatment (NT, black) and depends on the presence of CtIP (blue). Both MRN and MRN + CtIP reactions were carried
out in the presence of manganese. One 12 dpp mouse used per condition.
(b)Pretreatment with purified human MRN+CtIP reduces ExoVII+ExoT central peak detection (red) over no pretreatment
(NT, black) and depends on the presence of manganese (green). One 12 dpp mouse used per condition.

Increased Fraction of Unresected SPO11-Bound DSBs in Atm–/–
Because Tel1 regulates MRE11 initiated resection, there is a dramatic increase in
unresected DSBs in Tel1-deficient yeast (Mimitou et al., 2017). If ATM functions similarly to Tel1,
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then we would expect an accumulation of unresected SPO11 cleavage complexes (SPO11cc),
well above WT levels, at the center of the hotspots. The abundant MRE11 ChIP-seq signal
specifically in Atm–/– cells, indicative of incomplete processing, would also predict a vast increase
in SPO11cc in the mutant.
We therefore sought to modify END-seq to specifically probe for SPO11cc. We
hypothesized that preincubation with purified tyrosyl-DNA phosphodiesterase 2 (TDP2) 42 would
remove the remaining phosphotyrosyl adduct after proteinase K treatment, generating a twonucleotide, protein-free 5’ overhang that ExoT could readily blunt for adapter ligation. While ExoT
alone detected no central peak in ATM-null cells, similar to WT, TDP2+ExoT END-seq captured
an astonishingly robust central signal (Figure 26a). Moreover, this peak was strongly detected at
all hotspots (Figure 26a, right). SPO11cc detection by TDP2+ExoT far exceeded the efficiency of
detection with ExoVII+ExoT in Atm–/– spermatocytes both at autosomes and at the non-PAR X
chromosome (Figure 26b-c), most likely reflecting the biochemical preference for TDP2 over
ExoVII to remove the phosphotyrosyl bonds and allow for adapter ligation (Cortes Ledesma et al.,
2009). These data indicate that ATM-deficient spermatocytes accumulate unresected SPO11cc,
similar to yeast lacking Tel1 (Lange et al., 2016).
In WT cells, the ExoVII+ExoT central signal, which is also SPO11-bound, represents
11% of the total DSB fraction. Yet, in contrast to Atm–/–, combination of TDP2 and ExoT only
recovered a small fraction (16%) of the ExoVII+ExoT central signal found in WT cells (Figure
26d), corresponding to 0.5-2% of the total DSB signal. Given the high efficiency of TDP2+ExoT in
ATM-null cells for detection of SPO11cc, it was initially unclear why the WT TDP2+ExoT central
signal was so low. We speculated that in WT cells, the central signal might not simply reflect
unresected SPO11cc, as observed in Atm–/– spermatocytes. Rather, there might be an additional
structure at the break site associated with SPO11-bound DNA in WT cells that somehow
prevented recognition by TDP2.
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Figure 26. WT and Atm–/– hotspots contain distinct species of DNA-bound SPO11.
(a) END-seq with ExoT blunting alone also shows no central peak in Atm–/– cells (black line). Pretreatment with purified
human TDP2 before ExoT incubation recovers SPO11 signal, indicating abundance of unresected, bona fide SPO11
cleavage complexes (red line). Aggregate plot (left, normalized to same resection height) and heatmap (right) ± 3 kb
around SPO11-oligo summits.
(b) Aggregate plot of Atm–/– END-seq signal (normalized to the same resection height) comparing ExoVII+ExoT,
TDP2+ExoT, and ExoT alone. TDP2+ExoT is more efficient at detecting SPO11 cleavage complexes (SPO11cc) than
ExoVII+ExoT processing.
(c) Aggregate END-seq signal of Atm–/– non-PAR X chromosome hotspots (normalized to the same resection height) for
TDP2+ExoT and ExoVII+ExoT. SPO11cc are present at non-PAR X chromosome hotspots in the absence of ATM.
(d) END-seq aggregate plot of WT ExoT blunting with (red line) and without (black line) TDP2 pretreatment shows only
minor recovery of central peak signal.

DNA-Bound SPO11 is Dependent on Homolog Engagement and PRDM9
Our first clue to understanding the distinct nature of SPO11-bound DNA in WT vs. Atm–/–
cells was the observation that it was missing from all hotspots in Dmc1–/– spermatocytes (Figure
27a). This prompted us to ask whether the central peak associated with DNA-bound SPO11 was
also dependent on ssDNA strand invasion into the homologous partner. Remarkably, we found a
loss of central signal at all non-PAR X chromosome hotspots (Figure 27b), which repair from the
sister chromatid since the X chromosome has no homolog in males.
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The residual central signal resembled the TDP2+ExoT signal in WT cells and therefore
might simply reflect the amount of unresected SPO11 naturally present on all chromosomes. In
striking contrast, the central signal associated with autosomes and the non-PAR X chromosome
was virtually identical in Atm–/– spermatocytes, again confirming that the central signal is largely
SPO11cc in the absence of ATM (Figure 27c-d). Finally, we found that the central signal was
absent in Hop2–/– spermatocytes (Figure 27e), which fully load recombinases but fail to engage
the homologous template (Petukhova et al., 2003).

Figure 27. WT central peak relies on homolog engagement.
(a) Aggregated END-seq signal around SPO11 oligos, with hotspot example, showing absence of SPO11 central peak in
Dmc1–/–.
(b) Reduction in central signal at non-PAR X chromosome hotspots; aggregated signal on ChrX compared with all
autosomes.
(c-d) Aggregate plot of Atm–/– ExoVII/ExoT (c) and TDP2/ExoT (d) END-seq signal (normalized to the same height)
comparing SPO11cc intensity at non-PAR X chromosome hotspots and hotspots on all autosomes.
(e) Aggregated END-seq signal around SPO11 oligos showing absence of SPO11 central peak in Hop2–/–.

The analysis of hybrid mouse strains with different PRDM9 alleles has revealed that the
degree of asymmetry in PRDM9 binding—that is, whether PRDM9 binds unequally to both
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homologs predicts increased asynapsis and hybrid infertility (Davies et al., 2016; Hinch et al.,
2019). When PRDM9 fails to bind the unbroken homologous chromatid, there is a severe
reduction in both crossover and noncrossover events (Hinch et al., 2019; Li, R. et al., 2019).
Indeed, it has been suggested that similar to the X chromosome, asymmetric hotspots might be
repaired from the sister chromatid (Li, R. et al., 2019). We therefore performed END-seq on
spermatocytes derived from juvenile B6xCAST hybrids with divergent genomes. Strikingly, the
central peak was reduced to 2-3% of the total DSB signal in B6xCAST compared to the 11%
observed in B6 (Figure 28a) and much lower than in CAST alone (Figure 28b). Altogether, these
findings support the idea that the central signal detected by ExoVII+ExoT in WT spermacotyes is
associated with DNA-bound SPO11 and is dependent on the degree of homologous chromosome
engagement.

Figure 28. M. musculus musculus and M. musculus castaneous (CAST) F1 hybrids have decreased central signal.
(a) Aggregated END-seq signal of B6 (centered on B6 SPO11 oligos) versus B6xCAST hybrid (centered on hybrid SSDS
hotspot centers).
(b) Aggregate plot of END-seq signal of an adult CAST parent from the B6xCAST F1 hybrid crosses. Unlike the hybrid
pups, CAST males have prominent central signal at hotspot centers, determined by DMC1 SSDS.

In mice lacking PRDM9, DSBs occur at H3K4me3 sites mainly associated with promoters
(Grey et al., 2018; Brick et al., 2012; Paigen et al., 2018). However, these DSBs are not repaired
efficiently as crossovers resulting in meiotic arrest (Brick et al., 2012). To test how PRDM9
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deficiency impacts homolog engagement and resection we performed END-seq on Prdm9–/–
spermatocytes. As SPO11 can generate multiple breaks within the H3K4me3 sites at promoters,
we focused our analyses on Prdm9–/– SSDS sites that exhibited the least overlap between top
and bottom strand reads, i.e. hotspots that are most likely to have one main SPO11 cut site within
the promoter (Figure 29a). Such SSDS hotspots showed limited signal at the center, in line with
these sites having a strong preference for a single SPO11 cut site (Figure 29a, b). Strikingly,
END-seq analysis of Prdm9–/– spermatocytes revealed a total absence of the central peak at
hotspots with the least SSDS strand overlap, examined either on aggregate or individually in the
genome browser, whereas short-and long-range resection appeared to be relatively intact (Figure
29c-e). The absence of central signal is consistent with the idea that PRDM9 promotes homolog
engagement, which in turn facilitates crossovers. Alternatively, delay in homolog engagement
might allow more time for processing DNA-bound SPO11, resulting in loss of SPO11-bound DNA.

Figure 29. WT central peak relies on PRDM9 in addition to homolog engagement.
(a) Strand-separated aggregate plots of Prdm9–/– SSDS hotspots that have either the most top and bottom strand overlap
(left, 375 hotspots) or least overlap (right, 199 hotspots), i.e. multiple SPO11 cut sites around the center (left) or a
preferred SPO11 cut site (right). Overlap was determined by calculating, for each strand, the integration of signal from one
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side of the hotspot divided by the integration of total hotspot signal. “Most overlapped” hotspots have integration ratios of
0.75-0.85 (i.e. only 75-85% of total signal comes from one side of the hotspot) and “least overlapped” have ratios greater
than 0.9.
(b) Aggregate END-seq signal around Prdm9–/– SSDS hotspot centers at sites described as “most overlapped” in “a, left”.
At these sites in which there is no clear center for SPO11 cutting, END-seq resection signal from multiple, adjacent cut
sites within the promoter results in ambiguous central signal detection. We therefore focused analyses on the “least
overlapped” hotspots described in “a, right”.
(c) Prdm9–/– END-seq signal aggregated around default SSDS hotspot centers at ~ 200 sites with least overlap in SSDS
top and bottom strands. WT END-seq is centered around WT SPO11 oligos at PRDM9-dependent hotspots.
(d) Prdm9–/– SSDS and END-seq tracks at a single default hotspot (Yaf2 gene) with minimal SSDS top and bottom strand
overlap. Main SPO11 break site (red dotted line) is inferred from SSDS pattern. Aggregate plots in all panels are
normalized to the same height for visual comparison.
(e) Aggregate plot of non-strand-separated Prdm9–/– END-seq around SSDS hotspot centers at the least strand
overlapped SSDS sites shown in “a, right”.

SPO11 is Associated with a Recombination Intermediate
At a meiotic DSB that has been fully resected on both sides and SPO11 completely
released, adapters ligated to the right end of the break will align to the top (+) DNA strand,
whereas adapters ligated to the left end will align to the bottom (–) strand (Figure 30a, top). When
reads from all hotspots are aggregated, the distal resection signal around SPO11 cuts exhibited
this “correct” polarity for the top and bottom strands (Figure 30a, top). However, a close
examination of the WT END-seq reads associated with the central signal unexpectedly revealed a
“wrong” polarity, in which top strand reads aligned slightly to the left within the NDR and bottom
strand reads aligned slightly to the right (Figure 30a, bottom).
As SPO11 generates a DSB with only 2 nt overhangs, if the central signal were merely a
collection of unresected SPO11cc, then aggregating the top and bottom strand DSB endpoints
should show no separation between them. However, we observed a top and bottom strand shift
of ~60 nts in the “wrong” orientation (Figure 30a, bottom). Detecting a significant reversal in the
expected polarity indicated that the central peak was not simply SPO11cc, which should generate
a canonical DSB pattern (see Atm–/– below). This suggested that while SPO11 remains bound to
a fraction DSBs, there is some kind of asymmetry associated with DNA-bound SPO11 that
influenced END-seq detection compared to when SPO11 is released and both DNA ends are fully
resected (Figure 30a).
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Figure 30. Asymmetric and incomplete processing of SPO11 at hotspots.
(a) At fully processed and resected SPO11 DSBs, END-seq top and bottom strand reads exhibit a “correct” polarity to the
right and left of the DSB, respectively (left). WT reads at the center of hotspots show a strand polarity that is reversed
from what is expected (right, zoomed in at NDR).
(b) PRDM9 as a barrier to SPO11 processing that results in a SPO11-bound recombination intermediate (SPO11-RI)
structure. In WT, SPO11 cutting to one side of chromatin-bound PRDM9 within the NDR may block MRE11 activity on one
side of the break, leaving SPO11 covalently bound to a short stretch of dsDNA, capping the DMC1-loaded ssDNA that
extends ~ 1 kb from the NDR. SPO11-RI is sequenced starting from the first SPO11-bound nucleotide where an adapter
is ligated. SPO11 that cut left of PRDM9 would result in top strand reads aligning to the left of the PRDM9 motif and
bottom strand reads from fully resected ssDNA aligning at a distance away from the break site.

One potential mechanism that could contribute to the wrong polarity is asymmetric
processing of SPO11. That is, if the two DNA ends bound by SPO11 are processed at different
efficiencies by MRE11, one end might be incompletely processed, leaving SPO11 covalently
bound to its cut site, while the other end is processed to completion and SPO11-oligo released. In
this scenario, only the incompletely processed SPO11-bound end would contribute to central
peak signal. The fully processed end (Figure 30b, top, left end of the DSB) would result in the
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release of the SPO11-oligo that would generate a protein-free 3’ overhang. This (SPO11-free)
DNA end would in turn be blunted by END-seq and sequencing reads would be detected within
the distal, long-range resection peaks (Figure 30b, bottom, left end of the DSB). In contrast, the
other side of the DSB would be incompletely resected by MRE11 and retain SPO11-covalently
bound to a two-nucleotide, 5’ overhang (Figure 30b, top, right end of the DSB). END-seq
detection (with ExoVII+ExoT) would then remove SPO11 and sequence the remaining dsDNA,
with the first nucleotide sequenced being the SPO11 break site itself (Figure 30b, bottom, right
end of the DSB). This would result in top and bottom strand central peak reads with reversed
polarity within the NDR, as SPO11 breaks to the left of the NDR center would contribute top
strand reads aligning left of center, and SPO11 breaks to the right would contribute bottom strand
reads aligning right of center (Figure 30b). In a population of spermatocytes in which there is
cutting on both sides of the hotspot center, END-seq would detect an overall signal of resection
reads with correct polarity and central reads with reversed polarity (Figure 30b, bottom).
How could such asymmetric MRE11-mediated processing arise? Most SPO11-oligo
sequencing reads cluster in the center of the nucleosome free depleted region where PRDM9 is
also bound, suggesting that PRDM9 does not block SPO11 access (Lange et al., 2016; Grey et
al., 2017). It has been suggested that PRDM9 often remains bound on the uncut chromosome
(Hinch et al., 2019) while SPO11 has been proposed to be associated with DNA ends 19 until or
even subsequent to strand invasion (Hinch et al., 2019; Neale et al., 2005). If PRDM9 similarly
remains bound post-cleavage between the SPO11 cut and MRE11-endonucleolytic nicking
position, it could interfere with MRE11 release of SPO11 via 3’-5’ resection. This would prevent
MRE11 from generating a fully ssDNA overhang only on one side of the DSB. Because the
natural on/off binding affinity of PRDM9 would determine the frequency at which MRE11 activity
is blocked and SPO11-bound DNA is captured by END-seq, we would expect that the central
peak to be detected at all hotspots genome-wide, as observed. Moreover, all hotspots had equal
ratios of central peak to resection signal (~11%), indicating that no hotspot had preference over
others, regardless of break frequency.
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The central signal not only reflected asymmetric MRE11-mediated processing, but also
required DMC1- and HOP2-mediated strand invasion and engagement with the homologous
chromosome template (as shown above). Due to this dependency, we infer that SPO11 remains
bound post homolog engagement and during the formation of a recombination intermediate (RI).
We therefore refer to this RI, with SPO11 capped to the 3’ resected end, as SPO11-RI (Figure
30b). Consistent with our results, an independent genomic sequencing method (S1-seq) revealed
SPO11-RI with a reversed central signal polarity in WT spermatocytes (Yamada et al., 2020).

Increased SPO11 double-cutting at the same hotspot in Atm–/–
The central signal in ATM-null spermatocytes is largely comprised of unresected
SPO11cc, which accumulates MRE11 in vivo and is sensitive to TDP2-mediated processing
(Figure 23a, Figure 26a). This is distinct from the enrichment of SPO11-RI observed in WT cells.
Elevated levels of SPO11cc in Atm–/– cells could arise from decreased MRE11 endonucleolytic or
3’-5’ exonuclease activity (Figure 23c), which is also characteristic of yeast Tel1 deficiency
(Mimitou et al., 2017). If SPO11cc reflects fully unresected DSBs, the END-seq signal should
have the correct polarity, similar to resection endpoints, because the top and bottom strands, still
bound by SPO11, would be equally susceptible to ExoVII-mediated processing.
To examine this, we strand separated the central signal in Atm–/– cells. As predicted, we
observed the correct polarity expected for canonical DSBs (Figure 31a). Unexpectedly, the
strands still exhibited a 50 base-pair gap within the nucleosome-depleted region (Figure 31a). If
SPO11 cut once on each chromatid throughout the NDR within the population of cells and
remained bound to DNA, there would be a 2-bp gap between top and bottom strand DSB
endpoints. We therefore infer that the larger gap size reflects frequent SPO11 double-cutting
within the same hotspot (Figure 31a-b) (Garcia et al., 2015). These measurements are consistent
with the increased 40-70 nucleotide SPO11-oligo species that were detected in ATM-null mice
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(Lange et al., 2011), as two distinct SPO11 cuts adjacent to one another could release these
longer oligos even without MRE11 endonuclease activity (Figure 31b).

Figure 31. Central signal in ATM-null cells results from multiple, unprocessed SPO11cc.
(a) Atm–/– END-seq central reads have correct separated strand polarity within the NDR.
(b) Unresected SPO11 double-cutting within the same hotspot in Atm–/– cells would show the correct polarity of top and
bottom strands after adapter ligation to SPO11-bound DSBs and ~ 50 bp separation, as observed in c. Decreased MRE11
activity at these breaks would result in the direct sequencing of SPO11 cleavage complexes within the NDR rather than
SPO11-RI in WT.

Increased double-cutting around PRDM9 binding sites would preclude it from blocking
any MRE11 short-range resection that does occur, thereby reducing the frequency of SPO11-RIs
in ATM-null cells. Our finding that central signal in Atm–/– spermatocytes exhibits the correct
polarity (Figure 31b), and that this signal is identical on the autosomes and non-PAR X
chromosome (Figure 27c-d), is consistent with a significant reduction in SPO11-RI in Atm–/–
spermatocytes. Therefore, through its regulation of SPO11 cutting and resection, ATM indirectly
regulates the formation of SPO11-RI.
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Discussion
We show here the capacity of END-seq to elucidate early meiotic pathways that are
critical for proper chromosome segregation and fertility. Because the method requires little
starting material (as low as a single mouse) and can be modified through differential enzymatic
reactions to detect distinct DSB structures, we are able to bypass the limitations imposed by
previous meiotic hotspot profiling techniques. In doing so, we uncovered a pattern of resection,
strikingly uniform at all DSBs. This reflects the fact that short- and long-range resection are tightly
coupled in a single processive reaction that is mediated by ATM. This pattern is highly
reminiscent of meiotic resection in yeast and reflects the evolutionary conservation of DSB
processing pathways.
While yeast do not possess obvious homologs of BRCA1, BRCA1 has a well-described
function in supporting the resection of DSBs in somatic mammalian cells (Chen et al., 2018).
Surprisingly, we find that BRCA1 does not similarly promote resection during meiotic
recombination. One potential reason could be that 53BP1 is not recruited to DSBs in mitotic cells
or in early prophase meiocytes (Orthwein et al., 2014; Ahmed et al., 2007), which may reflect
similarities in pathways that suppress DSB repair during mitosis and meiosis. If the primary
function of BRCA1 is to counteract 53BP1’s block to resection at DSBs, this function of BRCA1
would not be needed during mitosis or meiosis.
In addition to promoting resection in somatic cells, BRCA1 also facilitates the loading of
RAD51/DMC1 onto ssDNA (Kowalczykowski et al., 2015), a function which appears to be
conserved in meiosis (Xu et al., 2003). In several BRCA1-deficient mouse strains with known
defects in RAD51/DMC1 filament formation, we observed a slight increase in resection tracts.
We suggest that this reflects an indirect role for BRCA1 in limiting resection by promoting
recombinase loading onto ssDNA. Consistent with this idea, Dmc1–/– but not recombinase
proficient Hop2–/– spermatocytes displayed a dramatic increase in minimum and maximum
resection endpoints. We additionally observe hyper-resection in ATM-null spermatocytes, which
we propose is due in part to the limited availability of recombinases to form filaments in the

71

presence of excessive SPO11 cutting. Thus, we imagine that in BRCA1-, DMC1-, and ATMdeficient spermatocytes, defective recombinase loading permits reiterative engagement of the
long-range resection machinery.
While some aspects of resection are highly conserved in yeast and mammals, SPO11processing appears not to be. Unlike yeast, mammalian cells accumulate significant levels of
DNA-bound SPO11 that represent SPO11-RI. Our model suggests that incomplete processing of
SPO11 in mammals, perhaps due to PRDM9 blocking, still allows for, and may even promote,
strand invasion via DMC1 into a homologous template. Such a structure, with SPO11 bound to a
small stretch of dsDNA, would grant stability to the large ssDNA tract generated, making it a
suitable substrate for end-ligation and sequencing. While SPO11-RI is readily detectable by ENDseq using ExoVII+ExoT and represents 11% of the total DSB signal, processing with TDP2+ExoT
only detects SPO11cc. We therefore estimate that out of the total DSB signal detected by
ExoVII+ExoT in WT cells, 0.5-2% is truly unresected SPO11cc, as detected by TDP2+ExoT, and
the remaining ~10% is SPO11-RI.
What is the biological relevance of SPO11-RI? One possibility is that SPO11-RI facilitates
noncrossover (NCO) and/or crossover (CO) events necessary for the exchange of genetic
information between homologs. The majority of NCO and CO events occur only in the 4,000
hottest hotspots (Li, R. et al., 2019), and we have found that SPO11-RI occurs across all 5,000
DSBs detected by END-seq. NCO and CO events are reduced in strains with asymmetric PRDM9
hotspots, and we found strong depletion of the central signal in hybrid strains. Finally, the
positioning of NCO and CO tracts are highly enriched in a small region (generally <500 bp)
surrounding the PRDM9 motifs (Li, R et al., 2019; Cole et al., 2014). It is possible that the
“capping” of the 3’ ssDNA by SPO11 delays polymerization or double Holliday junction migration,
therefore restricting SPO11-RI to a 400 bp region surrounding the PRDM9 motif. Although
SPO11-RI correlates with NCO and CO events, additional studies will be necessary to determine
its precise physiological function.
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The loss of the central signal in mouse hybrids, in Dmc1–/– mice, and on the WT non-PAR
X chromosome could potentially be explained if DSB repair is delayed. With a fixed on/off rate for
PRDM9, the longer DSBs persist, the more time MRE11 may have to process and remove
SPO11-bound DNA, as PRDM9 will eventually exit the hotspot. Similarly, in PRDM9-deficient
mice with defective repair, DSBs persist longer, and SPO11-RI is absent.
We find limited evidence of SPO11-RI in ATM-null cells. Instead there is a concomitant
increase in SPO11cc and MRE11 binding due to incompletely processed DSBs. Given the
dramatic in vitro activity of TDP2 in Atm–/– spermatocytes, SPO11cc might be rejoined in part by
TDP2-dependent NHEJ in vivo. Direct hydrolysis of PRDM9-blocked SPO11 by TDP2 in WT cells
would also likely result in aberrant end-joining. However, we found that purified TDP2 does not
act on SPO11-RI in vitro. Although it remains unclear why SPO11-RI is an inefficient substrate for
TDP2, it is possible that TDP2 cannot recognize SPO11-RI due to steric hindrance associated
with the heteroduplex DNA. If TDP2 were similarly inactive on SPO11-RI in vivo, the formation of
SPO11-RI could serve to prevent NHEJ and instead favor repair towards high fidelity HR.
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CHAPTER 4: Dual Histone Methyl Reader ZCWPW1 Facilitates Repair of Meiotic
Double-Strand Breaks in Male Mice

Summary
Meiotic crossovers result from homology-directed repair of DNA double-strand breaks (DSBs).
Unlike yeast and plants, where DSBs are generated near gene promoters, in many vertebrates
DSBs are enriched at hotspots determined by the DNA binding activity of the rapidly evolving zinc
finger array of PRDM9 (PR domain zinc finger protein 9). PRDM9 subsequently catalyzes trimethylation of lysine 4 and lysine 36 of Histone H3 in nearby nucleosomes. Here, we identify the
dual histone methylation reader ZCWPW1, which is tightly co-expressed during spermatogenesis
with Prdm9, as an essential meiotic recombination factor required for efficient repair of PRDM9dependent DSBs and for pairing of homologous chromosomes in male mice. In sum, our results
indicate that the evolution of a dual histone methylation writer/reader (PRDM9/ZCWPW1) system
in vertebrates remodeled genetic recombination hotspot selection from an ancestral static pattern
near genes towards a flexible pattern controlled by the rapidly evolving DNA binding activity of
PRDM9.

Background
Meiotic recombination generates genetic diversity in sexually reproducing organisms and
facilitates proper synapsis and segregation of homologous chromosomes in gametes. During
meiotic prophase I, recombination is initiated by programmed double strand breaks (DSBs) in
DNA at thousands of specific 1-2 kb regions called hotspots (Kauppi et al., 2004). DSBs are
repaired as either crossovers or non-crossovers. At crossovers, DSBs are repaired using the
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homologous chromosome as a template, which is critical for homolog pairing, synapsis, and the
successful completion of meiosis (Baudat et al., 2013; Zickler and Kleckner, 2015). In many
species, hotspots are distinguished by the presence of active histone marks in chromatin. For
example, in yeast, plants, and birds, hotspots are located at regions enriched with histone H3 trimethylated on lysine 4 (H3K4me3), typically at gene promoters (Choi et al., 2013; Lam and
Keeney, 2015; Lichten, 2015; Singhal et al., 2015). In contrast, in mammals hotspots are
determined by the DNA binding zinc finger array of PRDM9 (PR domain zinc finger protein 9)
(Baudat et al., 2010; Myers et al., 2010; Parvanov et al., 2010). PRDM9 catalyzes tri-methylation
of lysine 4 and lysine 36 of Histone 3 (H3K4me3 and H3K36me3 respectively) in nearby
nucleosomes (Eram et al., 2014; Powers et al., 2016; Wu et al., 2013). This methyltransferase
activity is essential for localization of DSBs at PRDM9 binding sites (Diagouraga et al., 2018).
Prdm9 loss-of-function in Mus musculus leads to sterility (Hayashi et al., 2005), and Prdm9
heterozygosity in some hybrid mice causes sterility (Davies et al., 2016), making Prdm9 the only
known speciation gene so far identified in mammals (Mihola et al., 2009). Furthermore, single
nucleotide polymorphisms in PRDM9 have been linked to non-obstructive azoospermia in
humans (Irie et al., 2009; Miyamoto et al., 2008)
During meiotic prophase I, chromosomes re-organize as arrays of DNA loops stemming
from an axis composed of protein complexes (Cohen and Holloway, 2014; Xu et al., 2019).
Meiotic recombination occurs simultaneously with homologous chromosome pairing and
synapsis, and the relationship between these events is complex (Gray and Cohen, 2016; Santos,
1999; Zickler and Kleckner, 2015). Recombination is achieved via homologous repair of
programmed DSBs at hotspots. DSBs are initiated by SPO11 protein binding and DNA nicking at
recombination hotspot sites (Bergerat et al., 1997; Keeney, 2008; Keeney et al., 1997; Lange et
al., 2016), followed by DNA end resection. Single strand DNA binding proteins DMC1 and RAD51
are then recruited to facilitate homologous strand invasion, formation of Holliday junctions, and
subsequent resolution as either a crossover or non-crossover (Baudat et al., 2013). Synapsis is
achieved simultaneously with meiotic recombination by connecting the two proteinaceous cores
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of each homolog axis through a central region containing the synaptic protein SYCP1, which self
assembles via its N-terminus, facilitating the closure of the synaptonemal complex (SC) like a
zipper (Fraune et al., 2012). In mice, a fully assembled SC is required for later steps in
recombination and crossovers (De Vries et al., 2005; Hamer et al., 2008). Thus, the formation of
the SC may facilitate meiotic recombination by physically connecting the two chromosomes.
Likewise, SC formation and proper synapsis requires meiotic recombination machinery including
Dmc1, Rad51, and Mre11 (Buis et al., 2008; Dai et al., 2017; Yoshida et al., 1998).
Despite PRDM9’s role in specifying hotspots in mice, DSBs are still produced in Prdm9
knock-out (KO) mice, but they are re-positioned to the “default” position at promoters (Brick et al.,
2012). However, these DSBs are not repaired efficiently, leading to meiotic arrest and partial
asynapsis. In F1 hybrid mice, the presence of symmetric PRDM9 binding motifs on both
homologs improves recombination rates (Hinch et al., 2019; R. Li et al., 2019), suggesting that
PRDM9 itself, and perhaps its downstream factors, play important roles beyond merely initiating
DSBs.
Prdm9 first evolved in jawless vertebrates, and it has been either completely or partially
lost in several lineages of vertebrates, including several fish lineages, birds, crocodiles, and
canids, indicating it is not absolutely required for meiotic recombination, synapsis, and fertility
(Baker et al., 2017). Furthermore, Prdm9 KO mice crossed into other strain backgrounds partially
restores fertility in male mice (Mihola et al., 2019). Nonetheless, the evolution of PRDM9 in
vertebrates replaced a pre-existing hotspot selection system based on the presence of single
H3K4me3 marks at promoters with a new selection system based on the presence of dual
H3K4me3/H3K36me3 marks at PRDM9 binding sites. In yeast, the histone reader Spp1 links
H3K4me3 sites at promoters with the meiotic recombination machinery, promoting DSB formation
(Adam et al., 2018). However, in mice, the Spp1 orthologue CXXC1, which also interacts with
PRDM9, is not essential for DSB generation or meiotic recombination (Tian et al., 2018). It
remains unknown whether species with PRDM9 (like mammals) evolved a specialized histone
reader (equivalent for Spp1 in yeast) to recognize the dual histone marks catalyzed by PRDM9.
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Here, we identify Zinc Finger CW-Type and PWWP Domain Containing 1 (ZCWPW1) as a dual
histone methylation reader specific for PRDM9 catalyzed histone marks (H3K4me3 and
H3K36me3) that facilitates the repair of PRDM9-induced DSBs. Our study reveals a novel histone
methylation writer/reader system that controls patterns of meiotic recombination in mammals.

Results
ZCWPW1 is a dual histone methylation reader co-expressed with PRDM9 in spermatocytes
To identify PRDM9 co-factors that may play a role in meiotic recombination, we searched
for Prdm9 co-expressed genes in single cells during meiosis from a published dataset (Chen et
al., 2018). As expected, the top Prdm9-correlated genes are known factors in spermatogenesis or
DNA metabolism (Figure 32A), however the most correlated gene in our analysis was Zcwpw1
(rho = 0.519, p-value = 2E-6). Similar to Prdm9, Zcwpw1 mRNA is highly expressed exclusively in
the testis in both mouse and human (Supplementary Figure 1A- B). To detect endogenous
expression of ZCWPW1 protein, we generated polyclonal rabbit antibodies against full-length
ZCWPW1. We confirmed that ZCWPW1 expression is mostly restricted to the testis in mice
(Figure 32B). We also ruled out the possibility of cross reactivity of our antibody with ZCWPW2, a
paralog for ZCWPW1 (Liu et al., 2016) (Supplementary Figure 2).
Mouse ZCWPW1 has three recognizable domains from the NCBI conserved domain
(CD) database: SCP1, zf-CW and PWWP (Figure 32C). The PWWP domain found in multiple
proteins binds specifically to histone H3 containing the H3K36me3 mark (Qin and Min, 2014),
while the zf-CW domain of ZCWPW1 was found to possess H3K4me3-specific binding activity
(He et al., 2010). The SCP1 domain has homology to the synaptonemal complex protein 1
(SYCP1), the major component of the transverse filaments of the synaptonemal complex (De
Vries et al., 2005). The N-terminal region of SYCP1 homologous to the SCP1 domain of
ZCWPW1 plays a role in SYCP1 dimerization that facilitates synaptonemal complex assembly
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(Seo et al., 2016). It is notable that the NCBI CD database does not recognize the SCP1-like
domain in other ZCWPW1 orthologs, including human (Figure 32C).

Figure 32. ZCWPW1 tissue expression and methyl histone binding activity in vitro.
(a) Heatmap of the top 25 genes co-expressed with PRDM9 during meiosis in single cells (Chen et al., 2018). Rows
(genes) are ordered based on PRDM9 correlation coefficient (rho). Columns (single cells) were clustered by hierarchical
clustering using euclidean distance and complete linkage.
(b) Western blot for endogenous ZCWPW1 protein expression in different tissues from WT B6 mice. The arrow indicates
ZCWPW1 band.
(c) Schematic representation of mouse and human ZCWPW1 proteins with structural domains shown as annotated from
NCBI Conserved Domain Database.
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(d) Recombinant ZCWPW1 was mixed with indicated biotinylated histone peptides and bound proteins were identified by
Coomassie staining.
(e) Isothermal titration calorimetry measurements were performed with recombinant ZCWPW1 and indicated histone
peptides. The top panel is the raw data showing the heat released and measured by the sensitive calorimeter during
gradual titration of the peptide into the sample cell containing ZCWPW1 until the binding reaction has reached equilibrium.
The bottom panel shows each peak in the raw data is integrated and plotted versus the molar ratio of peptide to protein.
The resulting isotherm can be fitted to a binding model from which the affinity (KD) is derived. The Y-axis measures
enthalpy change (ΔH) using the relationship ΔG=ΔH-TΔS where ΔG is the Gibbs free energy, ΔS is the entropy change
and T is the absolute temperature. N refers to the reaction stoichiometry.

PRDM9 catalyzes the formation of both H3K4me3 (Hayashi et al., 2005; Wu et al., 2013)
and H3K36me3 (Eram et al., 2014; Powers et al., 2016) on the same histone molecules in vitro
and the same nucleosomes in vivo (Powers et al., 2016). Therefore, we reasoned that ZCWPW1
may link the PRDM9-induced histone marks to the meiotic recombination machinery by binding to
the dually marked histone tails. Using in vitro biotin-streptavidin pulldown assays, we determined
that recombinant ZCWPW1 (residues 1-440) binds with higher affinity to H3K4me3 and
H3K36me3 than non-methylated biotinylated H3 peptides (Figure 32D). Importantly, dualmodified H3K4me3/K36me3 peptides had the highest binding affinity for ZCWPW1 compared to
peptides with either single modification (Figure 32D). We further quantified the binding of
ZCWPW1 to histone peptides by Isothermal Titration Calorimetry, which demonstrated that
ZCWPW1 binds with the highest affinity to H3K4me3/K36me3 peptides (KD =1.7±0.3 μM)
compared to H3K4me3 or H3K36me3 alone (KD > 10 μM each), with a 1:1 stoichiometry (Figure
32E). In sum these results indicate that ZCWPW1 is a meiosis specific histone methylation reader
for the unique dual methyl marks catalyzed by PRDM9, suggesting that ZCWPW1 and PRDM9
have complementary roles in meiosis.

Co-evolution of Zcwpw1 and Prdm9 in Vertebrates
PRDM9 has an extraordinary evolutionary pattern as it possesses a rapidly evolving zinc
finger array leading to distinct hotspots even among species belonging to the same genus (Baker
et al., 2017; Oliver et al., 2009; Thomas et al., 2009). Furthermore, while it emerged in jawless
fishes, it has been repeatedly lost in several species across different clades including in birds,
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crocodiles, and amphibians, as well as in several lineages of fish. To determine the evolutionary
pattern of Zcwpw1, we retrieved Zcwpw1 orthologs from three databases: (1) NCBI HomoloGene,
(2) Ensembl and (3) OrthoDB (Kriventseva et al., 2019). We then performed a motif analysis in
these orthologs using the ScanProsite tool (de Castro et al., 2006) and NCBI CD search, and
excluded orthologs lacking a zf-CW or PWWP domain. Using this strategy, we identified 174
vertebrate species with ZCWPW1.
To find additional Zcwpw1 orthologs, we extended our search by performing BLAST
(blastp and tblastn) searches using the NCBI nr and nt databases respectively against all
vertebrate genomes. We used sequences of zf- CW and PWWP domains from mouse ZCWPW1
as a query for our search. BLAST hits were then scanned for presence of both zf-CW and PWWP
domains, and only hits with the two domains present were considered for further analysis. In
addition to ZCWPW1, our analysis uncovered orthologs for ZCWPW2, a ZCWPW1 paralog which
also contains zf-CW and PWWP domains and diverged from ZCWPW1 in the last common
ancestor of vertebrates.
To differentiate between ZCWPW1 and ZCWPW2 orthologs in our BLAST results, we
added known orthologs for both proteins (ZCWPW1 and ZCWPW2) to our candidate sequences
from BLAST and performed a multiple sequence alignment and built a maximum likelihood
phylogenetic tree. ZCWPW1 and ZCWPW2 orthologs clustered into two distinct branches, and
their branching node was supported by a bootstrap value of 99% (Supplementary Figure 3).
BLAST hits which clustered with ZCWPW1 are considered as novel orthologs in our analysis.
Using this approach, we identified an additional 19 species with ZCWPW1 orthologs. Next, we
looked for sequence conservation of ZCWPW1 by performing multiple sequence alignment of all
identified orthologs. Both the zf-CW and PWWP domains are highly conserved (Figure 33A-B,
Supplementary Figure 4). Furthermore, the N-terminal region corresponding to the SCP1 domain
in mouse ZCWPW1 showed weaker but detectable conservation. When we aligned the SCP1
domain of mouse ZCWPW1 with SCP1 domain of mouse SYCP1 (Supplementary Figure 5A), we
observed 30% identity. Furthermore, the amino acids that match between ZCWPW1 and SYCP1
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have detectable conservation among ZCWPW1 orthologs (Supplementary Figure 5B), albeit less
that what is seen in zf-CW and PWWP domains (Supplementary Figure 4).

Figure 33. Evolution of Zcwpw1 in vertebrates.
(a) ZCWPW1 protein sequences available from public databases (174 species) were aligned by CLC Genomics
Workbench using MUSCLE algorithm (Edgar, 2004). Alignment conservation score is plotted as heat map across different
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regions of mouse ZCWPW1 shown in the schematic figure above the heatmap. Alignment segments corresponding to
gaps in the reference sequence (mouse ZCWPW1) were removed.
(b) Multiple sequence alignment from (A) showing regions corresponding to zf-CW and PWWP domains in 13 species
representing different vertebrate clades. Consensus sequence logo is shown below the alignment.
(c) Plot showing number of conserved catalytic tyrosines (n = 3) in the SET domain of PRDM9 in bony fish species that
have a PRDM9 ortholog. PRDM9 orthologs are divided into two groups depending on whether the corresponding species
of that ortholog has ZCWPW1 ortholog (with ZCWPW1 group) or lacks ZCWPW1 ortholog (without ZCWPW1 group).
Different colors represent different domain architecture of PRDM9 ortholog in the particular species. PRDM9 information
reproduced from Baker et al. 2017.

Like Prdm9, Zcwpw1 emerged in jawless fishes and is present in some bony and in
cartilaginous fishes. Interestingly, we could not identify any birds or crocodile species with
Zcwpw1 orthologs, similar to Prdm9 (Baker et al., 2017). However, unlike Prdm9, some
amphibians and dogs have Zcwpw1 orthologs. Bony fishes represent a heterogenous group in
regard to Prdm9 evolution, as there have been multiple events of Prdm9 loss and they have
variable PRDM9 domain structures (Baker et al., 2017). According to our analysis, several bony
fish species with Prdm9 contain Zcwpw1 orthologs (n = 9), while the majority lack Zcwpw1
orthologs (n = 29) (Supplementary Figure 6). Also, we did not detect any association between
PRDM9 domain structure and the presence of a Zcwpw1 ortholog. Next, we looked for the
conservation of the catalytic tyrosine residues of PRDM9 SET domain (Y276, Y341 and Y357),
which are critical for PRDM9 methyltransferase activity (Wu et al., 2013). Strikingly, we found that
all species with both Prdm9 and Zcwpw1 orthologs maintained the three catalytic tyrosine
residues of PRDM9, whereas the three catalytic tyrosines were present in only 3 out of 29
species lacking Zcwpw1 orthologs (Figure 33C). These findings are similar to the findings of a
recent report (Wells et al., 2019). This co-evolutionary pattern of Prdm9 catalytic tyrosines and
Zcwpw1 in bony fishes, as well as the concomitant loss of both Prdm9 and Zcwpw1 in birds and
crocodiles might imply that, at least in some species, the two genes are essential in a cooperative
manner.
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ZCWPW1 binds specifically to dual methylated nucleosomes at meiotic hotspots
Meiotic recombination DSB hotspots in mice are primarily determined by PRDM9 binding
(Baudat et al., 2010; Davies et al., 2016; Grey et al., 2017; Myers et al., 2010; Parvanov et al.,
2010). In addition to the C2H2 zinc finger domain, PRDM9 contains a KRAB, SSXRD, and PRSET domains which are critical for its function (Diagouraga et al., 2018; Imai et al., 2017;
Thibault-Sennett et al., 2018). DSB hotspots are characterized by PRDM9-dependent histone H3
methylation (H3K4me3 and H3K36me3) (Baker et al., 2014; Grey et al., 2018, 2011; Hayashi et
al., 2005; Smagulova et al., 2011). To determine whether ZCWPW1 binds to these chromatin
sites in vivo, we performed Cleavage Under Targets and Release Using Nuclease (CUT&RUN)
(Christoph and Siegenthaler, 2016) using custom polyclonal ZCWPW1 antibodies on mouse
spermatocytes. We identified 4,487 ZCWPW1 peaks (p < 0.001). Most ZCWPW1 peaks overlap
with previously identified hotspots defined by the presence of the single-strand (ss) DNA binding
protein DMC1 (Brick et al., 2018) (Figure 34A) or released SPO11-oligos (Lange et al., 2016)
(Supplementary Figure 7A) (89% and 58% respectively). Additionally, ZCWPW1 signal exhibits
positive correlation with SPO11-oligo density, DMC1-SSDS and PRDM9 binding signals
(Supplementary Figure 8).
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Figure 34. Mapping of ZCWPW1 chromatin biding in vivo using CUT&RUN in spermatocytes from B6/B6 mice.
(a) Heatmaps representing ZCWPW1, H3K4me3 and IgG (anti-GFP) CUT&RUN read coverage
in B6/B6 mouse spermatocytes at hotspots determined by DMC1 SSDS (GSE99921). Signals are centered around
PRDM9 motifs. Hotspots with multiple motifs were excluded from plotting (11,350 DSB hotspots were used in total). Yaxis of line plots in the top represents mean coverage (trimmed fragments/50 bp)
(b) Upset plot showing intersections of ZCWPW1 peaks (n = 4,487) with SPO11 oligos (GSE84689), DMC1 SDDS
(GSE99921), prophase H3K4me3 and H3K36me3 peaks (GSE121760) and transcription starting sites (TSS). Y-axis
represents number of ZCWPW1 peaks intersecting with the specified regions.
(c) Left: pie chart showing tri-methylation states of lysine 4 and 36 of histone H3 at ZCWPW1 peaks in B6/B6
spermatocytes. Right: ZCWPW1 signal strength at different ZCWPW1 peak subsets shown in the pie chart on the left. Xaxis represents the strength of ZCWPW1 signal (read coverage) per peak.
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(d) Read coverage plots for DMC1 SSDS hotspots (GSE35498/red), H3K4me3/H3K36me3 (GSE121760/Green) and
ZCWPW1/IgG (CUT&RUN/blue) across a region on chromosome 4. Hotspots and TSSs are highlighted. Y-axis
represents coverage (fragments/bin). The track in the bottom represents the bedGraph of ZCWPW1 called peaks using
MACS2.

PRDM9 binding generates a nucleosome-depleted region with nucleosomes organized
symmetrically around PRDM9 binding sites (Baker et al., 2014). When centering our CUT&RUN
signals around PRDM9 motifs, we also found a central region which lacks both ZCWPW1 and
H3K4me3 signals. This H3K4me3/ZCWPW1 depleted region is surrounded by symmetrically
distributed peaks of H3K4me3 and ZCWPW1 indicative of nucleosome positioning around the
hotspots’ central nucleosome depleted region (Figure 34A, Supplementary Figure 7B). It is
notable that DSB hotspots that fail to overlap with ZCWPW1 peaks still show ZCWPW1 signal
that is below the peak detection threshold (Supplementary Figure 9A).
Next, we looked for ZCWPW1 overlap with functional regions in the genome:
Transcription Start Sites (TSS), Transcription End Sites (TES) and CpG islands (CGI), and we
found only 8%, 9% and 5% of our ZCWPW1 called peaks overlap with these sites respectively
(Supplementary Figure 9B). Despite ZCWPW1 peaks overlapping with these sites, there was no
significant ZCWPW1 enrichment genome-wide in these functional sites compared to IgG control
(Supplementary Figure 9A,C). The weak ZCWPW1 recruitment around transcriptionally active
regions (rich in both H3K4me3 and H3K36me3 marks which rarely overlap) suggests that the
mere presence of either of these modifications alone is not associated with recruitment of
ZCWPW1 in spermatocytes.
To investigate whether the presence of both H3K4me3 and H3K36me3 marks is
associated with higher ZCWPW1 recruitment to chromatin in vivo, we used a published ChIP-seq
dataset of H3K4me3 and H3K36me3 binding in prophase I spermatocytes (Lam et al., 2019).
While ZCWPW1 binding strength showed positive correlation with H3K4me3 signals, the
correlation with H3K36me3 was weaker, probably because the H3K36me3 signal at hotspots is
notably weaker than that of the other commonly used DSB metrics (Supplementary Figure 8).
The vast majority of ZCWPW1 peaks overlapped with regions containing both H3K4me3 and
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H3K36me3 marks (85%), with significantly less peaks overlapping with regions marked by either
mark alone (Figure 34C-D). In agreement with in vitro binding assays (Figure 32D-E), we found
that ZCWPW1 CUT&RUN signals are significantly stronger in peaks with H3K4me3/H3K36me3
dual marks compared to regions with a single mark (Figure 34C).
Finally, we did not observe any enrichment of ZCWPW1 relative to control in the pseudoautosomal region (PAR) of sex chromosomes, which undergoes PRDM9-independent
recombination in mice (Brick et al., 2012) (Supplementary Figure 10). Collectively, genome-wide
mapping of ZCWPW1 demonstrates its selective binding at PRDM9 determined hotspots at
regions containing dual trimethylation of histone H3 lysine 4 and lysine 36. ZCWPW1 chromatin
occupancy is determined by PRDM9 in allele-specific manner.
To determine factors responsible for ZCWPW1 recruitment to chromatin in vivo in an
unbiased manner, we searched for enriched motifs within ZCWPW1 peak regions. This analysis
identified exclusively the PRDM9 binding motif of the Dom2 allele (PRDM9Dom2), found within
the C57Bl/6J strain (p = 1e-261), suggesting that ZCWPW1 occupancy is solely PRDM9dependent. To test this hypothesis, we mapped ZCWPW1 binding in F1-hybrid mouse
spermatocytes from a C57Bl/6J (B6) and CAST/EiJ (CAST) cross, since CAST mice encode a
unique PRDM9 allele (PRDM9Cast) with distinct DNA binding properties. In these mice, we
identified 8,976 peaks, 60% of which overlap with previously described CAST/CAST hotspots
(Smagulova et al., 2016), while only 18% overlap with B6/B6 hotspots (Supplementary Figure
11A), a finding consistent with reported PRDM9Cast dominance in hybrid mice (Baker et al.,
2015).
Furthermore, ZCWPW1 also binds to 1,383 novel hotspots that do not exist in either
B6/B6 or CAST/CAST mice, but only appear in F1-hybrids, where PRDM9Cast binds to the B6
genome and PRDM9Dom2 binds to the CAST genome (Supplementary Figure 11A). These sites
have been shown to be due to PRDM9-binding-site erosion that occurs as a result of
accumulated gene conversion events within each sub-species (Baker et al., 2015). De novo motif
discovery in the hybrids revealed two motifs identical to PRDM9Cast and PRDM9Dom2 (p = 1e-
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768 and 1e-60 respectively) (Figure 35A). This resemblance between ZCWPW1 and PRDM9 in
their chromatin binding motifs is reflected in the pattern of nucleosome occupancy of ZCWPW1
genome-wide in a PRDM9-allele specific manner in both B6/B6 and B6/CAST mice (Figure 35B,
Supplementary Figure 11B). Overall, these results indicate that ZCWPW1 occupancy is a novel
marker for meiotic hotspots that reflects PRDM9 allele specificity, and ZCWPW1 CUT&RUN is a
useful method to infer PRDM9 binding sites.

Figure 35. Mapping of ZCWPW1 chromatin biding in vivo using CUT&RUN in spermatocytes from F1 B6/CAST hybrid
mice.
(a) Comparisons of de novo discovered motifs for PRDM9Dom2, PRDM9Cast and ZCWPW1. For PRDM9Dom2 and
PRDM9Cast, PRDM9 ChIP-seq peaks (GSE93955) for either allele were queried by HOMER to identify the consensus
DNA motif for their binding sites. For ZCWPW1, CUT&RUN peaks from either B6/B6 or B6/CAST F1 hybrid were used to
identify ZCWPW1 binding motifs in pure and mixed genomic backgrounds, respectively. The first motif hit is shown for
binding in B6/B6 and the first and second hits are shown for B6/CAST.
(b) Heatmaps comparing ZCWPW1 read coverage for CUT&RUN performed in spermatocytes from either B6/B6 or
B6/CAST F1 hybrid. ZCWPW1 signal is plotted around F1 hybrid hotspots defined by DMC1 SSDS (GSE73833) and
regions categorized based on PRDM9 allele motif in the center of the hotspot (Prdm9Dom2 and Prdm9Cast for B6 and
CAST strains respectively). Signals are centered around PRDM9 motifs, and hotspots with multiple motifs were excluded
from plotting (10,466 DSB hotspots from B6xCAST F1 were used in total). Y-axis of line plots in the top represents mean
coverage (trimmed fragments/50 bp).
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Zcwpw1 knockout mice are azoospermic and display asynapsis and repair defects
PRDM9-induced DSBs are critical for successful chromosome synapsis during meiosis,
and Prdm9-null male mice (M. m. domesticus) are azoospermic as a result of meiotic arrest due
to compromised DSB repair and chromosomal asynapsis (Hayashi et al., 2005). As ZCWPW1
binding overlapped PRDM9 binding sites, we hypothesized it also plays important role in homolog
synapsis during meiosis. To test that hypothesis, we generated mice with homozygous deletion of
Zcwpw1 (Zcwpw1 KO), which were born healthy and at mendelian ratios. Western blotting
confirmed the absence of ZCWPW1 in testis from Zcwpw1 KO mice (Supplementary Figure 12A),
which are smaller and have reduced mass (Supplementary Figure 12B) compared to wild type
(Zcwpw1 WT) (80 mg vs.190 mg). Hematoxylin and Eosin (H&E) staining of tissue sections
demonstrated the total absence of spermatids in the seminiferous tubules of Zcwpw1 KO testes
(Figure 36A and Supplementary Figure 12C).
To look for possible defects in homolog pairing and synapsis, we performed double
immunofluorescence staining of spermatocyte spreads with the SC axial element marker SYCP3
(which labels the axis of sister chromatids) and the SC central element marker SYCP1 (which
stains the synaptonemal complex formed between paired homologs). SYCP3/SYCP1 staining
revealed that Zcwpw1 KO mice arrest at a pachytene-like stage of prophase I (Figure 36B). In
Zcwpw1 KO mice, almost all spermatocytes displayed partial chromosomal asynapsis (Figure
36C), with an average of 12 autosomal chromosomes synapsed per spermatocyte (out of 19), in
contrast to Zcwpw1 WT spermatocytes which -with rare exceptions- have all homologous
autosomal chromosomes fully synapsed in spermatocytes at the pachytene stage (Figure 36D).
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Figure 36. Zcwpw1 KO mice are azoospermic and display hallmarks of defective synapsis and DSB repair.
(a) Hematoxylin & Eosin staining of paraffin embedded tissue sections from testes of Zcwpw1 WT or Zcwpw1 KO. Scale
bar is 100 μm.
(b) Percentage distribution for meiotic prophase I stages in spermatocyte spreads from Zcwpw1 WT (n = 183) or Zcwpw1
KO (n = 194). Staging is based on double immunofluorescence staining of SYCP3 and SYCP1.
(c) Indirect immunofluorescence staining with SYCP3 and SYCP1 in spermatocyte spreads from Zcwpw1 WT or Zcwpw1
KO. Scale bar is 10 μm.
(d) Counts for number of fully synapsed homologous chromosomes (autosomes) per spermatocyte. Counting was
performed on spermatocyte spreads with double staining of SYCP3 and SYCP1. Only spermatocytes in
pachytene/pachytene-like stage are considered for counting in Zcwpw1 WT or Zcwpw1 KO (n = 127 for each genotype).
(e) Indirect immunofluorescence staining with SYCP3 and DMC1 in spermatocyte spreads from
Zcwpw1 WT or Zcwpw1 KO. Scale bar is 10 μm.
(f) DMC1 foci count per cell in spermatocyte spreads double stained with SYCP3 and DMC1 in Zcwpw1 WT (Leptotene =
4, Zygotene = 10, Pachytene = 27) or Zcwpw1 KO (Leptotene = 6, Zygotene = 18, Pachytene-like = 31) spermatocytes. pvalue shown is calculated with Welch’s t-test.
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As synapsis is initiated by PRDM9-induced DSBs, we tested whether asynapsis in
spermatocytes from Zcwpw1 KO mice were due to failure in DSB formation. We stained
spermatocytes with antibodies recognizing the DSB marker γ-H2AX and the repair factor DMC1,
which is recruited to single stranded DNA resulting from DSBs. Spermatocytes from Zcwpw1 KO
mice have widespread focal accumulation of DMC1 in the cells arrested at pachytene-like stage
(Figure 36E, Supplementary Figure 12D), with significantly increased numbers of DMC1 foci, per
spermatocyte in Zcwpw1 KO (Figure 36F). Furthermore, γ-H2AX staining showed significant
accumulation on autosomes and the absence of the XY sex body, indicating prophase blockage
before sex body formation (Supplementary Figure 12D).
Our observations from immunofluorescence staining are in agreement with what has
been recently reported by two different groups who found that Zcwpw1 KO spermatocytes have
pachytene-like meiotic arrest with partial asynapsis and increased DMC1 foci compared to
Zcwpw1 WT spermatocytes (M. Li et al., 2019; Wells et al., 2019). These results suggest intact
DSB formation by SPO11 but defective repair and synapsis. Collectively, Zcwpw1 KO mice
phenocopy Prdm9 null male mice in which sperm production is compromised by partially
defective DSB repair and synapsis with meiotic arrest at a pachytene-like stage (Brick et al.,
2012; Hayashi et al., 2005).

DSBs are generated at PRDM9-dependent hotspots but are not fully repaired in Zcwpw1
knockout mice
In Prdm9-null male mice, meiotic DSBs reposition away from PRDM9 bound motifs to
promoters and at other sites of PRDM9-independent H3K4me3 (Brick et al., 2012). As Zcwpw1
KO mice phenocopy Prdm9 null mice, we predicted that DSBs in Zcwpw1 KO mice would be
similarly repositioned to promoters. To map hotspot locations, we utilized END-seq, a quantitative
method that sequences DSBs at nucleotide resolution (Paiano et al., 2020). We performed ENDseq using bulk testicular cells from Zcwpw1 KO and Zcwpw1 WT adult mice. Peak calling on
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END-seq reads identified 2,098 and 3,147 DSB sites in spermatocytes from Zcwpw1 WT and
Zcwpw1 KO mice respectively. Surprisingly, unlike the case in Prdm9 KO, DSBs in Zcwpw1 KO
mice nearly completely overlapped with DSBs in Zcwpw1 WT, and with previously identified
hotpots in B6 mice using DMC1 SSDS (Figure 37A-C). Importantly, unlike in Prdm9 KO mice,
DSBs were not repositioned towards promoters (Figure 37B).

Figure 37. Double Strand Break mapping by END-seq in spermatocytes from adult Zcwpw1 WT and Zcwpw1 KO mice.
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(a) Venn diagram showing END-seq peak overlap between Zcwpw1 KO and Zcwpw1 WT (left) or between Zcwpw1 KO
END-seq peaks and DMC1 SSDS hotspots (GSE35498) (right).
(b) END-seq read coverage heatmaps comparing Zcwpw1 WT and Zcwpw1 KO DSBs at different indicated regions:
DMC1 SSDS hotspots (WT and PRDM9 KO/ GSE35498) and transcription starting sites (TSS). All signals are normalized
with spike-in controls. Y-axis of line plots in the top represents spike normalized Reads Per Million Reads (RPM)
(c) Read coverage plots for H3K4me3 (CUT&RUN/green), DMC1 SSDS hotspots from WT and PRDM9 KO
(GSE35498/red) and END-seq (blue).
(d) Read coverage heatmaps for END-seq reads from Zcwpw1 WT and Zcwpw1 KO spermatocytes. Signal is plotted
around WT END-seq called peaks (total peaks on the left, and non-PAR of chromosome X peaks on the right). Signals
are centered at the overlapping SPO11 oligo summits (GSE84689). Signal is normalized with spike-in controls. Y-axis of
line plots in the top represents spike normalized Reads Per Million Reads (RPM).

After normalizing the END-seq signal using spike-in controls, we observe a distinct ENDseq signal profile across all hotspots, with an increased flanking peak signal with relatively
unchanged central peak signal (Figure 37D). This central peak region largely reflects a
recombination intermediate with covalently bound SPO11 resulting from single strand invasion
into the unbroken homologous chromosome, whereas the flanking peak regions reflect the extent
of end-resection (Paiano et al., 2020). This interpretation of central signal is supported by the loss
of the central peak at non-PAR region of the X chromosome in Zcwpw1 WT testes (whose repair
does not involve homolog engagement) (Figure 37D). The minimal change in the central signal in
comparison to end-resection signal might suggest that, in Zcwpw1 KO spermatocytes, DSB repair
is defective downstream of homolog invasion and formation of recombination intermediates.
However, given that asynapsis is only partial in Zcwpw1 KO, and the END-seq signal is
representative of both a heterogenous cell population and many hotspots, we can’t exclude a
potential role of ZCWPW1 in facilitating homolog invasion at some hotspots. In sum these data
indicate that unlike PRDM9, ZCWPW1 is not required for the positioning of DSBs, rather it is
required exclusively for efficient DSB repair and HR.
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Supplementary Figures

Supplementary Figure 1. Zcwpw1 transcript expression in human and mouse tissues ZCWPW1 transcript expression from
different tissues in human (GTEx) (a), and mouse (Li et al., 2017) (b).
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Supplementary Figure 2. ZCWPW1 antibody specificity. Testing ZCWPW1 antibody specificity for ZCWPW1 and potential
cross-reactivity with ZCWPW2. His-tagged recombinant ZCWPW1 (~ 70 kDa) and ZCWPW2 (~ 49 kDa) were loaded in
SDS-PAGE gel and transferred to PVDF membrane. Membranes were then subjected for either Ponceau S staining
(right) or immunoblotting with anti-ZCWPW1 rabbit polyclonal antibody (left).
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Supplementary Figure 3. Phylogenetic analysis of potential ZCWPW1 orthologs discovered by BLAST. Maximum
likelihood phylogenetic tree to differentiate ZCWPW1 orthologs from ZCWPW2 orthologs among tentative sequences
discovered by BLAST (see methods). Using CLC Genomics Workbench (progressive alignment algorithm), tentative
sequences were aligned with known ZCWPW1 and ZCWPW2 reference sequences (text highlighted with blue and red
respectively for ZCWPW1 and ZCWPW2 reference sequences). Mouse NSD2 was used as outgroup sequence. 1000
bootstrap replicates were performed, with bootstrap values ≥ 70% are shown in the tree. ZCWPW1 and ZCWPW2
sequences clustered into distinct branches (blue and red box respectively) with node support of 99%. "Ref": known
reference sequence for ZCWPW1 or ZCWPW2 ortholog, "nr" : sequence discovered using BLAST blastp, "nt" : sequence
discovered using BLAST tblastn, "CD" : evidence for presence of zf-CW and PWWP domain was through NCBI
conserved domain database search (evidence for other sequences is by ScanProsite).
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Supplementary Figure 4. Amino acid variability in ZCWPW1 orthologs.Plot for variability of amino acid residues in aligned
sequences of ZCWPW1 orthologs in Figure 2A. Amino acid positions in mouse ZCWPW1 were used as reference for
plotting. Shannon entropy analysis was used to calculate variability scores (Shannon, 1948. see methods). X axis
represents amino acid positions in mouse ZCWPW1 (schematic representation of it shown above the plot). Y axis
represents Shannon entropy (H) for every position in X. Small H score means low variability of amino acid reside in the
corresponding position, and therefore greater conservation.
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Supplementary Figure 5. Alignment of SCP1 domains from mouse ZCWPW1 and SYCP1.
(a) Alignment of SCP1 domain from mouse ZCWPW1 (76 – 228 aa) with SCP1 domain from mouse SYCP1. Alignment is
done by CLC Genomics Workbench using MUSCLE algorithm (Edgar, 2004). Alignment segments corresponding to gaps
in ZCWPW1 were removed.
(b) Upper: Heatmap representation for the alignment in (A). Lower: Plot for variability of amino acid residues in aligned
sequences of ZCWPW1 orthologs. It is partial subplot from the plot in Figure 2 – figure supplement 2), showing only the
SCP1 domain region (76 – 228 aa).
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Supplementary Figure 6. PRDM9 domain structure in bony fishes. Comparison of PRDM9 domain structure in bony fish
species with or without ZCWPW1 ortholog. PRDM9 information reproduced from Baker et al. 2017.
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Supplementary Figure 7. Mapping of ZCWPW1 chromatin biding in vivo using CUT&RUN in spermatocytes from B6/B6
mice.
(a) Heatmaps representing ZCWPW1, H3K4me3 and IgG (anti-GFP) CUT&RUN read coverage in B6/B6 mice
spermatocytes at SPO11 oligo summits (GSE84689). Y-axis of line plots in the top represents mean coverage (trimmed
fragments/50 bp).
(b) Representation of mean coverage plot from Figure 3A to emphasize the signal pattern around PRDM9 motifs. Y-axis
represents mean coverage (trimmed fragments/50 bp). The central regions lack ZCWPW1 and H3K4me3 signal. These
H3K4me3/ZCWPW1 depleted regions are surrounded by symmetrically distributed peaks of H3K4me3/ZCWPW1
indicative of nucleosome positioning around the hotspots’ center.
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Supplementary Figure 8. ZCWPW1 correlation with other metrics of meiotic recombination at DSB hotspots. Correlation of
ZCWPW1 CUT&RUN signal strength (left) and SPO11 oligo intensity (GSE84689) (right) with other metrics of
recombination at DSB hotspots: DMC1 SSDS (GSE35498), H3K4me3 12dpp (GSE35498), PRDM9 (GSE93955),
H3K36me3 (GSE93955) and H3K4me3 Zygonema (GSE121760). ZCWPW1 CUT&RUN data is from B6 mice. For all
panels, only autosomal hotspots that coincide with a ZCWPW1 peak were used. ZCWPW1 strength is calculated as the
sum of in-peak sequencing CUT&RUN reads at each hotspot. SPO11 strength is represented as SPO11-oligo density
(Lange et al., 2016). DMC1 strength is represented as DMC1 SSDS signal at hotspots (Khil et al., 2012). For remaining
metrics, the strength is calculated as the sum of all reads at the SSDS-defined hotspot.
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Supplementary Figure 9. ZCWPW1 binding at functional genomic sites.
(a) Heatmaps representing ZCWPW1, H3K4me3 and IgG (anti-GFP) CUT&RUN read coverage in B6/B6 mouse
spermatocytes at indicated regions. Y-axis of line plots in the top represents mean coverage (trimmed fragments/50 bp).
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The purpose is to compare ZCWPW1 occupancy at DSB hotspots with occupancy at functional sites in the genome:
Transcription Start Sites (TSS), Transcription End Site (TES) and CpG islands (CGI). Hotspots regions are based on
DMC1 SSDS (GSE99921), and they are categorized into two groups based on whether ZCWPW1 peak was called in the
individual hotspot (n = 2,446) or not called (n = 8,904). Heatmap for ZCWPW1 signal around hotspots without called
ZCWPW1 peak is zoomed in at the right panel. For hotspots, signals are centered around PRDM9 motifs, and hotspots
with multiple motifs were excluded from plotting. TSS and TES were retrieved from GENCODE release M20. After mm10
blacklisted regions in TSS and TES were filtered out, 67,579 TSS and 82,380 TES sites were used for plotting.
(b) Upset plot showing intersection of ZCWPW1 peaks (n = 4,487) with DMC1 SSDS hotspots (GSE99921), TSSs, TESs
and CGIs. Y-axis represents number of ZCWPW1 peaks intersecting with the specified regions.
(c) Enrichment of reads from different experiments at indicated genomic regions. All experiments are from CUT&RUN with
exception of 12dpp H3K4me3 reads which are from ChIP-seq (GSE35498). Genomic regions represent (i) peaks called
from ZCWPW1 and H3K4me3 CUT&RUN from both B6 and B6XCAST mice (ii) hotspots (HS) regions from DMC1 SSDS
(B6: GSE99921), (B6/CAST: GSE73833) and (iii) functional genomic sites: Transcription Start Sites (TSS), Transcription
End Site (TES) and CpG islands (CGI). Sequencing reads (q > 30) at each set of genomic intervals were counted for our
four CUT&RUN experiments as well as for H3K4me3 ChIP-Seq data in 12dpp testis. Thereafter, percentage of total reads
in each set of genomic intervals was determined. For all experiments, the enrichment of percentage reads relative to IgG
control (anti-GFP) CUT&RUN in B6 mice is shown. Color legend is scaled by the log of enrichment values.

103

Supplementary Figure 10. ZCWPW1 binding at chromosome X pseudoautosomal region. Read coverage plots for
ZCWPW1, H3K4me3 and IgG (anti-GFP) CUT&RUN, and DMC1 SSDS hotspots from WT and PRDM9 KO (GSE35498)
in chromosome X pseudoautosomal region (PAR) or at PAR-adjacent PRDM9-independent hotspots. Y-axis represents
coverage (fragments/bin).
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Supplementary Figure 11. Mapping of ZCWPW1 chromatin biding in vivo using CUT&RUN in spermatocytes from F1
B6/CAST hybrid mice.
(a) Upset plot showing intersections of ZCWPW1 CUT&RUN peaks (from B6/CAST F1 hybrid spermatocytes, n = 8,976
peaks) with DMC1 SSDS hotspots (GSE75419) from (i) B6/B6, (ii) CAST/CAST and (iii) B6/CAST F1 hybrid
spermatocytes. Y-axis represents number of ZCWPW1 peaks intersecting with the specified regions.
(b) Read coverage plots for ZCWPW1 occupancy in B6/B6 and B6/CAST spermatocytes. Y-axis represents coverage
(fragments/bin).
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Supplementary Figure 12. Phenotyping of Zcwpw1 KO spermatocytes.
(a) Western blot with ZCWPW1 specific polyclonal antibody in tissues from WT (blue lanes) or KO male mouse (red
lanes) tissues. The arrow indicates ZCWPW1 band.
(b) Photo comparing size of testes from Zcwpw1 WT (left) and Zcwpw1 KO mice (right).
(c) Hematoxylin & Eosin staining of testes sections from Zcwpw1 WT or Zcwpw1 KO mice. Scale bar is 1 mm.
(d) Indirect immunofluorescence staining with SYCP3 and γ-H2AX in spermatocyte spreads from Zcwpw1 WT or Zcwpw1
KO. Scale bar is 10 μm.
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Discussion
In this study, we used a computational approach to identify PRDM9 co-expressed genes
and identified a novel factor, ZCWPW1, that is critical for the repair of PRDM9-induced DSBs
during meiosis. Like PRDM9, ZCWPW1 is expressed at very low/undetectable levels in most
tissues but becomes expressed at high levels prior to and during meiotic prophase 1. Zcwpw1 is
necessary for fertility in male mice, as Zcwpw1 KO mice are azoospermic, similar to Prdm9 KO.
In contrast, Zcwpw1 KO females are initially fertile, but suffer from ovarian insufficiency as they
age, likely due to delayed meiosis in fetal ovaries (M. Li et al., 2019). This is also in contrast to
Prdm9 KO females, which are completely infertile (Hayashi et al., 2005). These data highlight the
distinct checkpoint sensitivities in males and females for meiotic progression defects.
Furthermore, the distinct phenotypes of Prdm9 and Zcwpw1 loss-of-function in females suggest
that PRDM9 has ZCWPW1 independent function in females that will require additional
exploration.
PRDM9 is a unique SET domain containing histone methyltransferase in several
respects. First, it contains its own specific DNA binding domain, a rapidly evolving C2H2 zinc
finger array that binds to target sequences with high specificity. Second, it contains a dual
specificity histone methyltransferase activity for histone H3 K4 and histone H3 K36 (Eram et al.,
2014; Powers et al., 2016; Wu et al., 2013). Likewise, ZCWPW1 is a unique protein that
possesses dual histone methylation reader domains; a zf-CW domain that has previously been
shown to bind to the H3K4me3 mark (He et al., 2010), and a PWWP domain, which has been
shown on multiple proteins including DNMT3a and DNMT3b to bind to the H3K36me3 mark
(Rondelet et al., 2016). ZCWPW1 can bind to histone H3 peptides with double H3K4me3 and
H3K36me3 marks in vitro with high affinity at a 1:1 ratio. Furthermore, PRDM9 predominantly
methylates H3K4me3 and H3K36me3 on the +1, +2, –1 and –2 nucleosomes flanking its binding
sites, which provides a short platform for ZCWPW1 interaction with chromatin at sites in vivo.
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Thus, we prefer a model in which ZCWPW1 interacts with both marks on the same H3 peptide,
but it cannot be ruled out that ZCWPW1 binds to the two marks on separate H3 molecules on the
same or adjacent nucleosomes. Resolving these possibilities will require additional biochemical
studies.
The mapping of ZCWPW1 binding to chromatin genome-wide by CUT&RUN
demonstrated that the majority of binding sites overlap with meiotic DSB hotspots. Most of these
sites are characterized by the concurrent presence of PRDM9-dependent tri-methylation marks:
H3K4me3 and H3K36me3. This implies that ZCWPW1 plays a central role as PRDM9 co-factor.
Nevertheless, we could still find weak binding of ZCWPW1 to a few functional sites in the genome
including Transcription Start Sites (TSS), Transcription End Site (TES) and CpG islands (CGI).
Similarly, Huang and colleagues showed that ZCWPW1 is recruited to some promoter and CGI
sites (Huang et al., 2019). However, Huang and colleagues found minimal gene dysregulation in
Zcwpw1-null mice, including little changes in genes whose promoters were bound by ZCWPW1.
Wells et al. also found ZCWPW1 recruitment to CGIs when overexpressed in 293T cells, but the
binding at these sites was considerably weaker than to PRDM9-dependent hotspots (Wells et al.,
2019). We conclude from these studies that ZCWPW1 may bind weakly to some promoters and
CGIs which is enhanced by overexpression, but at physiological expression levels, ZCWPW1 is
primarily recruited to dually marked (H3K4me3/H3K36me3) sites in a PRDM9-dependent
manner. Based on these findings and the rapid evolution of PRDM9 DNA binding zinc finer array,
we think it is unlikely that ZCWPW1 plays an important role as transcriptional regulator during
meiosis.
Against our expectations, ZCWPW1 is dispensable for initiating DSBs at PRDM9-bound
hotspots, as DSBs in Zcwpw1 KO male mice are still located at PRDM9 bound sites. Our data
instead suggests that ZCWPW1 is critical for the efficient repair of these PRDM9-dependent
breaks. This conclusion is supported by the partial asynaptic pachytene-like meiotic arrest
observed in Zcwpw1 KO, which coincides with accumulation of γ-H2AX and DMC1, both
characterizing failed DSB repair. The findings that PRDM9 histone methyltransferase activity is
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essential for DSB formation at PRDM9 binding sites (Diagouraga et al., 2018; Powers et al.,
2016) would therefore seem to suggest that a yet to be described PRDM9 histone methyl reader
may link PRDM9 to the DSB machinery upstream of ZCWPW1. ZCWPW2, a paralog of
ZCWPW1 that diverged early in evolution, is a possible candidate.
In Zcwpw1 KO spermatocytes, the END-seq profile at hotspots demonstrates the
presence of a central peak comparable to WT mice. Such central peaks are lost in Dmc1 KO
mice which fail to undergo strand invasion (Paiano et al., 2020). This result might suggest that
strand invasion is intact in Zcwpw1 KO. However, because the asynapsis in arrested
spermatocytes in Zcwpw1 KO is only partial, it is difficult to infer the source of the central peak of
END-seq in a heterogenous population of synapsed/asynapsed homologous chromosomes.
Therefore, we conclude that ZCWPW1 is a critical factor for DSB repair, and it might act either
upstream or downstream of strand invasion step in DSB repair. We propose a model in which
ZCWPW1 functions as a PRDM9 specific synapsis factor that is necessary to bind both the cut
and uncut orthologs to link PRDM9-bound DNA loops to the SC, to facilitate later steps in meiotic
recombination. This model is supported by a recent study which suggested that symmetrical
PRDM9 binding is critical for meiotic recombination. But how exactly does ZCWPW1 facilitates
such synapsis and repair? A hint may lie within the moderately conserved SCP1 domain found at
the N-terminus of mouse ZCWPW1 which shares homology to a region of the central axis protein
SYCP1 that makes a coiled-coil and facilitates dimerization (Seo et al., 2016). Thus, PRDM9
bound loops could be directly tethered to the SC via ZCWPW1. Further studies are needed to
explore potential interactions of ZCWPW1 with chromosomal axis and SC components.
In this study we have developed and applied two novel, independent and sensitive
methods for mapping meiotic hotspots; END-seq, and ZCWPW1 CUT&RUN. These methods
have distinct advantages over previous methods, that include SPO11 oligo sequencing (Lange et
al., 2016) and SSDS coupled with DMC1 ChIP-seq (Khil et al., 2012). END-seq is a method of
directly sequencing DSBs, and we have applied it to a single mouse testis to map thousands of
hotspots. This method could therefore be applied to virtually any organism for mapping hotspots
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as it does not require the use of antibodies. ZCWPW1 CUT&RUN also maps mouse hotspots, by
mapping the occupancy of the factor ZCWPW1 that is directly downstream of PRDM9-induced
histone methylation marks using a polyclonal antibody. Importantly, ZCWPW1 occupancy
correlates positively with the strength of hotspots in mice. We applied ZCWPW1 CUT&RUN to
300,000 bulk testicular cells from adult mice (a tiny fraction of the material obtained from a single
adult testis) to sensitively map thousands of mouse hotspots. Thus END-seq provides a greater
breadth of possible uses including non-model organisms, whereas ZCWPW1 CUT&RUN
provides greater flexibility with lower cell numbers in mice. However, both methods currently fall
short in detecting the weakest DSB hotspots which could be mapped by SPO11 oligo sequencing
and DMC1 SSDS. With optimizations to both techniques, they could be potentially pushed for
improved sensitivity for weaker hotspots with low starting cell numbers. This would allow hotspot
mapping for currently challenging situations like mouse females or in species with low meiotic cell
numbers.
In yeast, plants and at least some vertebrates (those that lost PRDM9 like canids and
birds); meiotic hotspots are located in the nucleosome free regions at gene promoters. However,
within species that evolved PRDM9, hotspots are specified by the DNA binding activity of the
PRDM9 zinc finger array. Therefore, the emergence of PRDM9 was a landmark that re-shaped
patterns of meiotic recombination during evolution. The PRDM9-derived pattern of hotspot
selection provided more flexibility in hotspot evolution compared to the ancestral, fixed pattern of
hotspots found at promoters and within genes by decoupling hotspot selection away from
functional genetic elements. In this work, we identified ZCWPW1 as an essential factor in the
PRDM9 hotspot selection system. This system evolved by co-emergence of (i) a histone writer
(PRDM9) which catalyzes formation of H3K4me3 and H3K36me3 dual marks and (ii) a histone
methylation reader (ZCWPW1) which recognizes these dual marks to facilitate DSB repair at the
PRDM9 bound sites. The presence of these two factors is crucial for hotspot selection and
successful meiotic recombination in mice.
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CHAPTER 5: A Discussion on Biological Identity from Genome to Organism

The purpose of this chapter is to argue for the evolutionary connection between the
protein repair of DNA and the immune cell repair of tissues. This perspective has allowed me to
recognize many biological parallels between the two systems. I realized that these parallels are
likely uncoincidental and represent the establishment, maintenance, and regulation of
multicellular identity, that is, the biological basis for distinction between organisms in a species.
For simplification (and to highlight direct connections between the two), organismal identity in this
chapter is divided into two components: genetic identity and immunologic identity. As DNA
provides the code for all life activities, it is obvious why genetic identity influences organismal
identity. Immunologic identity, as further defined by me below, is simply the competence of the
immune system, through its discriminatory recognition and activation (i.e. identity), to maintain the
integrity of tissues. DNA repair maintains genetic identity, and the immune system, as directed by
its identity (both conserved and trained, discussed later in this chapter), maintains multicellular
function. I intend to demonstrate by the end of this chapter that analogizing DNA repair and
immunity has allowed me to broaden my understanding of immune function and how it may have
evolved. For me, a more comprehensive view of multicellular systems, including, but not limited
to, immunity, is a more fruitful approach to addressing complex disease phenotypes, such as
cancer and aging, which I attempt to adequately discuss in this chapter as well.
I define here genetic identity as the genomic DNA sequence of an organism at the time of
fertilization and zygote formation. I define immunologic identity as the capacity of immunity to
both recognize and react to agents, in a specific, contextual fashion, that threaten tissue integrity.
With this definition, I hope to merge concepts from both self-non-self theory and danger theory in
immune activation and purposefully avoid preference of one model over the over (Matzinger,
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2002; Pradeu and Cooper, 2012). Although “agents that threaten tissue integrity” echoes danger
theory tenants, I do not intend to define what is and is not dangerous. My intention in this chapter
is to draw parallels between the establishment and maintenance of genetic integrity and the
establishment and maintenance of tissue integrity, the latter of which relies mostly on
immunologic activities. Thus, my definition of immunologic identity here specifically pertains to
those activities in which immune function is critical to maintain tissue function.
This definition in an evolutionary context implies that immunity has largely evolved to do
what unicellular repair pathways (such as DNA repair) cannot do in a multicellular organism,
namely to communicate stress across cells to repair tissues. In this way, it is not surprising that
so many parallels exist between DNA repair and immune repair, as the latter may have evolved
to apply the general activities of genome maintenance to the organismal level. The evolution of
immunity across animals is not irrelevant here and likely demonstrates important aspects of
multicellular biology that necessitated the increasing layers of immunity that have evolved in
animals. In summary, I aim to argue in this chapter that immunity could be viewed in many ways
as an evolutionary extension of biological identity maintenance required in multicellular
organisms. Without it, tissue integrity would not be possible.
As humans, we carry significant evolutionary baggage in our genomes. I will not discuss
here modes of allele inheritance, such as gene flow, genetic drift, and other aspects of population
genetics, although these are critical aspects to the generation of individual genetic identities.
Instead, suitable for this thesis, I will start this chapter by discussing meiosis. But first, I want to
highlight many fascinating aspects of biology that can modulate inherited genetic identity in
sometimes semi-permanent ways. Most critical are epigenetic mechanisms that directly modify
DNA without changing sequence, such as DNA methylation and small non-coding RNAs, that
direct heritable changes in a cell’s capacity to interpret its genetic code (Skvortsova et al., 2018).
In females, X chromosome inactivation is a similar mechanism by which only one X chromosome
is accessible to any given cell, resulting in allelic mosaicism for expression of X chromosome
genes (Panning, 2008; Migeon, 2007). Chromatin alterations, through post-translational
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modifications of histones, are pivotal features that drive transcriptional identities and
differentiation of cells within tissues (Lawrence et al., 2016; Henikoff and Smith, 2015). Beyond
control at the DNA level are mechanisms to modulate the transcriptional and translational outputs
of genes, such as differential codon usage and non-coding RNAs, respectively (Quax et al., 2015;
Patil et al., 2014; Fernandes, et al., 2019). For the purposes of the chapter, I will give focus to the
many mechanisms that maintain genome stability and preserve DNA sequences in cells.

Generation of genetic identity
Genetic identity as defined at fertilization, comprises maternal and paternal copies of
each chromosome. The constituent DNA of those chromosomes were generated during meiotic
division in parents. Meiotic recombination results in the exchange of genetic information between
each parent’s own maternal and paternal chromosomes, referred to as crossover events (Hunter,
2015). Crossovers occur at variable locations with each meiotic division; thus, each gamete
harbors a unique chromosome composition that will ultimately help define the genetic identity of
offspring. This allele shuffling during meiosis is a primary mechanism to ensure biodiversity in the
next generation, a process likely evolutionarily selected for to aid in fitness advantages.
As discussed in previous chapters, meiotic recombination not only produces evolutionary
benefits but is actually required for the proper segregation of homologous chromosomes to avoid
fertility issues (Wang et al., 2015). Mis-segregation of chromosomes could result in gametes
carrying abnormal numbers of chromosomes. Therefore, meiosis must confer new genetic
identity in a highly controlled process, otherwise alterations that are too drastic, such as
aneuploidies, will be deleterious to offspring. The induction of DNA damage by SPO11 across all
chromosomes provides the opportunity to diversify genetic identity through recombination events.
This extensive DNA damage must be tightly regulated and processed, such as the activities of
ATM described in Chapter 3. Improper repair of these lesions could beget heritable genomic
instability (e.g. translocations, fragmented chromosomes, and nondisjunctions) that threatens the
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health and viability of descendants. In fact, recent evidence suggests that increasing errors in
meiotic chromosome segregation (a process linked to accurate recombination) during human
oogenesis directly contributes to age-associated infertility (Gruhn et al., 2019). As with many
aging phenotypes, this may reflect a general lack of evolutionary pressure for fitness as
populations age; however, the evolution pressures on meiosis have yet to be fully characterized,
as discussed below.
In the late 19th century, August Weismann proposed the germ plasm theory of inheritance
(Weismann, 1893). Countering Lamarckism, the theory proposed that biological diversities that
drive evolution are inherited through germ cells in reproductive tissues rather than somatic cells
that accumulate incremental changes over time. Our understanding of homologous recombination
gives us insight into how allele frequencies can be successively recombined each generation
within a population, but we still lack clear mechanisms of how and when heritable mutations, i.e.
new alleles and genes, that can drive natural selection are introduced to germ cells. Germline
mutations are not exclusive to meiotic events and can theoretically be inserted at many stages of
development, ranging from embryogenesis to gametogenesis to fertilization. Despite this, several
studies have defined ostensible evolutionary pressures on meiotic recombination to generate and
ensure speciation, namely through the DNA methyltransferase PRDM9 (Smagulova et al., 2016).
In most animals, histone methylation by PRDM9 marks genomic locations for SPO11
breakage, thus locations of meiotic recombination, and downstream crossovers, are determined
by the sequence specificity of PRDM9 zinc finger binding (Paigen and Petkov, 2018).
Interestingly, there exist many of PRDM9 alleles within species, including humans, that bind
distinct DNA sequences (Kono et al., 2014; Buard et al., 2014). Therefore, genomic sites of
meiotic recombination and crossovers are determined by the specific PRDM9 alleles an individual
has. Recent findings demonstrated that symmetric PRDM9 activity between homologous
chromosomes significantly promotes successful meiotic division, and two PRDM9 alleles that
result in widespread asymmetric binding between homologs may lead to sterility (Hinch et al.,
2019). In this way, PRDM9 alleles have proven to be a driver of hybrid sterility in subspecies
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mating and enforces reproductive barriers, ultimately leading to hybrid speciation (Kono et al.,
2014; Buard et al., 2014). Two incompatible alleles will result in failure of meiotic recombination
and meiotic arrest, leading to sterility (Hinch et al., 2019). In fact, PRDM9 is considered to be the
only known speciation gene in mammals for these reasons.
Due to the nature of recombination repair of meiotic DNA damage, loss of heterozygosity
between maternal and paternal chromosomes is expected at sites of SPO11 activity (Keeney,
2008). This may result in the loss of a unique PRDM9 binding sequence on one chromosome (as
it may be replaced by a different binding sequence from the opposite chromosome) and would
prevent that location from future binding of PRDM9 in offspring. This phenomenon, known as
hotspot erosion, is a perplexing evolutionary problem (Tiemann-Boege et al., 2017; Paigen and
Petkov, 2018). For example, gametes will contain one of two parental PRDM9 alleles. If the
binding sites for that allele are eroded (i.e. replaced by binding sequences of the other allele),
then during meiosis in offspring, PRDM9 will not be able to bind chromosomes, recombination will
not be initiated, and gametogenesis will fail. Because of this, numerous (potentially hundreds)
PRDM9 alleles exist within species to counterbalance hotspot erosion. PRDM9 is one of the
fastest evolving genes in humans for this reason, as heavy evolution pressures are exerted to
prevent the dominance, and ultimate erosion, of one PRDM9 binding sequence (Schwartz, et al.,
2014; Grey et al., 2018). This further increases biodiversity in gametes by constantly changing
locations of crossovers within individuals, allowing for vast increases in allele shuffling potential.
Despite these remarkable conclusions of PRDM9 evolution, not all sexually reproducing
organisms have PRDM9. It is exclusive to vertebrate animals, with several notable exceptions,
including amphibians, birds, and dogs (Paigen and Petkov, 2018). In contrast, all sexually
reproducing life, including budding yeast, uses SPO11-induced DNA damage to initiate requisite
meiotic recombination and crossovers (Keeney, 2008). In organisms that lack PRDM9, SPO11
acts at functional genomic elements, such as gene promoters, that also contain the histone
methylation that PRDM9 places on meiotic hotspots (Brick, 2012; Paiano, 2020). Interestingly,
PRDM9 genetic knockout mice also initiate SPO11 damage at gene promoters rather than typical
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meiotic hotspots, yet these breaks are unable to initiate recombination and fail to repair, resulting
in sterility (Mahgoub and Paiano, 2020). While the reason for this is not yet clear, it seems likely
that PRDM9 has additional roles to histone methylation that are critical for proper homologous
chromosome synapsis and segregation. One such important factor may be the chromatin reader
ZCWPW1 (see Chapter 4).
We found that mice lacking ZCWPW1 retain PRDM9 activity and SPO11 cutting at proper
meiotic hotspot locations, yet are unable to repair damage, likely from an inability to engage
homologous chromosomes (Mahgoub and Paiano, 2020). The coordinated activity of PRDM9 and
other protein complexes, potentially including ZCWPW1, may be required for usual recombination
in species that evolved PRDM9. In line with this, those vertebrate species that have lost PRDM9
have also lost ZCWPW1 (see Chapter 4). The strong co-evolution of PRDM9 and ZCWPW1
imply that the two are required for, and potentially deleterious in the absence of, each other.
Much work remains to understand why PRDM9 evolved but likely benefits include those
mentioned above, such as malleability in determining crossover locations and the generation of
reproductive barriers in populations that contribute to speciation.

Maintenance of genetic identity
After fertilization, genetic identity directs cell development and function for the lifespan of
an organism. This requires continuous preservation and readability of DNA sequences to
maintain cell identity and operation. Myriad stressors, both of endogenous and exogenous origin,
regularly threaten this preservation and demand constant cellular monitoring, detection, and
repair. DNA damage is a common stressor that, if not properly handled, can result in wideranging consequences, including genomic instability. The genome of a cell is said to be unstable
if the rate of mutations, especially deleterious mutations, are greater than expected in a given
period of time. This definition presumes (accurately so) that a basal rate of mutations is
anticipated from normal cellular function (Baer et al., 2007). These mutations can arise from
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many sources, including endogenous replication errors or exogenous damaging agents such as
UV radiation. We consider these mutations benign if they occur in noncoding regions or do not
disrupt protein activity. However, these mutations are nonetheless alterations to genetic identity
and can result in genetic heterogeneity and clonality within an organism, even if there are no
phenotypic effects.
We place far greater significance on mutations that create abnormal (especially disease
causing) phenotypes, such as oncogenic driving mutations. Regardless of our definitions of
mutational severity, cells must respond to all types of DNA damage. This begs the question if a
cell can anticipate damage that would result in what we consider deleterious mutations versus
damage with less overall consequence. The answer is yes! Cells have evolved elaborate
pathways of DNA repair that exist explicitly to minimize harm in the repair outcome. Recognition
and repair pathway choice is nontrivial and highly contextualized to engage responses
appropriate to the damage presented.
Many factors influence this decision process, including the genomic location of damage,
such as heterochromatin, actively transcribed genes, telomeres, etc. The genome could be
viewed as a diverse landscape comprising these unique features. Certain regions by nature
necessitate specialized machinery, just as one would not wear skis while mountain climbing. For
example, DNA damage in active genes invokes a form of nucleotide excision repair (NER) known
as transcription-coupled NER (TC-NER) to specifically repair damage on template DNA during
transcription (Fousteri and Mullenders, 2008). TC-NER has been shown to preferentially and
more quickly repair damage on template strands to maintain gene identity (Vrieling et al., 1998).
Non-template or intergenic sequences that do not employ TC-NER may be more prone to
mutagenic repair, perhaps resulting in benign mutations. Chromatin modifications are increasingly
demonstrated to influence repair outcomes as well and provide important environmental
information on what a proper repair outcome should be (Clouaire et al., 2018; Stadler and Richly,
2017; Raschella et al., 2017).
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Additionally important is the cell cycle stage at the time of damage. Cells that are nondividing (G1 and G0 phases) preferentially utilize certain repair pathways over those employed in
dividing cells (S, G2, and M phases) (Hustedt and Durocher, 2016). If the genome is a landscape
of assorted terrain, then cell cycle status could be thought of as day or night, i.e. dividing or nondividing. Many activities done in the day could be very dangerous in the darkness of night.
Climbing a mountain with skis might end up all right if one can easily see where one steps but
likely will have poor outcomes if done after midnight. DNA damage, especially double-strand
breaks (DSBs), in G1/G0 cells are preferentially repaired by nonhomologous end-joining (NHEJ)
pathways that minimally process DSB ends and simply ligate them back together (Hustedt and
Durocher, 2016; Chang et al., 2017). However, S phase cells allow for massive processing of
DSB ends to initiate high-fidelity repair using homologous sister chromatid sequences (Hustedt
and Durocher, 2016; Jasin and Rothstein, 2013). Utilizing NHEJ in S phase is very dangerous
and can lead to many chromosomal aberrations, such as translocations. Conversely, in G1, there
is no homologous sister template, so massive DSB end processing would only prevent repair by
NHEJ. In these ways, and many more, the protein activities on DNA are very much not random
(although an argument can be made for a certain degree of stochastic behavior on a DNA
polymer), and evolution has selected for discrete repair complexes and signaling pathways to
communicate damage in many contexts.
Repair pathways are not the only gatekeepers of genome integrity. Cell cycle checkpoints
and tumor suppressor proteins are also critical in maintaining genetic identity (Chao et al., 2017;
Sherr, 2004; Dasika et al., 1999). At a certain threshold of damage recognition, a cell will pause
its cell cycle progression until repair is largely complete. Many proteins, namely cyclin-dependent
kinases (CDKs), regulate entry into the next phase (Malumbres and Barbacid, 2009; Malumbres,
2014). As discussed above, certain repair pathways, especially those of DSBs, should be
operated only in a specific cycle, such as G1 or S phase. Prolonging phases allows enough time
to properly repair damage and, once alarm signals of damage detection diminish, cells are
permitted to continue cycling (Chao et al., 2017).
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An important checkpoint is the G2-M transition, in which mitosis is delayed until complete
genome duplication is achieved (Lobrich and Jeggo, 2007). This is primarily mediated by active
ATR and CHK1 signaling that prevents the activation of CDK1 and entry into mitosis (Saldivar et
al., 2018). Active replication and DNA damage in S phase signals through CHK1 to suppress
CDK1 until replication is complete and damage is resolved (Sorensen and Sylijuasen, 2012).
Recent studies have shown the role of mitosis in repairing replication-associated abnormalities,
and it is becoming increasingly clear that several mitotic proteins, such as the nucleases MUS81
and GEN1, are beneficial to digest potentially harmful replication intermediate structures that
could hinder chromosome segregation (Sarbajna et al., 2014). In Chapter 2, I discussed data that
further suggest that some sites of replication stress in the human genome may preferentially wait
for mitosis to repair. These are nontrivial points as cancer cells routinely disregard and bypass
checkpoints, especially those associated with replication. This promotes increasing genomic
instability and loss of genetic identity in tumors, even if DNA repair pathways are technically intact
and capable. Ultimately, cells are programmed to sense distinct species of DNA damage but
more importantly adapt their repair pathways to best suit their current status.
While many mechanisms are in place to best ensure genetic identity is maintained, a
critical facet of multicellularity is programmed cell death. Programmed cell death can be greatly
beneficial to the organism and is used to communicate various stresses to surrounding cells
(Fuchs and Steller, 2011). In its simplest form, cells experiencing too much DNA damage to
repair in a timely fashion, even with checkpoint arrest, may undergo p53-mediated apoptosis
(Fridman and Lowe, 2003; Aubrey et al., 2018). In this process, cell death is intentionally induced
in a controlled manner to prevent deleterious tissue outcomes that may harm the organism. If a
severely damaged cell (or many cells) were to continue living within a tissue, disrupted function of
that cell may disrupt the entire organ.
Apoptosis is an interesting mechanism to maintain genetic identity of the organism as a
whole while at the expense of preserving genetic identity in a single cell. In addition to the
evolved capacity to sense DNA damage in a contextual manner, multicellularity has evolved
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further thresholds to determine when damage is uncorrectable and potentially harmful to
surrounding cells, thus threatening the broader organismal identity. The abandonment of genome
repair is particularly palpable in the very process of apoptosis: intentional fragmentation of
chromosomes. Upon apoptosis, DNA is cut into irreparable pieces, starting a metaphorical paper
shredding of genetic identity (Zhang and Xu, 2000; Elmore, 2007). This is just one example of
how tissue integrity is in tune with the genome integrity of individual cells in order to maintain
organismal homeostasis (Zhang and Xu, 2002). The remainder of this chapter discusses how
immune cells mediate many of these types of pathways, demonstrating much interplay of genome
and tissue integrity, and showcases the parallels between immune repair and DNA repair to
maintain biological integrity at multiple scales.

Generation of immunologic identity
I want to reiterate that my definition of immunologic identity here is not to simply describe
mechanisms of self versus non-self discrimination. However, much of what immune cells respond
to are agents that are not genetically encoded in the organism. While far from a novel concept, a
better way of thinking is discrimination between what the immune system is genetically
programmed and actively trained to respond to versus what it is not. For example, innate
immunity, the most ubiquitous and evolutionarily conserved components of immunity, is typically
mediated by short-lived cells that are genetically programmed in their responses (Buchmann,
2014). Pattern recognition receptors (PRRs) bind conserved ligands, such as nucleic acids,
peptides, and a plethora of other biomolecules, that tend to be presented by non-self agents such
as bacteria and viruses (Takeuchi and Akira, 2010). Yet ligands derived from self, such as
intracellular genomic DNA, are equally capable of activating PRRs, and are especially important
in responding to tissue damage and stressed cells (Yu et al., 2010). Moreover, resultant
inflammatory responses after PRR recognition from non-self sources can still result in significant,
sometimes inadvertent, damage to self and temporary alteration of tissue homeostasis (Fonseca
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et al., 2015; Wynn, 2008; Mack, 2018). Thus, there are not always clear boundaries of self versus
non-self targeting during immune responses.
There is heavy evolutionary pressure to respond to PRR ligands, from invertebrates to
humans, because they typically present potential threats to tissue integrity (Mushegian and
Medzhitov, 2001; Janeway et al., 2001; Brennan and Gilmore, 2018; ). Again, I refrain from using
the definitive term “dangerous” because, as discussed above at the level of DNA, life has the
capability to preempt probable threats, yet it does not seem to discern that any individual event
itself is necessarily a danger. For example, DNA damage repair is sometimes directed more by
the context of the damage rather than the damage itself. Because the cell must safeguard against
potentially large, downstream compromises to function, the context of damage, such as cell cycle
or genomic location, can make a DNA break more or less of a threat than the inherent nature of
the lesion itself. Of course, an argument can be made that the contextual promise of a threat is in
fact the very definition of danger. And in many ways, innate immunity requires multiple contextual
inputs to determine the trajectory of a response, similar to DNA repair. While terminology such as
danger can be very helpful, a more mechanistic explanation is required to understand the
discrimination of immune responses. In this way, discussing the generation of immunologic
identity as a result of programmed (i.e. evolutionarily conserved) and trained (i.e. actively
selected and tolerized) responses is more helpful.

Evolutionarily conserved immunologic identity
As already mentioned, innate immunity is the most critical component of the immune
system and is largely evolutionarily conserved across phyla. In fact, most non-mammalian
animals, invertebrates included, rely almost solely on innate immune pathways to maintain tissue
integrity, utilizing both cellular components (e.g. PRRs, phagocytosis) and extracellular
components (e.g. cytokine signaling, complement system activation) (Henneke and Golenbock,
2004; Altan-Bonnet and Mukherjee, 2019; Noris and Remuzzi, 2013). Moreover, numerous
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factors outside of canonical immune function are equally important in maintaining tissue health
and communicating stress, such as extracellular matrix components, hormones, metabolites, and
commensal bacteria (Humphrey et al., 2014; Garcia-Leme and Farsky, 1993; Straub, 2014;
Arpaia and Rudensky, 2014; Artis, 2008). Defining immunity by the capacity to maintain
multicellular integrity inherently broadens the scope of what we historically consider immune cells
and signaling components, traditionally hematopoietic cells and cytokines.
Innate immunity is not alone in genetically programmed responses, as some adaptive
immunity represents evolutionary conservation as well. Natural antibodies circulate blood without
prior exposure and are considered almost innate-like in their ability to recognize bacterial
components (Holodick et al., 2017). These genetically programmed antibodies, with limited
repertoire range, are secreted as a baseline serum defense against pathogens. In mice, B1 cells,
a separate B lymphocyte lineage developmentally independent of bone marrow-derived B2 cells
that constitute canonical antibody responses, represent a population of cells with minimal
receptor repertoire with moderate preference for conserved ligands, such as bacteria (Morris et
al., 2019; Aziz et al., 2015). While their existence in humans remains controversial, B1 cells are
proposed to aid clearance of apoptotic cells in tissues to prevent autoimmune recognition
(Baumgarth, 2011). Some unconventional T lymphocyte populations, such as natural killer T
cells, MAIT cells, and gamma delta T cells, exhibit PRR-like recognition of their invariant T cell
receptors (Chiba et al., 2018; Krovi and Gapin, 2018; Chien et al., 2014). Additionally, several
classes of innate lymphoid cells (ILCs) have been discovered to mediate tissue homeostasis
particularly at barrier surfaces (Klose and Artis, 2020). ILCs do not express antigen receptors,
although developmentally derived from lymphoid lineages, and are indeed innate-like in function
(Diefenback et al., 2014). These few examples illustrate that evolutionary conservation of
immunity is not limited to canonical innate pathways, such as myeloid cells. Much of the immune
system, including in humans, is predefined by genetic identity. Thus, DNA repair of genetic
identity is a critical, intertwined component of establishing immunologic identity to repair tissues.
That said, there are several very important exceptions in immunity that do not simply follow
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genetic code; however, DNA repair is an integral aspect for the rules that these immune cells
adhere to.

Modulation of genetic identity to generate adaptive immunologic identity
Conventional B and T lymphocytes remain in a naïve, quiescent state until encounter with
their cognate antigen. Specific recognition by the B cell (BCR) or T cell (TCR) receptor, along with
co-receptor stimulation, induces activation programs and initiates adaptive immune responses
(Janeway, 2001). This system requires an incredibly vast capacity to bind virtually any antigen
presented. Genomes are not large enough to directly equip lymphocytes with all possible receptor
binding combinations. Instead, lymphocyte development is programmed to rearrange the genetic
sequence of the BCR and TCR to generate clonal specificity in antigen recognition. This diversity
is accomplished in a manner not very dissimilar to SPO11 during meiotic division. RAG nucleases
introduce DSBs at specific antigen receptor genomic loci. In a process known as V(D)J
recombination, RAG DSBs are uniquely repaired to create new combinations of V, D, and J
segments that constitute lymphocyte receptors (Jung and Alt, 2004). This results in a permanent
alteration of genetic identity that is specific to a single lymphocyte. Thus, lymphocytes as a
population represent a tremendous mosaicism of receptor gene identities that is engineered by
intentional DNA damage and repair during development. B lymphocytes, if activated by antigen,
will continue to mutate their receptor binding sequences in a process called somatic
hypermutation (SHM) (Maul and Gearhart, 2010). SHM is initiated by AID-induced DNA damage
that yield (mostly) beneficial mutagenic outcomes during B lymphocyte expansion. This process
further ensures that only the most specific antibody will be lastingly produced. While lymphocyte
recognition is not directly encoded by the genome, alterations of genetic identity through DNA
damage and repair are required to generate diversity through mutations.
As discussed earlier, meiotic DSBs are purposefully induced at specific locations to
promote biodiversity in the next generation. Adaptive immune cells operate similarly through
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calculated mutagenic DNA repair to produce massive diversification within an organism. At this
level, immunologic identity, particularly in higher vertebrate species, has evolutionarily coopted
DNA repair pathways to make a more specific immune system that better maintains tissue
integrity. There are of course inherent risks with intentional mutagenesis, and lymphomas have
been linked to improper activity of RAG and AID, but, overall, the organismal benefits far
outweigh the hazards (Haines et al., 2006; Greeve et al., 2003). It is important to emphasize that
the rearrangement of antigen receptors is developmentally encoded by genes, and that V(D)J
recombination is not an example of immune activity per se altering genetic makeup. It is actually
genetic identity altering itself through immune cells for the benefit of multicellularity. There are,
however, many examples of direct consequences to immunologic and genetic identity when the
two intersect in function (Palmai-Pallag and Bachrati, 2014).

Intersection of genetic and immunologic identities
The simplest intersections are examples of DNA damage influencing immune function
and immune function affecting genomic health. While V(D)J rearrangements seem like a case of
the latter, the produced DNA damage is developmentally programmed and not a consequence of
immunity per se. B lymphocyte SHM is a better example, as AID mutations are a result of B cell
activation and antigen recognition. A better example is the generation of reactive oxygen (ROS)
and nitrogen (NOS) species during inflammation. Innate immune cells routinely produce
ROS/NOS to kill pathogens and communicate (Mittal et al., 2014; Nathan and CunninghamBussel, 2013). However, ROS/NOS are well known DNA damaging agents, and local production
in a tissue can injure host DNA and cause inadvertent mutagenesis (Canli et al., 2017; Kay et al.,
2019).
Another example is the high demand for cell proliferation during an immune response. As
discussed in Chapter 2, increased DNA replication stress can challenge a cell’s ability to faithfully
duplicate its genome per division and could result in several deleterious mutations. Rapidly
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dividing lymphocytes must handle the proliferation stress, which can be exceptionally tricky for B
cells, as AID contributes DNA damage with each round of division in a germinal center reaction.
Additionally, hematopoietic stem cells and other immune cell progenitors must balance increasing
replication demand with minimal genomic instability, as they must self-renew and remain longlived (Schuettpelz and Link, 2013; Ruzankina and Brown, 2007).
There are many well-characterized examples of DNA damage influencing immune
responses. Prominently researched now is the intracellular recognition of broken host DNA in the
cytoplasm by cGAS-STING and the subsequent innate immune activation (Li and Chen, 2018).
Involved in the detection of pathogenic DNA within a cell, recognition of self DNA by cGASSTING has major implications for cancer, cellular senescence, and autoimmunity (Harding et al.,
2017; Mackenzie et al., 2017; Dou et al., 2017; Gao et al., 2015). Other studies have more
generally linked the presence of DNA damage in innate immune cells to more primed and
effective inflammatory responses, perhaps through intracellular signaling crosstalk between DNA
lesions and immune recognition (Hartlova et al., 2015; Chatzinikolaou et al., 2014; Nakad and
Schumacher, 2016). To produce more efficacious anti-tumor therapies, much research is
underway to identify neoantigens within tumors that can be targeted by host immune cells and
allow for cancer vaccinations (Schumacher et al., 2019; Peng et al., 2019). Neoantigens are new
antigenic peptide sequences that are not selected against during T cell development. These “nonself” sequences would theoretically be recognized by T cells during vaccination to eliminate tumor
cells. The intrinsic genomic instability of cancer cells confers mutations that generate
neoantigens. In this way, loss of genetic identity can help immunologic identity preserve tissue
function.
While these are beneficial examples, DNA damage is not always helpful to immunity.
Damage-induced cell death can have deleterious consequences for immunologic identity, as
dead cell components, such as released DNA, can be recognized by immune cells and trigger
autoimmunity (Clemens et al., 2000; Lleo et al., 2008). Antibodies reactive to self DNA are
commonly observed in autoimmune conditions, such as systemic lupus erythematosus (Wang
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and Xia, 2019). While apoptosis is generally considered nonimmunogenic (i.e. will not mount an
immune response), several forms of cell death are highly immunogenic, such as pyroptosis and
necroptosis, and could theoretically stimulate autoimmunity and degenerative diseases through
self-recognition (Galluzi et al., 2017; Ma et al., 2018). Neutrophils are an interesting example of
the interplay of immunity, cell death, and DNA damage. Neutrophil activation, which usually
always results in cell death, can trigger a process called NETosis, in which the DNA is actively
fragmented and expelled from the cell to trap pathogens in net-like, extracellular snares
(Papayannopoulous, 2018; Iba et al., 2013). While DNA damage is weaponized to clear
infections, the presence of these extracellular DNA nets may also be instigators of autoimmune
reactions and other tissue malfunctions, such as kidney disease (Darrah and Andrade, 2013;
Salazar-Gonzalez et al., 2019).

Final thoughts
In summary, DNA damage and the maintenance of genetic identity has been
evolutionarily tied to immunologic identity and maintenance of tissue integrity. Both exist as
means to establish, preserve, and modulate organismal identity at the unicellular and multicellular
levels. The many intersections of DNA repair and immune pathways highlight both the mutuality
and interference that exist between the health of the genome and the health of the tissue.
Moreover, immunity repairs tissues in biologically thematic parallels to the repair of DNA. Both
heavily rely on contextual signals accompanying a potential threat to interpret the severity (or
danger). Recognition begins broadly and gradually specifies repair components as more
information is attained. Importantly, more harm to DNA or the tissue is intentionally induced to
control the environment surrounding the insult, such as the nuclease digestion of DSBs and the
localized inflammatory conditions within an organ. Above all, communication and systematic
feedback are key to ensure fast and appropriate responses. DNA repair complexes use posttranslational modifications, such as protein phosphorylation, sumoylation, and ubiquitylation, to
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communicate with each other at sites of damage (Oberle and Blattner, 2010). Analogously,
immune cells receive cytokines, hormones, metabolites, and antibodies to communicate locations
and status of repair.
Ultimately, the end result of both DNA and immune repair should be more advantageous
for the organism than if repair had not occurred at all. While that is typically the case, numerous
scenarios are possible in which repair can yield more disadvantages for organismal health.
Improper or incomplete repair of DNA can trigger mutational outcomes that are potentially more
disastrous than if repair did not take place. For example, oncogenic transformations that lead to
tumor formation are potentially worse outcomes for the organism than if repair did not occur or
apoptosis was induced. Improper immune recognition can lead to autoimmune and
autoinflammatory conditions that pose significant threats to organismal homeostasis. Even if
repair does not result in aberrant, deleterious conditions, proper repair events commonly leave
minor complications behind that, on their own, may not pose danger; however, accretion of these
minor consequences can. Less severe DNA mutations, such as indels and copy number
variations, may not cause imminent concern for cellular health, but the accumulation of these
events can influence later outcomes. Likewise, tissue remodeling and scarring associated with
immune activity can accrue over time and severely affect organ function.
These are very important considerations when addressing aged populations.
Accumulation of damage and repair byproducts, at both the DNA and tissue level, can result in
some of the multifaceted disease phenotypes associated with aging. From an evolutionary
perspective, DNA and immune repair may exist to maintain biological identity, but as lifetime
extends beyond prime reproductive age, less evolutionary pressure exists to maintain this
identity. Thus, unintentional consequences of repair likely will not affect younger populations, as
evolution would select against those types of repair that do. However, little pressure may exist to
limit the accrual of these consequences over a lifetime.
A great example of this is cellular senescence. Considered a case of antagonistic
pleiotropy, senescent pathways are critical during embryogenesis to communicate cell clearance

127

as tissue development (Munoz-Espin et al., 2013; Munoz-Espin and Serrano, 2014). This is
accomplished through many cytokine and extracellular matrix remodeling pathways, known
collectively as the senescence-associated secretory phenotype (SASP) (Coppe et al., 2010;
Salama et al., 2014). In adult tissues, multiple genomic stressors, such as chronic DNA damage
or telomere dysfunction, can trigger senescence to recruit immune cell-mediated repair and
maintain tissue homeostasis. In aged tissues, however, the accumulation of senescent cells,
through persistent stress signaling, can lead to chronic inflammation that drives many ageassociated diseases, such as cancer and degeneration (Coppe et al., 2010; Campisi, 2013).
Therefore, senescence has pleiotropic functions in early and late life, the latter being more
detrimental to the organism and thus considered antagonistic. It is thought that the lack of
evolutionary pressures in aged organisms allows for a typically beneficial pathway in young
organisms to inadvertently cause harm with time (Williams, 1957).
As humans continue to extend lifespan, we are faced with many medical problems
associated with age. While DNA and immune repair exist to help us early in life, these
mechanisms are in some ways a disservice as we grow older. The onus will be on us to develop
technological and therapeutic advances that replace the functions of these evolutionary pathways
in order maintain longevity beyond what natural selection can act upon. The first step to
conceiving these advancements is to discern how evolution has built a maintenance system (i.e.
DNA repair and immunity) for multicellularity to thrive. Once we understand this, then we can
fundamentally replace and improve upon these systems to extend an intact biological identity as
long as possible.
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